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Traumatic brain injury (TBI) is a major cause of death and long-term disability worldwide. It
is elicited by an external force injuring the brain, and leads to two phases of neuronal cell death:
primary cell death, resulting from direct mechanical disruption of the tissue, and secondary cell
death, caused by delayed cytotoxic cascades. While primary cell death can only be prevented by
avoiding physical injury, secondary cell death occurs within hours to weeks following the initial injury
and therefore lies within a therapeutic window during which pharmacological agents targeting the
pathomechanisms of TBI could be applied. Pre-clinical models of brain injury in rodents have identi-
fied several neuroprotective compounds, but not a single drug has shown improved patient outcome
over placebo in multi-centre phase III clinical trials. Intriguingly, the largest randomised controlled
trial for TBI to date reported a higher mortality in patients treated with an immunosuppressive
drug compared to patients treated with placebo, suggesting that the immune system may play a
neuroprotective role following brain injuries.
To investigate the role of the immune system in more detail, I developed a model of brain injury
in larval zebrafish. Larval zebrafish are amenable to genetic and pharmacological manipulation, and
their optical transparency in combination with the availability of a multitude of transgenic reporter
lines allows for efficient in vivo (timelapse) microscopy. This allowed me to visualise the cellular and
molecular reactions to brain injury in real-time in a living vertebrate organism, which provided an
advantage compared to the majority of studies so far, which had been done either in rodents with
static end points, or in vitro.
Characterisation of cell death dynamics revealed that larval zebrafish reproducibly exhibit
primary and secondary cell death following brain injury. In line with mammalian TBI models, I
demonstrated that excitotoxicity contributes to secondary cell death. Furthermore, I described early
calcium waves in reponse to injury that may instruct repair mechanisms; using pharmacological
agents, I identified the release of glutamate, acting on neurons surrounding the injury site, and
ATP, acting predominantly on glial cells, as the upstream mechanisms of calcium waves. In contrast
to observations in rodent models and human TBI patients, I observed little infiltration of periph-
eral macrophages or neutrophils. Microglia, the resident immune cells of the brain, were rapidly
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recruited to the injury site and significantly increased their phagocytic activity upon injury. Inhibi-
tion of microglial phagocytosis by targeting phosphatidyl serine receptors either pharmacologically
or genetically via CRISPR/Cas9-mediated gene editing resulted in a significant increase in the rate
of secondary cell death. This result demonstrated a role for rapid phagocytosis of debris in limit-
ing the extent of secondary cell death, and suggested an overall neuroprotective role for microglial
phagocytosis. Probing into the transcriptome of microglia/macrophages following injury using RNA
sequencing of sorted cells revealed profound transcriptomic changes within two hours of injury, and
will aid the future investigation of the role of microglia in neuroprotection.
To summarise, this body of work provides evidence for a neuroprotective role of microglia in
a new larval zebrafish model of brain injury, and the transcriptomic analysis will form the basis of
a more in-depth study of microglia-derived neuroprotective molecules. Using CRISPR/Cas9-guided
mutation of genes of interest in larval zebrafish, we will be able to investigate the role of these genes
following injury in microglia-mediated neuroprotection. Following further validation, these findings
could potentially be exploited for prevention of secondary cell death after human TBI.
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Lay summary
Traumatic brain injury (TBI), defined as injury to the brain caused by external force, is a major
cause of death and disability worldwide. TBI can lead to a significant loss of nerve cells, or neurons,
which occurs in two phases following injury: primary cell death, caused directly by physical damage,
and secondary cell death, which happens in a delayed manner in the minutes to weeks following
injury and is caused by cellular processes that are harmful to neuronal survival. It is thought that
targeting delayed cellular processes could potentially prevent secondary neuronal cell death, and
research in rodents has been aimed at understanding these harmful mechanisms and how to inhibit
them. However, no pharmacological compound was able to improve the outcome of patients fol-
lowing TBI in clinical trials compared to placebo so far, indicating that further research is required
in order to understand and treat secondary cell death. Recently, cells of the immune system are
of particular interest, as they have been implicated in protecting neurons following stroke, and the
largest clinical TBI trial to date showed that more patients died after receiving a drug inhibiting
the immune system. In my thesis, I aimed to investigate the role of immune cells, in particular
microglia, which are specialised immune cells in the brain, after brain injury.
For this purpose, I developed a new model of brain injury in larval zebrafish. Zebrafish are
native to Nepal, but have been used in laboratories all over the world for several decades. Despite
sharing 80% of disease-related genes with humans, zebrafish - unlike humans - have the remark-
able capacity to restore function following injury in many organs, including the heart, brain, and
spinal cord. Zebrafish develop rapidly and have a functional nervous system within three to four
days after being born. At this time, called the larval stage, they are transparent. Researchers have
established several fish lines to label distinct cell types or molecules in these fish with fluorescent
markers that emit light when activated with a certain laser; in combination with the transparency
of the larval zebrafish, we are therefore able to visualise cellular and molecular processes in these
fish under the microscope in real-time. This provides a significant advantage over the use of ro-
dents, where real-time microcopy in living animals proves significantly more challenging and invasive.
With my experiments, I could show that zebrafish, similar to humans, experience both primary
(direct) and secondary (indirect) cell death in response to injury. Using real-time microscopy, I found
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that microglia - the resident immune cells of the brain - are rapidly recruited to the site of injury and
remove cells damaged by the injury. As damaged or dead cells can release toxic substances to their
neighbouring cells and thereby harm them, I hypothesised that their clearance by microglia could
reduce the occurrence of secondary cell death following brain injury. I tested this by inhibiting the
clearance process either by application of a pharmacological compound, or genetic modification of
the larvae, and found clearance of debris indeed limited the rate at which cells die following an injury,
suggesting a neuroprotective role for this process. Furthermore, I performed an in-depth analysis
of changes in the genetic profile of microglia following brain injury, which revealed that the injury
induced the production of certain molecules which have been previously implicated in promoting
neuronal survival.
Taken together, this body of work provides an insight into the dynamic function of microglia
following brain injury, and will form the foundation of further investigations of microglia-derived
neuroprotective molecules that could be used as therapeutic approaches for patients with TBI.
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1.1 Schematic of some of the pathophysiological molecular and cellular mecha-
nisms occurring following traumatic brain injury. Not to scale; schematic created
by me. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23
1.2 Clinical trials in TBI since 1980. Multi-centre phase III RCTs for traumatic brain
injury plotted for initiation and success (defined as benefit over placebo). Modified
from Maas et al. (2010). * 1 RCT initiated in 2014 has not reported results yet. . . . . . . . 24
4.1 Description of the injury assay. (A) Schematic of the dorsal view of the larval ze-
brafish outlining forebrain (FB), optic tectum (OT), and hindbrain (HB). The site of
injury is indicated by a drawing of the needle. (B) Representative brightfield images
of a larva before and during injury. (C) Quantification of fractions of normal larvae,
larvae with haemorrhage, and dead larvae following injury in 6 different biological
replicates with a total n of 1075. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
4.2 Mechanical injury leads to rapid cell death as monitored by of PI uptake.
(A) Mechanical injury results in a prompt uptake of PI. Scale bar, 50 µm. (B)
Quantification of PI+ cells after mechanical injury. Dashed line indicates time of
injury. n ≥ 6 animals per experimental group. . . . . . . . . . . . . . . . . . . . . . 60
4.3 PI+ cells display morphological characteristics of necrosis immediately after
injury, and of apoptosis hours later. (A, B) The diameter of PI+ cells (arrow-
heads) is not significantly different from viable cell nuclei (H2A:GFP) at 0 hpi. Scale
bar, 10 µm. Values are the average of at least 10 PI+ and H2A:GFP+ cells in one op-
tical section per animal. n = 5; p > 0.999 in Mann-Whitney Test. (C, D) At 6 hpi,
the diameter of PI+ cells (arrowheads) is significantly smaller than that of viable cell
nuclei. Scale bar, 10 µm. Values are the average of at least 10 PI+ and H2A:GFP+
cells in one optical section per animal. n ≥ 5; p ≤ 0.005 in Mann-Whitney Test. . . 61
XV
4.4 Mechanical brain injury leads to delayed nuclear condensation peaking at 6
hpi. (A) Overview and close-ups of tectum in H2A:GFP transgenic animals before,
and at 0, 6, and 24 hpi. Scale bar, 50 or 5 µm, respectively. (B) Close-up of a
pyknotic nucleus with the Fire LUT (ImageJ), showing the distinct difference in size
and intensity of pyknotic nuclei compared with surrounding normal nuclei. Scale
bar, 5 µm. (C) Quantification of pyknotic nuclei present in entire tectum following
injury. Dotted vertical line indicates time of injury. n ≥ 6 animals per timepoint.
(D) Heat map illustrating the spread of secondary cell death throughout the tectum
in the hours following injury. XY coordinates of pyknotic nuclei from representative
animals at varying timepoints following injury were plotted in 2D using the Matlab
Scattercloud function. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 62
4.5 Cells with radial glial and microglial morphology take up PI, but survive long
after the injury. (A) Cells with radial glial morphology at 6 hpi and 48 hpi do not
appear condensed, but have PI in their cytoplasm. Arrowheads are pointing towards
cell bodies of radial glia. Scale bar, 15 µm. (B) At 6 hpi, large aggregations of PI+
debris were often present. Based on the size of these aggregates (larger than normal
neurons), these are likely microglia that have taken up PI+ cells but not yet degraded
them. At 48 hpi, some microglia and their processes appear PI+. Arrowheads are
pointing to microglial cell bodies. Scale bar, 15 µm. (C) Ventricular injection of P2X
subtype receptor inhibitor iso-PPADS ablates radial glial uptake of PI (6/6 animals).
Images shown taken at 6 hpi in either vehicle (Calcium-free Ringer solution) or iso-
PPADS injected larvae bathed in propidium iodide. Scale bar, 15 µm. . . . . . . . . 64
4.6 Occurrence of apoptosis following brain injury is confirmed in an apoptosis
reporter line and through Caspase-3 immunostaining. (A) Apoptotic cell death
takes place in the hours after mechanical injury as shown by an increase in the number
of cells externalising phosphatidylserine. Scale bar, 50 µm. (B) Immunostaining for
cleaved Caspase-3 shows a delayed increase in apoptosis after injury. 50 µm. (C)
Quantification of Annexin 5+ cells. n 12 animals per experimental group. *, p
< 0.05 in two-way ANOVA. (D) Quantification of cleaved Caspase-3+ cells. n 6
animals per experimental group. *, p < 0.05 in two-way ANOVA. . . . . . . . . . . 65
4.7 In vivo imaging of individual tectal neurons shows that both primary and
secondary cell death occur after brain injury. (A, C, E) Confocal images of
the optic tectum of H2A:GFP transgenic animals. A small number of tectal neurons
in the ipsilateral (A) or contralateral (C, E) hemisphere were mosaically labelled
through injection of elavl3 :memTdTomato plasmid DNA. Scale bars, 50 µm (B, D,
F) Close-up of neurons indicated in (A), (C) and (E). White arrow indicates pyknotic
nucleus. Scale bars, 10 µm. Data obtained and analysed by Dr. Leah Herrgen. . . . 67
XVI
4.8 The majority of apoptotic cells are neurons. (A, B) Most apoptotic cells in
control animals (A) and in injured animals at 6 hpi (B) colocalise with a neuronal
marker NBT (arrowheads). Scale bars, 10 µm. (C, D) Most apoptotic cells in control
animals (C) and in injured animals at 6 hpi (D) colocalise with a neuronal marker
elavl3 (arrowheads). Scale bars, 10 µm. (E) Quantification of Annexin 5-BFP+ and
dsRed+/Annexin 5-BFP+ cells in control and injured animals. n = 6 animals per
experimental group. (F) Quantification of Annexin 5+ and kaede+/Annexin 5+ cells
in control and injured animals. n = 6 animals per experimental group. . . . . . . . . 68
5.1 Injury, but not compression of the brain leads to long-range calcium waves.
(A, B) Representative images taken −10 s, 6 s, or 20 s after compression (A) or
mechanical injury (B) of the optic tectum in β-actin:GCaMP6f transgenic larvae.
Magenta arrowhead in (A) shows site of compression. Arrowheads in (A) (+ 6 s)
show sites of calcium activation in the skin. Magenta circle in (B) highlights cell
body activation surrounding injury site (+6 s), arrowheads show potential activation
of radial glial cells (+ 20 s). i Figures correspond to supplementary movies S1
(compression, A), and S2 (injury, B). . . . . . . . . . . . . . . . . . . . . . . . . . . 78
5.2 Calcium waves occur in cells expressing neuronal and radial glial markers.
Crossbreeding of β-actin:GCaMP6s animals with neuronal and radial glial marker
animals revealed that calcium waves occur in NBT+ cells expressing dsRed (A, ar-
rowheads), and her4.3+ cells expressing mCherry lining the ventricle (B, arrowheads).
These waves are spatially and temporally overlapping, but radial glial waves occur
slightly later than neuronal waves. Scale bar, 20 µm. . . . . . . . . . . . . . . . . . 79
5.3 Pharmacological inhibitors reveal a key role for NMDA receptors in the neu-
ronal calcium wave in response to injury, while ATP receptors are crucial
for the glial wave. (A-H) Representative images for each treatment (Vehicle,
MK801+AP5, DNQX, PPADS, iso-PPADS, Ononetin, CBX, and FFA) at 10 s fol-
lowing injury. Scale bar, 50 µm. (I) Quantification of neuronal wave intensity as
percentage of vehicle-injected controls on the same day. (J) Quantification of neu-
ronal wave area as percentage of vehicle-injected controls on the same day. (K)
Quantification of radial glial wave intensity as percentage of vehicle-injected con-
trols on the same day. (L) Quantification of radial glial wave area as percentage
of vehicle-injected controls on the same day. (M) Quantification of calcium wave
velocity as percentage of vehicle-injected controls on the same day. **, p ≤ 0.01;
*, p ≤ 0.05 in Student’s t Test. MK-801/AP5, n = 6; DNQX, n = 14; PPADS, n
= 6; iso-PPADS, n = 5; Ononetin, n = 11; CBX, n = 6; FFA, n = 6. i Figure
corresponds to supplementary movie S3. . . . . . . . . . . . . . . . . . . . . . . . 82
XVII
5.4 Injection of ATP or Glutamate leads to calcium waves similar to observed
after injury. Pregnenolone sulfate, an activator of TRPM3 channels, lead to
no changes in calcium activity. Images taken 6 s after injection of calcium-free
Ringer solution (vehicle), 5 mM ATP, 10 mM L-Glutamate, 0.45 mM Pregnenolone
Sulfate in β-actin:GCaMP6f larvae. . . . . . . . . . . . . . . . . . . . . . . . . . . . 83
5.5 MK801+AP5 inhibition of calcium signalling lasts for at least 1 h, while
PPADS lasts for less than 40 min and reduces recruitment of mpeg1+ cells
to the injury site. (A) Treatment with MK801+AP5 (ventricular injection) sig-
nificantly reduces neuronal wave intensity for at least 60 min following injury. *, p
≤ 0.05 in Kruskal-Wallis Test with Dunn’s post-test. n ≥ 3 animals / group. (B)
Treatment with PPADS (ventricular injection) inhibits radial glial wave area for less
than 40 min. **, p ≤ 0.01 in Kruskal-Wallis Test with Dunn’s post-test. n ≥ 4
animals / group. (C) Injection of PPADS leads to a significant reduction in the
number of mpeg1+ cells at the site of brain injury at 2 hpi, but did not lead to a
decrease in the overall number of mpeg1+ cells in tectum and skin (D) (i.e., does
not cause microglia/macrophage cell death). . . . . . . . . . . . . . . . . . . . . . . 85
5.6 Ventricular injection of BAPTA-AM 2 h prior to injury leads to significant re-
duction of neuronal and glial waves but solvent causes microglia/macrophage
changes. (A) Quantification of calcium wave parameters as % of control values.
**, p ≤ 0.01 in Student’s t-Test or Mann-Whitney Test, respectively. n ≥ 6 animals
/ group. (B) Representative images of mpeg1:GFP transgenic larvae 2 h post injec-
tion of Ca2+-free Ringer’s, Pluronic/DMSO, and BAPTA-AM (in Pluronic/DMSO),
including zoom on mpeg1+ cells on the right hand side. BAPTA-AM appears to
cause a reduction in number of mpeg1+ cells (not quantified) and more amoeboid
morphology. Scale bars, 50 µm (left), 15 µm (right). . . . . . . . . . . . . . . . . . . 86
5.7 Ventricular injection of BAPTA tetrasodium salt leads to significant reduction
to neuronal and radial glial wave area but not intensity. Quantification of
neuronal and radial glial wave intensity and area relative to control values. **, p ≤
0.01 in Student’s t-Test. n ≥ 5 animals / group. . . . . . . . . . . . . . . . . . . . 87
XVIII
5.8 Calcium transients are significantly increased for at least 6 hpi, and are in-
creased in both neurons and microglia/macrophages. (A, B) Live imaging of
calcium dynamics in the optic tectum of β-actin:GCaMP6f larvae in a sham animal
(A) and an injured animal at 0 hpi (B). White arrows indicate individual tectal cells.
Scale bars, 20 µm.(C, D) Calcium traces from the individual tectal cells highlighted
in (A) and (B). (E) Quantification of calcium transients in the whole tectum over
30 min from indicated time. **, p <0.01 in Two-Way ANOVA. n = 6 / group. (F)
Quantification of calcium transients in sham or injured animals (0 hpi) in NBT :dsRed
or mpeg1 :mCherry+ cells. **, p <0.01 in One-Way ANOVA. n ≥ 6 / group. Data
in (E) and (F) collected and analysed by Laura Pons. . . . . . . . . . . . . . . . . . 88
5.9 Pyknotic cell death occurs in regions of high calcium activity. Heatmaps of
calcium transients and pyknotic nuclei in 6 larvae. Calcium transients were quantified
between 2-3 h post injury, while pyknotic nuclei were quantified at 3 h post injury. . . 89
5.10 Treatment with NMDA receptor antagonists MK801 and AP5 abolishes injury-
induced sustained increase in calcium signalling and reduces secondary cell
death at 6 hpi. Treatment with NMDA receptor inhibitor mix MK801 and AP5 sig-
nificantly reduced calcium transients both immediately (A), and at 6 hpi (B) while
not affecting transients in sham animals. **, p ≤ 0.01 in Two-Way ANOVA. n ≥ 6
animals / group. (C) Representative close-up images of vehicle- or MK801+AP5-
treated H2A:GFP larvae at 6 hpi. Arrowheads are pointing at pyknotic nuclei. Scale
bar, 25 µm. Experiment performed and images acquired by Laura Pons. (D) Repre-
sentative close-up images of vehicle- or MK801+AP5-treated larvae stained with PI
at 0 hpi. Arrowheads are pointing at PI+ cells. Scale bar, 20 µm. (E) Quantification
of pyknotic nuclei in whole tectum of vehicle- or MK801+AP5-treated H2A:GFP
larvae (sham or 6 hpi). **, p ≤ 0.01 in Two-Way ANOVA. n = 6 animals / group.
(F) Quantification of PI+ cells in whole tectum of vehicle- or MK801+AP5-treated
animals (sham or 0 hpi). ns in Two-Way ANOVA. n ≥ 6 animals / group. . . . . . . 91
5.11 Treatment with NMDA receptor agonist L-glutamate causes a significant
increase of secondary cell death at 6 hpi. (A) Representative close-up images
of vehicle- or L-Glutamate-treated H2A:GFP larvae at 6 hpi. Arrows are pointing at
pyknotic nuclei. Scale bar, 25 µm. (B) Quantification of pyknotic nuclei in whole
tectum of vehicle- or L-glutamate-treated H2A:GFP larvae (sham or 6 hpi). **, p ≤
0.01 in Two-Way ANOVA. n = 6 animals / group. . . . . . . . . . . . . . . . . . . 92
5.12 Schematic of factors eliciting early and sustained calcium signalling following
mechanic injury. Magenta and green ellipses depict dead or healthy neurons, re-
spectively, and mechanisms inducing early and sustained calcium signalling following
injury are illustrated. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 97
XIX
6.1 Cells expressing the microglia/macrophage marker mpeg1 migrate to the site
of injury. Images taken before, 1, and 2 hours post injury from the same animal.
PI is indicating presence of dead cells. Scale bar, 50 µm In the lower right panel:
quantification of mpeg1+ cells at site of brain injury, excluding cells on the skin. n
= 6 animals. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 101
6.2 mpeg1+ cells change their behaviour from sedentary surveillance to respon-
sive migration in the first two hours following injury. (A) Traces visualiz-
ing mpeg1+ cell body movement before and 2 hpi. (B) Quantification of average
mpeg1+ cell body migration speed. **, p = 0.0011 in paired t test; n = 8 animals.
(C) Quantification of average mpeg1+ cell net displacement before and after injury.
**, p = 0.0001 in paired t test; n = 8 animals. i Figure corresponds to movies
S4 (A, before) and S5 (B, injured). . . . . . . . . . . . . . . . . . . . . . . . . . . 102
6.3 Virtually all macrophages recruited to the injury site express microglial mark-
ers P2Y12 or 4C4. A Representative images of mpeg1 :mCherry;p2y12:P2Y12-GFP
transgenic larvae at 6 hpi. Yellow arrows indicate microglia (P2Y12
+/mpeg1+ or
mpeg1-), blue arrows indicate immune cells on skin (P2Y12
+ or P2Y12
-/mpeg1+).
Scale bar, 40 µm. (B) Images of the brain injury site acquired at 6 hpi. Orange
arrows point to microglia (4C4+/GFP+ or GFP-), blue arrow points to macrophages
(4C4-/GFP+). Scale bar, 25 µm. (C) Images acquired from the spinal cord showing
microglial cell (orange arrow; 4C4+/GFP+) in spinal cord region and macrophages
(blue arrow; 4C4-/GFP+) in rest of the trunk. Scale bar, 25 µm. (D) Quantification
of microglia and macrophages at the injury site in mpeg1 :mCherry;p2y12:P2Y12-
GFP transgenic larvae. n = 6 animals per experimental group. (E) Quantification
of microglia and macrophages at the injury site using immunohistochemistry agains
4C4. n = 9. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
6.4 Traces visualising past cell body displacement of skin macrophages which do
not enter the brain. Traces showing past cell body displacement of mpeg1 :GFP+
cell within 2 hpi. Quantification of immune cell transitions during 2 h after injury. n
= 7 animals per experimental group. . . . . . . . . . . . . . . . . . . . . . . . . . . 105
6.5 Very few neutrophils are recruited to the brain injury. Representative images
of mpo:GFP transgenic larvae before, 1, 2, or 6 hpi. Magenta arrow indicates injury
site. Scale bar, 50 µm. Adjacent: quantification of mpo+ cells at the site of injury
(skin or brain). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
XX
6.6 irf8-/- mutants lacking microglia and macrophages exhibit increased numbers
of (secondary) cell death following brain injury. (A) Representative images
of a wild type and irf8-/- animal at 6 hpi labelled with PI bath application. Scale
bar, 50 µm. (B) Quantification of PI+ cells following injury. Significance relates to
wild type animals of respective treatment. **, p ≤ 0.01 in Two-Way ANOVA. (C)
Representative images of pyknotic nuclei in a wild type and irf8-/- animal at 6 hpi.
Scale bar, 50 µm. (D) Quantification of pyknotic nuclei following injury. Significance
relates to sham animals of respective genotype. **, p ≤ 0.01 in Two-Way ANOVA.
(E) Representative images of cleaved Caspase-3 immunostaining in a wild type and
irf8-/- animal at 6 hpi. Scale bar, 50 µm. (F) Quantification of cleaved Caspase-
3+ cells following injury. Significance relates to wild type animals of respective
treatment. *, p ≤ 0.05; **, p ≤ 0.01 in Two-Way ANOVA. . . . . . . . . . . . . . 107
6.7 Myeloid peroxidase (mpo) immunoreactive cells in are found in the tectum
of irf8-/-, but not wild type animals, and are increased at 6 hours post injury.
Scale bar, 50 µm. Quantification of mpo+ cells at site of injury (brain and skin)
before, 6, 24, and 48 hpi. Significance relates to wild type sham animals. **, p ≤
0.01 in Two-Way ANOVA with Bonferroni Post-Test. n ≥ 5 animals / timepoint. . . 108
6.8 Changes in cytokine and neurotrophic factor transcript levels elicited by injury
are altered in irf8-/- mutants. Relative quantification of mRNA transcript levels via
qRT-PCR. Significance was determined via Two-Way ANOVA and relates to sham
values of respective genotype. *, p ≤ 0.05; **, p ≤ 0.01. Per replicate, the heads
of 50 animals were pooled. n ≥ 3 per timepoint. . . . . . . . . . . . . . . . . . . . 111
6.9 Cells with microglia and macrophage morphology express il1b and tnfa. (A)
Images taken from il1b:GFP transgenic larvae either in control animals, or 2 or 6 hpi.
(B) Close-ups of images in (A); location in tectum indicated by dashed boxes in (A).
Notice the change of morphology of cells expressing il1b at 6 hpi (C) Representative
images acquired using the tnfa:eGFP-F transgenic line. . . . . . . . . . . . . . . . . 112
6.10 tnfa crispants exhibit a reduction in secondary cell death following brain in-
jury. (A) Representative close-up images of injury site in uninjected or tnfa crispant
transgenic H2A:GFP larvae at 6 hpi. Arrowheads point to pyknotic nuclei. Scale bar,
25 µm. (B) Quantification of pyknotic nuclei in uninjected or tnfa crispant animals
either uninjured (sham) or 6 hpi. *, p ≤ 0.05 in Two-Way ANOVA; n ≥ 9 per group. 113
6.11 Orthogonal view of neurons (magenta) in mpeg1+ cell (green) at 2 hours
post injury. Scale bar, 10 µm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 114
XXI
6.12 Phagocytosis is significantly increased upon injury. (A, B) Representative im-
ages of timelapses of mpeg1 :GFP animals stained with PI either before or 0.5 h after
injury. Scale bar, 15 µm. (C) Quantification of average phagocytic events of PI+
cells per mpeg1+ cell per 48 minutes. **, p ≤ 0.01 in Mann-Whitney Test. n ≥ 8
animals / group. (D, E) Representative images phagocytosis in mpeg1 :GFP animals
either before (D) or 0.5 h after injury (E). Representative mpeg1 :GFP+ cell in (D)
is engulfing PI- cargo, while mpeg1 :GFP+ cell in (E) has already engulfed PI+ cargo
and is currently engulfing PI- cargo. Scale bar, 15 µm. (F) Quantification of average
phagocytic events per mpeg1+ cell per 48 minutes. **, p ≤ 0.01 in Mann-Whitney
Test. n = 8 animals / group. i Figure corresponds to movies S6 (A, before) and
S7 (B, 0.5 hpi). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
6.13 No internalised PI+ cells or debris can be seen in her4.3+ radial glia in sham
or injured animals. Scale bar, 25 µm. ns in Mann-Whitney test; n = 6 animals /
group . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 116
6.14 Phagocytosis of PI+ cells is significantly decreased after treatment with L-
SOP. Representative images of timelapses of vehicle- (A) or L-SOP-treated (B)
animals following injury. Scale bar, 15 µm. (C) Quantification of average PI+ phago-
cytic events per mpeg1+ cell per 48 minutes. **, p ≤ 0.01 in Student’s t-Test. n ≥
6 animals / group. i Subfigure (B) corresponds to supplementary movie S8. . . . 117
6.15 Effect of L-SOP treatment on recruitment of mpeg1:GFP+ cells towards the
site of brain injury (A), and effect on calcium transients in uninjured and
injured β-actin:GCaMP6f larvae (B). L-SOP had no significant effect on either
of these two parameters. (A) ns for all timepoints in Two-Way ANOVA. (B) ns in
Two-Way ANOVA. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
6.16 Microglial phagocytosis limits secondary cell death. (A) Representative images
of vehicle- or L-SOP-treated animals at 6 hpi. Scale bar, 25 µm. (B) Representative
images of two timepoints of timelapse of vehicle- or L-SOP-treated animals between
4.5 and 5 hpi. Scale bar, 25 µm. (C) Quantification of pyknotic nuclei in sham or
injured animals treated with vehicle or L-SOP. **, p ≤ 0.01 in Two-Way ANOVA.
n ≥ 6 animals / group. (D) Quantification of newly appearing pyknotic nuclei in
sham or injured animals treated with vehicle or L-SOP. **, p ≤ 0.01 in Two-Way
ANOVA. n ≥ 6 animals / group. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
6.17 CRISPR-guided mutation of adgrb1a and adgrb1b causes loss of endonuclease
restriction site and reduction of transcript levels. (A) Representative gel image
following PCR product digestion with BslI in uninjected controls and crispants. (B)
qRT-PCR analysis of relative expression of adgrb1a and adgrb1b transcript levels
in whole larval bodies at 4 dpf. **, p ≤ 0.01 in One-Way ANOVA compared to
uninjected controls; 10 animals pooled per sample; n = 4. . . . . . . . . . . . . . . 120
XXII
6.18 Mutations in adgrb1a transcripts revealed by sequencing. First line shows wild
type sequence, with guide RNA target sequence underlined and highlighted proto-
spacer adjacent motive (PAM) site. Insertions are highlighted with purple, while
deletions are represented by -. Total number of inserted or deleted bases and fre-
quency of each mutation shown next to each sequence. . . . . . . . . . . . . . . . 121
6.19 Mutations in adgrb1b transcripts revealed by sequencing. First line shows wild
type sequence, with guide RNA target sequence underlined and highlighted PAM
site. Insertions are highlighted, with purple while deletions are represented by -.
Total number of inserted or deleted bases and frequency of each mutation shown
next to each sequence. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 121
6.20 Phagocytosis of PI+ cells is significantly decreased after CRISPR/Cas9 tar-
geted mutation of zebrafish paralogues of PS receptor BAI1. Representative
images of timelapses of uninjected (A) or crispant animals (B) following injury. Scale
bar, 15 µm. (C) Quantification of PI+ cells being engulfed per mpeg1+ cell in 48
minutes. **, p ≤ 0.01 in Two-Way ANOVA. n ≥ 6 animals / group. (D) Quantifi-
cation of mpeg1 :GFP+ cells at the site of brain injury before, 0, 1, 2, and 6 hpi. ns
for all timepoints in Two-Way ANOVA. n ≥ 9 animals / group. i Subfigure (B)
corresponds to supplementary movie S8. . . . . . . . . . . . . . . . . . . . . . . . 122
6.21 Inhibition of microglial phagocytosis through genetic manipulation of adgrb1a
and adgrb1b significantly increases number of pyknotic nuclei at 6 hpi, and
increases the rate of secondary cell death. (A) Representative images of unin-
jected or adgrb1a/b crispant animals at 6 hpi. Scale bar, 25 µm. (B) Representative
images of two timepoints of timelapse of uninjected or adgrb1a/b crispant animals
between 4.5 and 5 hpi. Scale bar, 25 µm. (C) Quantification of pyknotic nuclei in
sham or injured uninjected or crispant animals. **, p ≤ 0.01 in Two-Way ANOVA.
n ≥ 6 animals / group. (D) Quantification of pyknotic nuclei in sham or injured
uninjected or crispant animals. **, p ≤ 0.01 in Two-Way ANOVA. n ≥ 6 animals /
group. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 123
7.1 Representative plots of side scatter (SSC) to GFP intensity from FACS reports
sorting for 4C4 or mpeg1:GFP. (A) SSC against GFP intensity for 4C4+ cell
sorting. White asterisk indicates population of cells unspecifically stained by the
secondary antibody (as determined by no secondary control). (B) Population report.
Only 0.9% of live cells are GFP+. (C) SSC against GFP intensity for mpeg1 :GFP
sorting. (D) Population report. 2.1% of live cells are GFP+. . . . . . . . . . . . . . 134
7.2 Quantification of mpeg1+ and 4C4+ cells in the whole larval head. Acquired
from dorsal or ventral imaging of the whole head in mpeg1 :GFP transgenic larvae
and anti-4C4 immunostained larvae. . . . . . . . . . . . . . . . . . . . . . . . . . . 135
XXIII
7.3 Quality control gel of cDNA following Amplification using NuGEN R© Ovation
RNA-Seq System V2. A1, Ladder. B1, Sham 1. C1, Sham 2. D1, Sham 3. E1,
Sham 4. F1, Sham 5. G1, Sham 6. H1, 2 hpi 1. A2, 2 hpi 2. B2, 2 hpi 3. C2, 2
hpi 4. D2, 2 hpi 5. E2, 2 hpi 6. F2, Empty lane. . . . . . . . . . . . . . . . . . . . 135
7.4 Excerpt of significantly upregulated genes and their respective expression in
individual samples. FDR ≤ 0.05, fold change ≥ 1.2. . . . . . . . . . . . . . . . . . 138
7.5 Excerpt of significantly downregulated genes and their respective expression
in individual samples. FDR ≤ 0.05, fold change ≤ 1.2. . . . . . . . . . . . . . . . 138
7.6 Visual representation of enriched GO terms in list of upregulated genes from
RNA sequencing dataset. Genes were filtered by an FDR ≤ 0.05, and a fold
change of ≥ 1.2 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
7.7 Expression of genes previously analysed in whole head qRT-PCR in RNA
sequencing from sorted microglia/macrophages. . . . . . . . . . . . . . . . . . 142
7.8 Heatmaps of relative transcript levels of selected genes in RNA sequencing
dataset, normalised per row (assigned z-Score). (A) Relative transcript levels
for genes in the GO term MAP kinase inactivation. (B) Relative transcript levels for
cytokine and cytokine receptors that were upregulated in RNA sequencing dataset.
(C) Relative transcript levels for genes implicated in neurotrophic functions. . . . . 144
XXIV
List of Tables
1.1 Glasgow Coma Scale. Developed by Teasdale and Jennett (1974). . . . . . . . . . 2
1.2 Therapeutic approaches to treat TBI. Compounds that have been used in the
clinic, their respective targeted pathomechanism, and reported outcomes in clinical
trials. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
3.1 Zebrafish lines. Transgenic and mutant zebrafish lines used over the course of my
research. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
3.3 Drugs used for pharmacological manipulation. Drug name, concentration, and
mode of delivery. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
3.5 Primers used for qRT-PCR. Gene RefSeq numbers, primer sequence, length, melt-
ing temperature (Tm), and GC content. . . . . . . . . . . . . . . . . . . . . . . . . 47
3.6 Primer efficiency following optimisation. Gene target, optimal concentration,
slope on cDNA concentration curve including r2, and Efficiency (E/%) are included
in this table. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 48
3.7 Contrasts specified for differential analysis. Any variable specified under blocking
was used as part of an additive model, and accounted for in differential analysis of
that contrast. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
7.1 Cell and RNA yields using different markers for fluorescence activated cell
sorting. Values for antibody-dependent sorting of 4C4+ microglial cells, or sorting
using the mpeg1 :GFP) transgenic line. RNA amounts were determined on the the
LabChip GX24. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 134
7.2 Cell yields, RNA quantity/quality and cDNA quantity. Cell number obtained
following FACS of mpeg1 :GFP+ cells. RNA quantity and quality obtained following
RNA extraction by analysis on the LabChip GX24. cDNA quantity obtained by
analysis on the NanoDrop One following amplification reaction. . . . . . . . . . . . . 136
7.3 Gene ontology analysis of upregulated genes in RNA sequencing dataset.
Analysis shows mapped genes in background, and how many of these are represented
in the upregulated list. Fold enrichment is then performed based on expected values
in a random dataset. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
XXV
7.4 Counts per million (CPM) values for genes previously analysed using qRT-
PCR from whole heads in wild type and irf8-/- mutant animals. n.d. = not
detected; n.a. = not applicable. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
7.5 Counts per million (CPM) values for dusp genes. Notice the FDR for dusp6 and
dusp1 is > 0.05. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
7.6 Counts per million (CPM) values for cytokine and cytokine receptor genes. . 143




1.1 Traumatic brain injuries and their socio-economic burden
Traumatic brain injury (TBI) is defined as alteration of brain function, or other evidence of
brain pathology, caused by an external force (Menon et al., 2010). TBI is a critical problem in
public health and poses a significant socio-economic burden worldwide: direct medical and indirect
costs, such as lost productivity, have been reported to amount to an annual economic burden of
£5.7 billion in the UK (Fineberg et al., 2013). Internationally, TBI has been estimated to pose a
socio-economic burden of $400 billion, reflecting 0.5% of the global economic output (Maas et al.,
2017). TBI is one of the leading causes of death, particularly in adults under the age of 45, and
life-long disabilities are common in those who survive (Faul and Coronado, 2015; Maas et al., 2008).
TBIs are prevalent in both high- and low-income countries. Fifty million people experience
TBI worldwide per year, and it is estimated that about half of the population will have one or more
TBIs in their lifetime (Maas et al., 2017). It can affect people from all ages and genders, but is more
common in males than females across all ages (Peeters et al., 2015; Taylor et al., 2017; Thurman,
2016). Male to female ratios in Europe have been reported to range from 1.2:1 (Numminen, 2011)
to 4.6:1 (Mauritz et al., 2008). In terms of age distribution, TBIs are most common children or
adolescents and the elderly (below 25 and above 75, respectively) (Peeters et al., 2015; Taylor et al.,
2017). Falls are the most frequent cause of TBI in high-income countries both above the age of
75 and below the age of 15, as road traffic accidents (RTAs) have been significantly reduced by
implementation of safety regulations (Faul et al., 2010; Peeters et al., 2015; Taylor et al., 2017).
Between the ages of 15 to 25, RTAs remain the most prevalent cause of TBI (Faul et al., 2010;
Peeters et al., 2015; Taylor et al., 2017; Thurman, 2016). Furthermore, sports accidents are a
common and increasing cause of TBI in adolescents (Centers for Disease Control and Prevention
(CDC), 2011; Hootman et al., 2007; Ilie et al., 2013; Lincoln et al., 2011). Conversely, in low- and
middle income countries, where 90% of all TBIs occur, the incidence of TBI is steadily increasing
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Table 1.1: Glasgow Coma Scale. Developed by Teasdale and Jennett (1974).
Domain Response Score









Motor response Obeys command 6
Moves to localised pain 5




due to the enhanced use of motorised vehicles (Johnson and Griswold, 2017; Maas et al., 2008,
2017), and one TBI-related fatality occurs every three minutes in India (Maas et al., 2017).
TBI is classified according to severity. The most commonly used scale for this is the Glas-
gow Coma Scale (GCS) (Teasdale and Jennett, 1974). The GCS assesses the eye opening, verbal,
and motor response of patients with impaired consciousness and assigns them scores from 3 to a
maximum of 15 (Table 1.1). Scores from 15-13 are associated with mild TBI (mTBI), 12-9 with
moderate TBI, and 3-8 with severe TBI (sTBI) (Rimel et al., 1982). Based on this classification,
approximately 80% of all TBI patients admitted to hospital have been classified as mTBIs, while
the remaining 20% are split evenly between moderate and severe TBI (Rimel et al., 1982; Saatman
et al., 2008). It is difficult to estimate the total number of patients experiencing TBI, however, as
many patients with mTBI do not seek medical attention, but roughly 42 million people worldwide
are thought to experience mTBI per year (Gardner and Yaffe, 2015).
TBIs can be furthermore classified according to underlying mechanism: these include closed
head injury caused by rotational forces or acceleration/deceleration, and open brain injury caused
by penetration of the brain (Maas et al., 2008).
As seen in Table 1.1, the acute signs of TBI can vary considerably (Teasdale and Jennett,
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1974); symptoms range from disorientation, vomiting, nausea, dizziness, and headache to loss of
consciousness, coma, and even death (Bryan, 2013; Center for Disease Control and Prevention
(CDC) and National Center for Injury Prevention and Control, 2003; Faul and Coronado, 2015).
Long-term consequences depend on magnitude and location of the initial injury, but 43% of TBI sur-
vivors have been reported to develop long-term disabilities, increasingly so with age (Rutland-Brown
et al., 2003; Selassie et al., 2008). TBI can result in poor concentration, attention deficits, and
personality changes reflecting alterations in emotional and behavioural regulation such as irritabil-
ity, mood changes, aggressiveness, and self-centred behaviour (Belanger et al., 2010; Tramontana
et al., 2014). These changes in personality have been shown to affect interpersonal relationships and
contribute to poorer social and vocational integration following brain injuries (Roozenbeek et al.,
2013). Consistent with this, people with a history of TBI have been reported to experience social
isolation, have a lower quality of life and general health, and attempt suicide more frequently than
the general population (Hawthorne et al., 2009; Silver et al., 2001). Rimel et al. (1982) previously
showed that that 66% of TBI patients do not return to work. This has been confirmed to occur for
patients with moderate and severe TBI (Hawthorne et al., 2009; Rimel et al., 1982), where cognitive
impairment persists in as many as 65% of patients (Rabinowitz and Levin, 2014). Following mTBI,
return to work is not affected, but these patients often exhibit ongoing cognitive and memory deficits
interfering with everyday tasks (Cancelliere et al., 2014; Ponsford et al., 2011).
In addition to social, behavioural, and emotional consequences, TBI can result in a variety of
neurological, psychiatric, and neurodegenerative diseases which I have summarised below.
1.1.1 Neurological disorders
Traumatic brain injury is a significant risk factor for the development of epilepsy and sleep
disorders. Patients with a history of TBI were found to be eleven times more likely to develop
epilepsy (one and a half times more likely after mTBI, up to seventeen times more likely after sTBI)
(Annegers et al., 1998). This finding was recently also replicated in a population-based cohort study
of children and young adults in Denmark, where TBI increased the risk of epilepsy even after ten
years (Christensen et al., 2009).
Seventy percent of TBI outpatients self-reported sleep problems (McLean et al., 1984), and a
study employing polysomnography confirmed sleep disturbances in 45% of patients in a group of 71
patients on average three years following traumatic brain injury (Masel et al., 2001). A history of
TBI was additionally associated with an increased risk of obstructive sleep apnea, which occurred in
23% of patients (Castriotta et al., 2007), and TBI patients with obstructive sleep apnea performed
significantly worse in measures of cognitive function than TBI patients without obstructive sleep
apnea (Wilde et al., 2007).
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1.1.2 Psychiatric disorders
In a small 2004 case-controlled study, 33% of 91 patients with TBI developed major depres-
sive disorder (MDD) and exhibited a higher risk for depression than a control group of 27 patients
with other traumas but lacking damage to the brain (Jorge et al., 2004). TBI patients with MDD
were more likely to develop other comorbidities such as anxiety and aggressive behaviour, and had
reduced executive function and poorer social functioning. These findings were also correlated with
reduced gray matter volume in CT or MRI.
Two larger studies (559 and 722 patients, respectively) report similar values of MDD occur-
rence following TBI (53.1% and 42%, respectively), but lack control subjects (Bombardier et al.,
2010; Kreutzer et al., 2001).
For mTBI, mood disorders are the most common long-term consequence. Anxiety, MDD, and
post-traumatic stress disorder are frequently encountered in patients who suffered mTBI (as often
as in patients who suffered moderate or severe TBI), even if no gross brain scan abnormalities are
visible (Bombardier et al., 2010).
1.1.3 Neurodegenerative diseases
A particularly worrying perspective for the long-term consequences of traumatic brain injuries
is that they have been shown to significantly increase the risk of developing neurodegenerative
diseases. Several studies and meta-analyses have found an association of a history of TBI with
increased risk for several forms of dementia, such as Alzheimer’s disease (AD) (Barnes et al., 2014;
Fleminger et al., 2003; Gardner et al., 2014; Lee et al., 2013; Mortimer et al., 1991), young-onset
dementia (Nordström et al., 2014), and fronto-temporal dementia (Barnes et al., 2014; Kalkonde
et al., 2012; Rosso et al., 2003).
More recently, doubts have been cast on the link between TBI and AD, mainly because most
of the studies utilised retrospective self-reporting of TBI (which may be biased at a time when cog-
nitive impairment from dementia is already apparent) and the clinical diagnosis of AD, which lacks
specificity, rather than newly-developed biomarkers (Weiner et al., 2017). A 2016 neuropathological
study found no increased risk of AD in TBI patients (Crane et al., 2016), although the authors did
observe an increased risk for accumulation of Lewy Bodies and Parkinson’s disease. This suggested
that while the risk for AD was not increased, TBI may increase the risk for other forms of dementia
such as dementia with Lewy Bodies or Parkinson’s-associated dementia. On the other hand, the
study by Barnes et al. (2014) (detecting an increased link between history of TBI and AD) included
only male subjects (veterans), and Fleminger et al. (2003) only found the increased risk in males,
indicating there might be a gender-specific aspect to the link of TBI-AD which may in part be
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responsible for the lack of reproducibility in the study by Crane et al. (2016).
In contrast to AD, the link between TBI and Parkinson’s disease is much less controversial.
Several studies and meta-analyses have found a significantly increased risk of developing Parkin-
sonism after suffering from TBI (Crane et al., 2016; Gardner et al., 2015; Jafari et al., 2013).
Importantly, even mild traumatic brain injury increased the risk for Parkinson’s disease (Gardner
et al., 2015), although, as mentioned above, this is generally difficult to assess as many patients do
not seek medical attention after experiencing mTBI.
Furthermore, TBI has been found to increase the risk of developing amyotrophic lateral scle-
rosis threefold; with repeated injuries this risk rises up to elevenfold compared to control patients
with limb fractures and no evidence of central nervous system injuries (Chen et al., 2007).
It is unclear as to how exactly traumatic brain injuries can lead to these devastating long-term
consequences, but research is currently ongoing to untangle these effects.
To summarise, there is an increasing awareness that TBI is actually a disease process rather
than a single event (Masel and DeWitt, 2010). This idea is not new, and the concept that TBI
can lead to neurodegeneration was first established in 1927 by Osnato and Giliberti, shortly after
which dementia pugilistica, or punch-drunk syndrome, was described in retired boxers (Martland,
1928; Osnato and Giliberti, 1927). This form of post-traumatic neurodegenerative disease is caused
by repeated blows to the head - as occur in boxing or other forms of aggressive contact sports -,
and is characterised by a decline of cognitive and motor functions over time. In the last decades,
clinical research has investigated many more of the pathological consequences of TBI. The cost
figures mentioned above underline the fact that traumatic brain injuries not only pose a significant
health issue to the individual, but the health system as a whole, and treatments are duly needed
to prevent the pathological consequences of TBI, and potentially in further course, decline of brain
function and neurodegenerative disease.
1.2 Wound healing and regeneration: phases and contribution
of macrophages
Regardless of tissue context, complex molecular and cellular cascades must be initiated im-
mediately following an injury if tissue integrity and homeostasis are to be restored. Cells rapidly
undergo significant changes in gene expression profile and migration, proliferation, and differentia-
tion behaviour in response to injury, including cells of the immune system (Gurtner et al., 2008).
During the process of wound healing, previously functional tissue occasionally becomes a patch of
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cells with disorganised extracellular matrix (ECM), commonly referred to as a scar (Gurtner et al.,
2008). While scar formation helps to replace lost tissue and potentially provides a survival benefit
by preventing influx of pathogens and further mechanical deformation, it significantly hampers the
function of tissue, and results in loss of elasticity (skin) (Corr and Hart, 2013), reduced cardiac
output or even cardiac insufficiency (heart) (Talman and Ruskoaho, 2016), inability to regrow axons
(spinal cord injury, TBI) (Silver and Miller, 2004) or generate new neurons (TBI) (Moeendarbary
et al., 2017), amongst other functional deficits. However, some eukaryotic organisms have the ability
to completely restore original tissue architecture and function through a process called regeneration;
in fact, most organisms have the ability to regenerate during development, but it is frequently lost in
adulthood, particularly in mammals (Colwell et al., 2003). Conversely, some vertebrate organisms,
such as salamanders and zebrafish, retain the ability to regenerate in adulthood (Becker et al., 2004;
Godwin et al., 2013; Petrie et al., 2015). While is not yet known why humans lose the capacity to
regenerate after development, and why some adult human tissues retain the ability to regenerate
(liver) while others do not (heart, central nervous system), it is thought that the macrophages,
cells of the innate immune system, may play a role in regulating a switch between scar formation
and regeneration, as they are key to the orchestration of wound healing phases (Gurtner et al., 2008).
The response to injuries is remarkably similar between different mammalian tissues, including
skin, heart, or central nervous system. Wound repair is divided into three (overlapping) phases: (i)
inflammation, (ii) proliferation (generation of new tissue), and (iii) remodelling. Additionally, early
transcription-independent signalling mechanisms can influence and modulate wound repair. Here, I
have summarised phases of wound healing.
1.2.1 Phases of wound healing
Early, transcription-independent wound signals
Although the process of wound healing is often lengthy, wound repair actually starts immedi-
ately after an insult. The immediate detection of wounds is crucial for initiation and orchestration of
repair programms. To this end, conserved transcription-independent signals can both inform about
a wound and initiate a repair programme (Cordeiro and Jacinto, 2013). Transcription-independent
signals include calcium (Ca+) waves (Antunes et al., 2013; Herrgen et al., 2014; Razzell et al.,
2013; Sammak et al., 1997; Sieger et al., 2012; Xu and Chisholm, 2011; Yoo et al., 2012), release
of adenosine triphosphate (ATP) (Davalos et al., 2005; Kotwal et al., 2015), and the establishment
of a hydrogen peroxide (H2O2) gradient (Love et al., 2013; Niethammer et al., 2009).
Calcium has been described as one of the earliest damage signals. Calcium waves in response to
injury are observed in a variety of species and tissues, including epithelia of Drosophila melanogaster,
Caenorhabditis elegans and zebrafish (Danio rerio) (Antunes et al., 2013; Xu and Chisholm, 2011;
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Yoo et al., 2012), bovine endothelial cell culture (Sammak et al., 1997), human and rat astrocytic
cell culture (Ravin et al., 2016), and neural tissue of developing zebrafish and Xenopus laevis (Her-
rgen et al., 2014; Sieger et al., 2012). Calcium waves initiate repair by recruitment of immune cells
(Sieger et al., 2012; Razzell et al., 2013), and can promote wound closure through actin-dependent
mechanisms (Antunes et al., 2013; Herrgen et al., 2014; Xu and Chisholm, 2011). Similarly, calcium
waves can amplify the wound response by activation of hydrogen peroxide-generating enzyme dual
oxidase (duox) (Razzell et al., 2013; Yoo et al., 2012). Strikingly, inhibiting calcium signalling at
the time of injury can significantly diminish regeneration and wound repair in otherwise regenerating
systems, and therefore determines later recovery (Antunes et al., 2013; Xu and Chisholm, 2011; Yoo
et al., 2012).
In addition to calcium waves, ATP is a conserved transcription-independent damage signal
(Cordeiro and Jacinto, 2013). Following injury, ATP is released from injured cells (often passively
due to membrane rupture), and binds P2 receptors. As a consequence, this can enhance wound
closure (Takada et al., 2014; Yin et al., 2007), recruit immune cells (Davalos et al., 2005), and alter
immune cell polarisation (Kotwal et al., 2015).
Importantly, interference with early transcription-independent wound signals can impair late
regenerative success (Antunes et al., 2013; Love et al., 2013; Xu and Chisholm, 2011; Yoo et al.,
2012). Additionally, as the phases of inflammation described below are often only initiated after
a lag, transcription-independent signals have the capacity to fast-track repair and regeneration,
in particular by wound closure and modulation of macrophages (Kotwal et al., 2015), which are
critical regulators of wound healing. Therefore, transcription-independent signals are indispensable
mediators of tissue repair.
(i) Inflammation
Inflammation is the first phase of wound repair. It is initiated either by the presence of
pathogen-associated molecular patterns (PAMPs) or, in case of sterile injury, damage-associated
molecular patterns (DAMPs) such as ATP. This first phase of wound repair is primarily aimed
at removal of pathogens, debris, and cell corpses to pave the way for later stages of regeneration
(Gurtner et al., 2008). Cells of the innate immune system, in particular neutrophils and macrophages
can bind PAMPs and DAMPs via surface receptors and alter their behaviour, for example to induce




Following clearance of debris in the inflammatory phase, this second phase is initiated. It is
characterised by revascularisation, angiogenesis, migration, and proliferation of cells of the connective
tissue (in particular fibroblasts), and deposition of extracellular matrix (ECM) to fill the damaged
tissue that has been removed during the inflammatory phase. The proliferative phase is critical to
regain structural integrity of tissue (Gurtner et al., 2008; Stroncek and Reichert, 2008). Importantly,
macrophages are a key factor for induction of the proliferative phase; for example, they can promote
angiogenesis in hypoxic tissue environments by secretion of the angiogenetic vascular endothelial
growth factor (Henson, 2005).
(iii) Remodelling
The third and final phase of wound healing is the remodelling phase, which is characterised by
downregulation of the previously induced wound repair processes, wound retraction, and resolution
of inflammation. The aim is to reduce the amount of excessive ECM deposited during the prolifer-
ative phase in order to strengthen tissue, and align the ECM through contraction (Gurtner et al.,
2008). A failure to remove or remodel ECM results in fibrosis (thickening of scar tissue by excessive
ECM deposition) (Gurtner et al., 2008).
For successful wound repair to occur, all these phases have to be carefully orchestrated in a
timely and organised manner. For example, a failure to remodel impairs the regenerative capacity of
the liver and instead results in fibrosis. The transitions between phases are regulated by macrophages;
several macrophage polarisations are required sequentially (inflammatory, tissue repair, and resolving
macrophages) (Das et al., 2015; Wang et al., 2014; Wynn et al., 2016). When the transitions
between wound repair are dysregulated, overhealing (hypertrophic scar and keloids), or underhealing
(chronic scars associated with diabetes or radiation) can occur (Gurtner et al., 2008).
1.2.2 Wound repair in the CNS: differences to other tissues
The responses to injury are remarkably similar across adult mammalian tissues, and the general
principles of wound repair apply also to the CNS. Both calcium waves and ATP have been shown to
inform the surrounding tissue of a neural injury (Davalos et al., 2005; Herrgen et al., 2014; Sieger
et al., 2012). While enhanced calcium levels in the brain are typically associated with mediating cell
death via excitotoxicity (see Chapter 1.3), research suggests that early calcium waves following an
injury can be (neuro)protective: either by inhibiting excessive apoptosis following an injury (Justet
et al., 2016; Kanemaru et al., 2013), but also via other mechanisms such as actin remodelling, rapid
wound closure, and expulsion of dead cells from intact tissue (Herrgen et al., 2014; Minns et al.,
2016). Furthermore, calcium waves have been reported to attract microglia, the resident immune
cells of the brain, to sites of injury (Davalos et al., 2005; Sieger et al., 2012).
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However, there are several cellular players different from wound repair in other tissues. This
includes astrocytes, which are glial cells that provide the healthy CNS with trophic support and par-
ticipate in a plethora of other homeostatic functions essential to CNS function (reviewed by Allen
and Lyons (2018)). Following CNS trauma, astrocytes take on a similar role that fibroblasts serve
in the periphery, and proliferate to fill in the lesion site (for small CNS injuries) (Fitch et al., 1999;
Li and David, 1996), or form a border surrounding the lesion site (Shechter and Schwartz, 2013).
While this plug or barrier, called glial scar, is a necessary interim to contain damage and prevent
it from spreading to healthy tissue (Faulkner et al., 2004), it often persists for years; therefore, it
leads to a failure to remodel, and the lack of regenerative capacity of the CNS has been partially
attributed to the glial scar (Shechter and Schwartz, 2013).
Furthermore, unlike other tissues, the CNS is usually isolated from peripheral cells and molecules
by the blood brain barrier (BBB), consisting of endothelial cells forming tight junctions (Rubin and
Staddon, 1999). Therefore, the CNS does not depend on circulating monocytes for macrophages,
but has its own resident and self-renewing macrophages, called microglia. Microglia are derived
from primitive myeloid precursors in mammals (Ginhoux et al., 2010), and maintenance of microglia
is independent of circulating progenitors: the constant population of microglia has been shown
to be regulated by coupled proliferation and apoptosis of resident cells (Askew et al., 2017). Al-
though microglia are capable of carrying out similar functions as macrophages in the periphery and
have the capacity to phagocytose and release molecules modulating repair processes, it is known
that they exert additional functions critical to CNS development and homeostasis. Microglia reg-
ulate fasciculation of axons in the corpus callosum and thereby mediate proper wiring of the brain
during development (Pont-Lezica et al., 2014; Squarzoni et al., 2014). They furthermore instruct
positioning of newborn neurons in development (Squarzoni et al., 2014), as well as regulate neu-
ronal numbers during development by promoting neuronal survival via release of trophic factors
or phagocytosing superfluously generated neurons (Cunningham et al., 2013; Ueno et al., 2013).
In the adult brain, microglia are involved in regulating hippocampal neurogenesis (Sierra et al.,
2010). Furthermore, microglia are able to shape synaptic fields by synaptic pruning, an activity- and
complement-dependent process regulating uptake of synapses by microglia (Paolicelli et al., 2011;
Schafer et al., 2012; Stevens et al., 2007). Therefore, although microglia are named the resident
macrophages of the brain, they are known to carry out a multitude of functions contributing to
CNS development and homeostasis and are therefore specialised macrophages that may respond to
injuries differently than other macrophages.
In contrast to some mammalian tissues (liver), the CNS is not capable of full regeneration and
trauma results in a glial scar. The limited capacity of the CNS to repair has been proposed to result
from a failure to remodel wounds, elicited by the lack of timely orchestration of preceding phases
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of wound repair (Shechter and Schwartz, 2013), and may be the result of a dysregulated activa-
tion of immune cells. Indeed, functional magnetic resonance imaging in human patients revealed
that pathological immune cell activation persisted for up to 17 years after TBI (Ramlackhansingh
et al., 2011). In addition to potentially providing an explanation for the failure of CNS regen-
eration, dysregulation of inflammation has been associated with neurodegenerative diseases, and
may therefore explain the link between TBI and Alzheimer’s disease, Parkinson’s disease, and other
neurodegenerative diseases (reviewed by Colonna and Butovsky (2017) and Prinz et al. (2011)).
1.2.3 The role of microglia/macrophages in repair and regeneration
Macrophages, cells of the innate immute system named after the Greek word for big eater
(Metchnikoff, 1905), play a key role in each phase of wound repair and orchestrate transitions be-
tween phases. During the acute phase of an injury, macrophages react to damage signals (DAMPs
and PAMPs) and subsequently undergo changes in gene expression and phagocytosis, termed as
activation. Traditionally, two types of macrophage activation have been described: M1 (pro-
inflammatory), and M2 (anti-inflammatory) (Mantovani et al., 2004; Mills et al., 2000), based
on the previously described polarisation of T-helper cells Th1 and Th2 (Mosmann et al., 1986).
This classification is based on a subset of markers found on activated macrophages. Interferon γ
(IFNγ) and lipopolysaccharide (LPS, a particle found in the cell wall of bacteria) were seen as the
main factors eliciting an M1 phenotype, inducing expression of pro-inflammatory factors such as
inducible nitric oxide synthase (iNOS), tumour necrosis factor α (TNFα), and interleukin-1β (IL-
1β). In contrast, the cytokines interleukin-4 (IL-4) and interleukin-13 (IL-13) are typical inducers
of the anti-inflammatory M2 polarization that is associated, amongst other factors, with expression
of arginase-1 (Arg1), transforming growth factor β (TGFβ), and interleukin-10 (IL-10) (Martinez
and Gordon, 2014). During the inflammatory phase of wound repair, M1 macrophages are able
to neutralise bacteria and other pathogens via production of nitric oxid. In contrast to that, M2
macrophages are generally seen as suppressors of inflammation, and mediators of tissue remodelling.
With the availability of high-throughput transcriptomic and epigenomic methods, in combi-
nation with the use of more dynamic in vivo imaging tools in rodents and zebrafish, is has become
increasingly clear that rather than two specific polarisations, macrophages are able to adopt a wide
variety of activation patterns not limited to these ends of the spectrum (Martinez and Gordon,
2014; Mosser and Edwards, 2008; Ransohoff, 2016a). M1 and M2 polarisations were discovered
after stimulating cells in vitro; however, textbook M1 and M2 macrophages are rarely encountered
in vivo (Chiu et al., 2013; Morganti et al., 2016), and M1/M2 markers have actually been shown
not to predict the overall gene expression pattern (Kim et al., 2016). To this end, the simplified
classification of macrophage activation into M1/M2 could actually hinder research by overlooking
potential other factors, and it is argued that it is to be discarded (Ransohoff, 2016a).
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Macrophages have been shown to be crucial to repair by orchestration of the phases of wound
healing. For example, specific depletion of macrophages during acute liver injury (which normally
results in full regeneration) resulted in a failure to regenerate due to insufficient matrix restructuring
(Duffield et al., 2005). Similarly, in the neonatal rodent or adult salamander heart, the remarkable
capacity of cardiac regeneration depends on the presence of macrophages to instruct matrix remod-
elling and other pro-regenerative processes (Aurora et al., 2014; Godwin et al., 2017). Even in adult
rodents, when cardiac repair following an insult is known to be limited, depletion of macrophages
following cardiac injury leads to increased mortality, decreased wound debridement, and decreased
cardiac regeneration (Frantz et al., 2013; van Amerongen et al., 2007). Not only cardiac muscle,
but also skeletal muscle regeneration was found to depend on macrophages, and suppression of
macrophage function via anti-M-CSF-antibody injection was found to result in excessive fibrosis
(Segawa et al., 2008). Successful kidney repair has been shown to depend on macrophage infiltra-
tion and production of pro-regenerative Wnt7b (Lin et al., 2010). Epimorphic skin regeneration in
African spiny mice was found to depend on macrophages to stimulate regenerative processes (Simkin
et al., 2017). More complex regenerative processes, such as salamander limb regeneration, or ze-
brafish fin regeneration, have also been found to depend on the presence of macrophages (Godwin
et al., 2013; Nguyen-Chi et al., 2017; Petrie et al., 2015).
In contrast to the relatively well-established role for macrophages in the orchestration of re-
pair and regeneration in many tissues, they have historically been classified as detrimental following
CNS injuries due to activation and initiation of neuroinflammation (see Chapter 1.3.4), and this hy-
pothesis still remains present: Gerber et al. (2018) inhibited proliferation of microglia, the resident
macrophages of the brain, following spinal cord injury in mice and observed improved functional out-
come and tissue morphology. However, sparse correlational hypotheses that microglia/macrophages
could support CNS repair have been reported as early as the 1980s. Perry et al. (1987) observed
abundant macrophage infiltration following peripheral nervous system (PNS) injury but to a lesser
extent following injury in the CNS (optic nerve injury), and hypothesised that differing macrophage
number and activation could potentially explain the regenerative capacity of PNS over CNS. Simi-
larly, Prewitt et al. (1997) found that more macrophages were found in regions with a higher extent
of axonal outgrowth following spinal cord injuries. These findings were highly correlative, but further
studies directly investigated the capacity of microglia/macrophages to modulate axonal outgrowth;
indeed, it was found that microglia- (or ’brain macrophage’)-derived molecules can mediate axonal
outgrowth following optic nerve injury in vitro (Chamak et al., 1994) and in vivo (Yin et al., 2003,
2006). In contrast to these findings, another study reported that microglia/macrophages can lead
to axonal retraction following spinal cord injury (Horn et al., 2008). Upon closer inspection it was
however discovered that the retracted axons were highly dystrophic, and microglia/macrophages
in fact only removed debris via phagocytosis. Furthermore, three other recent studies found that
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microglia/macrophages play a distinct role in neuroprotection following stroke (Szalay et al., 2016)
and spinal cord injury in both zebrafish and mice (Brennan et al., 2018; Tsarouchas et al., 2018),
where they protect from lesion expansion and improve functional recovery.
The correct polarisation of microglia/macrophages is crucial to support repair and regenera-
tion, and polarisation can be modified in order to enhance repair. This was recently shown following
cardiac injury in rats, where adult macrophages were capable of being pushed to a cardioprotec-
tive phenotype (de Couto et al., 2015). To make matters more complex, macrophages are not
a homogeneous group of cells, and subsets have been reported to be beneficial. For example, in
cardiac repair, resident macrophages (derived from embryonic macrophages) were found to be cru-
cial for regeneration. However, following an injury, resident macrophages were replaced by heavily
infiltrating monocyte-derived macrophages. Inhibition of this infiltration and replacement improved
cardiac repair (Lavine et al., 2014). Furthermore, macrophage depletion following liver injury only
hampers regeneration if it occurs during the acute phase (Duffield et al., 2005). Conversely, during
continuous exposure to a liver toxin, depletion of macrophages proved beneficial, suggesting that
subsets of macrophages with different functions ultimately determine the outcome of regenerative
processes (Duffield et al., 2005). Furthermore, a transient pro-inflammatory response - despite being
usually thought of as being detrimental - is beneficial in some injury models, including zebrafish fin
and spinal cord injury (Hasegawa et al., 2017; Nguyen-Chi et al., 2017; Tsarouchas et al., 2018).
Successful regeneration may ultimately be achieved by shifting microglia/macrophage polarisation
to a pro-regenerative phenotype (whatever this may be in terms of tissue context) at the right time.
Depletion of all microglia/macrophages therefore only provides limited information on the overall
outcome, and may explain why it has been so difficult to reach a consensus on the overall role of
microglia/macrophages to repair and regeneration, especially in the CNS.
Over the past decade there has been mounting evidence of tissue regenerative and potentially
neuroprotective functions of microglia/macrophages. As microglia/macrophages are highly dynamic
and plastic cells, thorough investigation of these cell types requires analysis methods that are capable
of detecting these dynamic changes.
1.3 Pathophysiology of secondary cell death
In addition to scar formation, TBI is characterised by significant neuronal loss. TBI leads to
two waves of neuronal cell death: primary and secondary cell death. The key conceptual distinction
between these is their direct or indirect relation to the initial injury: while primary cell death is
a direct consequence of the initial injury (i.e., physical disruption of tissue), secondary cell death
is mediated by indirect, non-mechanical, biochemical alterations elicited by the injury. Secondary
cell death occurs within minutes to weeks of the injury, and TBI is characterised by progressive
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neuronal cell death that can spread to regions distant from the original injury site (Bayly et al.,
2006; Stoica and Faden, 2010). While enhancing CNS regeneration via inhibition of glial scar (or
axonal outgrowth, respectively) is an area of active research to improve outcome of TBI and SCI,
the prevention of secondary cell death is a promising additional therapeutic avenue. Secondary cell
death occurs with a delay, therefore presenting a potential therapeutic window, and application
of drugs could improve patient outcome. This is emphasised by the fact that secondary neuronal
cell death is associated with a poorer prognosis of patients following TBI (Miñambres et al., 2008;
Nathoo et al., 2004). Similarly, several rodent studies have suggested that inhibition of cell death
following TBI via several approaches (either general inhibition of apoptosis, or targeted inhibition
of pathomechanisms outlined below) resulted in a significantly improved cognitive outcome: for
example, inhibition of apoptotic cell death by administration of Caspase-3 inhibitors z-VAD-fmk or
z-DEVD-fmk 15 min after experimental TBI has been shown to improve cognitive outcome in rats
(Knoblach et al., 2002; Yakovlev et al., 1997). Similarly, targeting several other pathomechanisms
that elicit secondary cell death mentioned below significantly improved neurological outcome in ex-
perimental TBI models (Hall et al., 1988; Faden et al., 1989).
Along with several other cascades initiated by the primary cell death, secondary cell death
can contribute to the ’talk and die’ syndrome that was first described in 1975: patients who were
initially capable of talking and other cognitive functions following injury often progressively declined
(and potentially died) (Reilly et al., 1975). Nonetheless, the delayed nature of secondary cell death
allows for potential salvage of patients and prevention of further damage if applied within a given
therapeutic window. In order to prevent secondary cell death, there has therefore been considerable
pre-clinical research both in vitro and in vivo to elucidate mechanisms leading to neuronal cell death
following TBI, and to discover neuroprotective strategies. Overall, neuronal dysfunction and death
following an injury appears to stem from aberrant neurotransmitter and ion homeostasis, oxidative
stress, changes in the vasculature, and energy failure (summarised below; Park et al. (2008); Werner
and Engelhard (2007)).
1.3.1 Excitotoxicity
One of the key pathophysiological events eliciting secondary neuronal cell death following TBI
is a phenomenon termed glutamate excitotoxicity. Glutamate is the major excitatory amino acid in
the brain, and it is physiologically released for neurotransmission in a highly controlled temporal and
spatial manner at the synapse (Clements et al., 1992). Following an insult to the brain, however,
there is excessive release of glutamate from injured cells which can lead to death of neighbouring
cells (Lipton and Rosenberg, 1994). Glutamate acts on several receptors that have been named after
their specific agonists (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, or AMPA, receptor;
and N-methyl-D-aspartate, or NMDA, receptor). Excessive NMDA receptor activation can lead to
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cell death via several pathways:
• Cytotoxic cellular swelling.
NMDA receptors (and other ion channels responsive to glutamate) preferentially transport
Ca2+ ions but are also capable of transporting Na+ (and passively Cl-) into the cell, which in
turn leads to release of K+ into the extracellular space (Fig. 1.1) (Katayama et al., 1990).
This unregulated and excessive flux of ions leads to cellular influx of water molecules, pre-
dominantly through aquaporin-4 channels (Fig. 1.1) (Manley et al., 2000), which results in
cytotoxic cellular swelling, and on a tissue level, cytotoxic oedema (Liang et al., 2007). Cy-
totoxic oedema is frequently observed following traumatic brain injury and thought to be a
main cause of brain swelling and elevated intracranial pressure (ICP) (Unterberg et al., 2004).
In severe cases, this increased pressure may lead to compression of respiratory centres in the
brain stem and result in death. In addition to cell swelling, the disrupted ionic balance inter-
feres with physiological function of neurons; in order to fire again, ionic equilibrium must be
restored. Exchange of Na+ with K+ is achieved by the Na+/K+-ATPase, an ATP-dependent
ion pump working against the chemical gradient. The disruption of ionic homeostasis fol-
lowing traumatic brain injury therefore drastically increases the ATP demand and alters the
glucose metabolism, the predominant source of neuronal energy. Immediately following TBI,
this results to a hypermetabolic state, which can be prevented by application of glutamate
antagonists (Yoshino et al., 1991). This finding supported the hypothesis that the altered
metabolic state was linked to glutamate excitotoxicity (Kawamata et al., 1992).
• Mitochondrial dysfunction.
Under physiological conditions, mitochondria can buffer large amounts of intracellular calcium
(Nicholls and Saunders, 1996). However, abnormally high levels of calcium result in an al-
tered mitochondrial membrane potential, and therefore disrupt the cellular energy supply by
mitochondrial dysfunction, which is a key element of glutamate excitoxicity (Hiebert et al.,
2015; Schinder et al., 1996), and further exacerbates neuronal energy deficit in response to
TBI.
• Lipase and protease activation
NMDA receptor-dependent Ca2+ influx can lead to activation of a series of phosphatases and
lipases (Fig. 1.1), resulting in neuronal self-digest by protein breakdown and lipid peroxidation
(Choi, 1988; Lipton and Rosenberg, 1994). Lipid peroxidation is defined as the oxidative
breakdown of lipids and can lead to cell membrane instability and death. It can be initiated
by NMDA receptor-dependent calcium influx activation of enzymes (such as phospholipase
A2), or mediated by reactive oxygen species (Anthonymuthu et al., 2016). This pathway is
convergent with other NMDA receptor-induced molecular pathomechanisms, as activation of
NMDA receptors has additionally been shown to lead to synthesis of nitric oxide (NO) from
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L-arginine in vitro (Dawson et al., 1991; Garthwaite et al., 1989; Sattler et al., 1999) and in
vivo (Girouard et al., 2009). This occurs under physiological conditions, and NO has in fact
been shown to be involved in memory formation and its cellular correlates, synaptic plasticity,
whereby inhibition of NO in vivo has been shown to lead to learning impairments (Chapman
et al., 1992), and inhibition in vitro leads to decreased synaptic plasticity (Schuman and
Madison, 1991; Shibuki and Okada, 1991). However, under pathologically elevated conditions,
NO was shown to be a key mediator of glutamate excitotoxicity: NMDA receptor-elicited NO
has been shown to mediate apoptotic cell death in cell culture (Dawson et al., 1991; Leist
et al., 1997; Sattler et al., 1999), while inhibition of the neuronal NO synthase was able to
protect from NMDA receptor-dependent excitotoxic cell death in slice cultures (Izumi et al.,
1992), and resulted in a decreased lesion volume following excitotoxic brain injury in vivo
(Schulz et al., 1995).
While NMDA receptors have been mainly shown to be neurotoxic and their manipulation
(either genetical or pharmacologically) has been implicated in neuroprotection following traumatic
brain injury (Morikawa et al., 1998; Rao et al., 2001; Rothman and Olney, 1986; Simon et al., 1984),
NMDA receptors also serve neuroprotective roles. Developmentally, NMDA receptors are critical for
brain function, and genetic NMDA receptor knockout results in death within a few hours from birth
(Forrest et al., 1994). Transient pharmacological inhibition or genetic deletion of NMDA receptors
in perinatal rats caused extensive apoptosis of neurons (Adams et al., 2004; Gould et al., 1994;
Ikonomidou et al., 1999; Monti and Contestabile, 2000; Zhang-Hooks et al., 2016), exacerbated
neuronal loss in an adult model of neurodegeneration (Ikonomidou et al., 2000), and impaired
survival of newborn neurons in the dentate gyrus of the hippocampus (Tashiro et al., 2006), one
of the few regions of the adult mammalian brain with adult neurogenesis. It appears that both
too much and too little NMDA receptor activation can be harmful. Indeed, Hardingham et al.
(2002) found that synaptic NMDA receptors render neurons more resilient to apoptotic stimuli via
activation of CREB (cAMP response element binding protein) and BDNF (brain derived neurotrophic
factor), while activation of extrasynaptic NMDA receptors leads to mitochondrial dysfunction and
loss of mitochondrial membrane potential. It appears that as with nitric oxide, a delicate balance is
required for normal function and neuroprotection, and this may explain why several drugs targeting
NMDA receptors - which initially appeared to be ideal targets for neuroprotection from glutamate
excitotoxicity following brain injury - failed in clinical trials (see Chapter 1.4.2).
1.3.2 Oxidative stress
The brain is highly sensitive to oxidative stress as it consumes approximately 20% of the oxygen
amount of the body, and has the highest oxygen metabolic rate of any organ (Maiese, 2002). Free
radicals, including reactive oxygen species (ROS) and reactive nitrogen species (RNS), are usually
scavenged by endogenous antioxidant enzymes such as superoxide dismutase (SOD) and glutathione
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peroxidase (Chong et al., 2005). However, following TBI, an accumulation of both ROS and RNS is
observed (Fabian et al., 1998; Kontos and Wei, 1986). This is mediated by enhanced production of
ROS and RNS due to mitochondrial damage, NADPH oxidase upregulation, and enhanced inducible
nitric oxide synthase (iNOS) expression (Choi et al., 2012; Gahm et al., 2000; Hiebert et al., 2015;
Orihara et al., 2001; Sullivan et al., 1999; Wada et al., 1998; Zhang et al., 2012), and a concomitant
suppression of antioxidant enzyme expression (Cernak et al., 2000), tipping the balance to result in
oxidative stress.
The accumulation of ROS [superoxide (·O2
-), singlet oxygen (1O2), and hydroxyl radical (
·OH)]
and RNS [nitric oxide (NO) and peroxynitrite (ONOO-)] can result in significant neuronal injury.
Unscavenged excess of free radicals was shown to result in peroxidation of cellular lipid structures,
protein oxidation or nitration (depending on whether ROS or RNS are involved) (Hall et al., 2004),
cleavage of DNA via endonucleases, disruption of the mitochondrial electron transport chain (Radi
et al., 1994; Yamamoto et al., 2002), further exacerbating the energy dysfunction experienced follow-
ing TBI. These pathological events can be partly counteracted by increasing free radical scavenger
levels: overexpression of scavenging enzyme SOD resulted in reduced membrane lipid peroxidation,
protein nitration, and neuronal cell death after focal cerebral ischemia in vivo (Keller et al., 1998).
Treatments with antioxidants such as polyethylene glycol-conjugated SOD (PEG-SOD), transgenic
elevation of SOD levels, application of anti-oxidant hormone melatonin, or superoxide radical scav-
enger OPC-14117 have been shown to improve the neurological outcome and reduce cell death in
experimental models of TBI (Aoyama et al., 2002; Chan et al., 1995; Hamm et al., 1996; Mikawa
et al., 1996; Mésenge et al., 1998; Xiong et al., 2005). Interestingly, levels of endogenous melatonin
in the brain were found to be increased in patients with TBI, suggesting a potential rescue attempt
of the brain to scavenge excess free radical levels (Seifman et al., 2008). Moreover, direct targeting
of pathological events induced by ROS or RNS were shown to improve outcome following TBI:
inhibition of lipid peroxidation significantly improved neurological outcome following experimental
TBI in rats (Hall et al., 1988), and inhibition of endonucleases following TBI increased neuronal
survival in vitro (Vincent and Maiese, 1999).
As previous research had shown that ROS and RNS can significantly contribute to pathology
of TBI, inhibition of enzymes involved in generation of ROS and RNS was attempted to achieve
neuroprotection. However, deletion of iNOS actually enhanced oxidative stress after TBI: transgenic
iNOS knockout mice, and mice treated with NOS inhibitor aminoguanidine, were reported to have
a poorer functional outcome following TBI, although the authors state that a variety of mechanisms
could be linked to neuroprotection via (i)NOS not exclusive to oxidative stress (Sinz et al., 1999). NO
can promote neuroprotection at lower (physiological) levels by modulating ion channel permeability
via protein S-nitrosylation. The NMDA receptor is a target of this modulation: S-Nitrosylation alters
permeability, inhibits Ca2+ influx, and therefore reduces subsequent NMDA receptor-dependent
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neuronal cell death (Calabrese et al., 2007; Choi et al., 2000; Jaffrey et al., 2001). Furthermore,
NO can be produced by both neurons and immune cells (Bayir et al., 2005; Heneka and Feinstein,
2001). Bayr et al. (2006) showed that tyrosine nitrosylation of superoxide dismutase and subsequent
exacerbation of oxidative stress in response to NO is dependent on the neuronal NOS isoform nNOS.
Taken together, this suggests that timing, source, and concentration of NO may decide whether
neuroprotection or neurotoxicity occurs.
1.3.3 Blood flow dysregulation
Rodent models and a third of TBI patients experience a reduction of blood flow following
brain injury (Chesnut et al., 1993; Yamakami and Mcintosh, 1991). Most commonly, it occurs due
to a disruption of cerebral autoregulation: normally, the brain tightly regulates its blood flow by
energy demand. Following TBI, the brain increases its energy demand; if this cannot be met (via
a decrease of blood flow, and mitochondrial dysfunction), the secondary injury will be exacerbated.
Here, NO can act as a neuroprotective agent by enhancing blood flow via blood vessel relaxation
or protection of cerebral autoregulation (Curvello et al., 2018; DeWitt et al., 1997; Huang et al.,
1996).
1.3.4 Neuroinflammation
As with any injury, inflammation is a common consequence of TBI. Within minutes of a
traumatic injury, a robust inflammatory response is elicited in the injured brain, which consists of
cellular components and secreted factors.
Cellular components
 Innate immune system
The innate immune system is the first line of defense against pathogens or an injury. Mi-
croglia are the resident immune cells of the brain, and make up almost 10% of brain cells (Aguzzi
et al., 2013). Microglia sense injuries via DAMPs, excessive glutamate, or calcium waves, and are
among the first responders at the site of brain injury (Davalos et al., 2005; Sieger et al., 2012).
Upon sensing damage, often via purinergic P2 receptors (Davalos et al., 2005; Haynes et al., 2006),
microglia undergo marked changes in their morphology (changing from a resting-state ramified mor-
phology to an activated amoeboid-like morphology) and behaviour (including a release of pro- and
anti-inflammatory cytokines and phagocytosis) (Loane et al., 2014). The release of cytokines then
further alters activation states of microglia, rendering them either more pro-inflammatory or pro-
repair (see Chapter 1.2.3). The exact polarisation and contribution of microglia to injury progression
or repair heavily depends on the cues they are exposed to (Corps et al., 2015).
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A number of studies has assigned microglial responses to injury a neurotoxic function (Chao
et al., 1992; Festoff et al., 2006; Neher et al., 2011, 2013; Pyo et al., 1998; Qin et al., 2004; Rogove
and Tsirka, 1998; Tikka and Koistinaho, 2001; Yrjänheikki et al., 1998). The detrimental effect
of microglia on neuronal survival after TBI has been concluded from studies inhibiting the immune
system unspecifically, or in vitro studies. However, it is now clear that (a) many cells of the immune
system participate in the response to CNS injuries, therefore unspecific inhibition may suppress both
protective and destructive immune cell (sub)types, and (b) microglia (or any type of macrophage)
are not responding homogeneously to CNS injury. Hsieh et al. (2013) showed that experimental TBI
elicits distinct responses in microglial subpopulations, and the balance of microglial activation has
been suggested to determine the functional outcome, as an increased pro-inflammatory microglial
activation has been associated with the poorer outcome of aged animals following TBI (Kumar
et al., 2013). Therefore, generalistic studies on immune suppression are potentially only of limited
value for identification of the role of microglial cells following injury.
Furthermore, in vitro studies that have shown a neurotoxic effect of activated microglia suf-
fered from several limitations. Microglia adapt a distinctly different morphology as soon as they are
cultured, and flatten out on the surface (Giulian and Baker, 1986; Jeong et al., 2013). Adult home-
ostatic microglia have been found to lose their unique signature rapidly and partially de-differentiate
following removal from their CNS environment (as measured by downregulation of microglia-specific
signature genes such as Tmem119 or P2yr12) (Bohlen et al., 2017). Additionally, microglia in culture
assume characteristics of more neuroinflammatory and early developmental microglia, and appear
more pro-inflammatory than microglia in vivo (Bohlen et al., 2017). Cultured microglia produce
large amounts of inducible nitric oxide synthase (iNOS) and lead to neuronal death in co-culture
when stimulated with LPS or other inflammatory stimulators (Chao et al., 1992; Pyo et al., 1998).
In contrast to that, while morphologically activated microglia positive for pro-inflammatory cytokine
IL-1 are found in lesion sites in vivo, neurons in these regions are generally healthy, and microglia
lack expression of other cytotoxic mediators (Jeong et al., 2010a,b; Min et al., 2012). Furthermore,
microglia-mediated inflammation alone is not sufficient to cause cell death in vivo (Jeong et al.,
2010a). What could potentially cause this discrepancy between microglial function in vivo and in
vitro? As wound healing and inflammation are multicellular processes, it is important to see a system
as a whole. Neurons have been described to express certain receptors to keep microglial activation
at bay, such as CD200 (Hoek et al., 2000), or fractalkine (Cardona et al., 2006). These molecules
are recognised by receptors on microglia and can dampen microglial inflammation; for example,
fractalkine receptor knockout animals display significantly enhanced inflammation and neuronal loss
in mouse models of Parkinson’s disease or amyotrophic lateral sclerosis (Cardona et al., 2006). This
highlights the fact that for disease-relevant investigation of microglia, in vivo investigations are
critical.
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The immune response is elicited immediately following CNS trauma, but has been shown to
persist for years after trauma (Gentleman et al., 2004; Johnson and Griswold, 2017; Loane et al.,
2014; Nagamoto-Combs et al., 2007; Nonaka et al., 1999; Ramlackhansingh et al., 2011). While
microglial activation per se may not be neurotoxic (or is suggested to be neuroprotective), persistent
and dysregulated activation of microglia (called microgliosis) has been proposed to result in an in-
creased neuronal loss and neurodegeneration following CNS injuries (Faden et al., 2016; Ransohoff,
2016b), as responses can become maladaptive over time due to exposure to different combinations
of stimuli (Zhang et al., 2014). Inhibition of microgliosis with minocycline was shown to reduce
the lesion volume after spinal cord injury (Festoff et al., 2006). However, Bye et al. (2007) found
that while minocycline was able to inhibit microglial activation, it did not affect acute neuronal cell
death, and another study by Scott et al. (2018) found that neuronal loss was even exacerbated in
the chronic phase following minocycline treatment after experimental traumatic brain injury, which
highlights the fact that unspecific inhibition of the immune system may not be an appropriate tool
to target secondary cell death. Additionally, selective depletion of proliferating microglia was shown
to exacerbate brain injury (Lalancette-Hebert et al., 2007). The contrasting results on microglia
in neuroprotection or neurotoxicity illustrate how difficult it is to investigate the role of microglia,
as they exhibit tremendous functional plasticity in their responses dependent on tissue and injury
context. Recent transcriptomic studies demonstrate that even within the homeostatic brain there is
considerable heterogeneity of microglia transcriptomes from distinct brain regions (Böttcher et al.,
2019; Grabert et al., 2016).
Although microglia are the resident immune cells and primary responders to CNS injuries,
their activation results in amplification of the immune response by recruitment of peripheral cells of
the innate immune system via release of chemokines and an alteration of endothelial integrin levels
(Carlos et al., 1997; Kielian et al., 2002; Tang et al., 2014; Zhou et al., 2006). This is presumably
aimed at preventing a saturation of the phagocytic system by recruitment of phagocytic neutrophils
and macrophages (Carlos et al., 1997; Tang et al., 2014). Brain entry of neutrophils is mediated by
adhesion to vasculature by enhanced expression of integrins, and extravasation (Carlos et al., 1997).
Carlos et al. (1997) found that neutrophils can appear at the injury site within minutes, and peak at
two hours post injury. In autopsy samples collected from patients who died within five minutes of
TBI, 43% showed neutrophil presence within the injury site (Oehmichen et al., 2003). Despite this
recruitment, studies suggest that microglia are the predominant phagocyte following CNS injuries
(Greenhalgh and David, 2014; Lampron et al., 2015; Schilling et al., 2005) and the presence of
peripheral immune cells may, instead of providing phagocytic support, cause neurotoxicity. This is
supported by the fact that neutrophil depletion reduces tissue loss and apoptotic cell death following
TBI in mice (Kenne et al., 2012). Neutrophils are important mediators of inflammation in peripheral
lesions to prevent bacterial invasion, and while they may not be inherently neurotoxic, Allen et al.
(2012) reported that transmigration through the endothelial barrier activated a neurotoxic pheno-
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type and mediated the release of de-condensed DNA, called neutrophil extracellular traps (Allen
et al., 2012) (Fig. 1.1), which is of paramount importance to fight infectious agents in the periph-
ery (Brinkmann et al., 2004) but causes neuronal death following brain injury (Allen et al., 2012).
Similarly, the production and release of ROS by neutrophils is critical in peripheral injuries, but in
the brain contributes to their neurotoxic characteristics (Liao et al., 2013; Neumann et al., 2008;
Nguyen et al., 2007). Interestingly, although microglia initially participate in recruitment, they can
also counteract neutrophil neurotoxicity by rapid engulfment of neutrophils (Neumann et al., 2008).
In contrast to neutrophils, the role of peripheral macrophages in the CNS is not as clearly neu-
rotoxic following TBI. However, unlike resident microglia, macrophages exhibit a highly inflammatory
phenotype in the CNS which may confer neurotoxic effects (Yamasaki et al., 2014). Infiltration of
macrophages occurs only days after injury, and is mediated by binding of C-C motif chemokine ligand
2 (CCL2) to the C-C chemokine receptor type 2 (CCR2) receptor on macrophages. Recruitment
of inflammatory macrophage subpopulations via CCR2 was shown to be required for induction of
angiogenesis during wound healing in the skin (Willenborg et al., 2012), and genetic knockdown of
CCR2 in mice led to significantly impaired wound repair at all times, suggesting a crucial role for
inflammatory control of wound repair for CCR2 (Boniakowski et al., 2018). In the injured brain,
however, macrophages recruited by a CCR2-mediated mechanism appear to be neurotoxic: CCR2-/-
mice, or mice treated with a CCR2 antagonist, had a significantly improved functional long-term
outcome (Hsieh et al., 2014; Morganti et al., 2015). Similarly, genetic knockdown of CCL2 resulted
in an improved outcome after experimental brain injury (Semple et al., 2010). Interestingly, the
neuroprotective effect of CCL2 knockdown was only visible with a delay, showing a reduced lesion
size and functional benefit over wild type at two and four weeks after injury; this may correspond
with the fact that macrophages only appear at the lesion site with a delay (24 to 48 hours) and
therefore cannot mediate an effect in the acute phase (within a few hours of the injury) (Semple
et al., 2010; Soares et al., 1995).
 Adaptive immune system
Several studies have addressed the role of B- and T-cells in the pathogenesis of neuroinflamma-
tion following TBI. Fee et al. (2003) reported a detrimental role for CD4+ T cells in the acute phase
(within 24 hours) of TBI by transfer of these cells into Rag1-/- animals lacking the adaptive immune
system. However, T cell recruitment in wild type animals or human patients usually only occurs at
later times following injury, and both in experimental and human TBI, T cell infiltration at 24 hours
after injury is found to be minimal, or non-existent, respectively (Clausen et al., 2009; Holmin et al.,
1998). Weckbach et al. (2012) challenged the findings by Fee et al., and found that depletion of the
adaptive immune cells via knockout of the crucial immune regulator rag1 did not confer neuropro-
tection following TBI. Several more recent strands of evidence point to a potential neuroprotective
role of the adaptive immune cells. This can be achieved through production of neutrotrophins that
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have been shown to promote neuronal survival (Barouch and Schwartz, 2002; Moalem et al., 1999,
2000), and modulation of the microglial polarisation by release of anti-inflammatory cytokines IL-4
and IL-10 (Butovsky et al., 2006).
Secreted components
Following activation of immune cells, but also injury of neurons, a plethora of secreted im-
mune messengers can be released. These include pro- and anti-inflammatory cytokines, chemotactic
cytokines, prostaglandins, and ROS/RNS. Depending on their receptors, secreted components can
either initiate, propagate, or inhibit the inflammatory response. Common cytokines detected in the
CNS following TBI are interleukin-1β (IL-1β), TNFα, and IL-6. IL-1β and TNFα are potent pro-
inflammatory cytokines that are rapidly upregulated following brain injury. In experimental models
of brain injury, both IL-1β and TNFα were upregulated as early as one hour after injury (Fan et al.
(1995); Kamm et al. (2006); Kinoshita et al. (2002), and Fan et al. (1995); Knoblach et al. (1999);
Shohami et al. (1994), respectively). Similarly, in postmortem tissue from human TBI patients,
tissue upregulation was detected in patients who died within seventeen minutes of TBI (Frugier
et al., 2010). IL-1β levels in the serum of patients were found to correlate with GCS at six hours
post injury (Tasç et al., 2003), but no correlation with outcome was observed (Winter et al., 2004),
which suggests IL-1β serum levels are only of limited predictive value. Conversely, increased levels of
the immunomodulatory IL-6 were associated with a better outcome of patients (Winter et al., 2004).
TNFα is capable of both promoting neuronal survival and neuronal death, depending on re-
ceptor activation. This has been demonstrated by a number of studies and explains why previous
research yielded confusing results as to whether pro-inflammatory TNFα is neurotoxic or neuro-
protective. Contrary to the general belief that neuroinflammation and pro-inflammatory cytokines
may cause neurotoxicity (Jara et al., 2007; Talley et al., 1995), Bruce et al. (1996) showed that
genetic deletion of TNF receptors exacerbates damage following brain injury. Stahel et al. (2000)
reported that mice deficient for TNFα or IL-6 both had increased mortality following TBI. Longhi
et al. (2013) showed that deletion of p75 TNFα receptor results in a significant worsening of sen-
sorimotor deficits following TBI in mice, while knockout of p55 TNFα significantly reduced lesion
volume, cell death, and improvement of sensorimotor ability compared to wild types. This suggested
that different receptor subtypes determine the outcome. Activation of TNF receptor 2 on microglia
can promote an anti-inflammatory polarisation of microglia (Veroni et al., 2010), and can rescue
neurons directly from oxidative stress (Fischer et al., 2011). Therefore, while TNFα may confer
neuroprotection in many situations, this heavily depends on receptor subtype activation.
In contrast to TNFα, the role of IL-1β appears more neurotoxic overall; IL-1β antagonism
inhibits neuronal damage after brain injury (Toulmond and Rothwell, 1995; Relton and Rothwell,
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1992). Interestingly, IL-1β has an endogenous antagonist, interleukin 1 receptor antagonist (IL-
1ra), which is a secreted glycoprotein preventing the action of IL-1β by acting as a decoy receptor
(Boraschi et al., 1995). Endogenous IL-1ra provides significant neuroprotection in a variety of brain
insults (Hutchinson et al., 2007; Loddick et al., 1997; Pinteaux et al., 2006), and administration
of recombinant IL-1ra can provide neuroprotection and reduce seizure susceptibility following TBI
(Relton and Rothwell, 1992; Semple et al., 2017; Sun et al., 2017b). A phase II human trial with
recombinant human IL-1ra (Anakinra) was successful in demonstrating safety and brain penetration
(Helmy et al., 2014), with a dose-range study for moderate to severe TBI being currently underway
(ClinicalTrials.gov, registration number NCT02997371).
To discuss the role of additional individual cytokines in more detail would be beyond the scope
of this thesis; a summary of the role of pro- and anti-inflammatory cytokines and their respective roles
in TBI is provided by Ziebell and Morganti-Kossmann (2010) and Morganti-Kossmann et al. (2018).
Considerable progress has been made in elucidating molecular pathways initiating secondary
neuronal cell death following TBI, yet it appears that there is an intricate interplay of multiple
molecular factors that is not easily dissected. This may be additionally complicated by the fact that
many of these studies rely on static snapshots of what is happening at a certain timepoint, or in
vitro work, which may give an incomplete picture of the underlying molecular pathophysiology.
1.4 The quest for a magic bullet: past and present clinical
trials
Epidemiological numbers of the incidence of TBI as well as the high percentage of long-term
disability and death highlight that TBI is a prevalent and pressing medical issue. To reduce the im-
pact and ameliorate the consequences of TBI, both preventative and curative strategies have been
aimed for. Prevention of TBI can be achieved on three levels (Park et al., 2008): primary prevention
aims to obviate TBI altogether, mainly by policy changes such as enforcing speed limits, helmet
use, or changing culture such as reducing alcohol intake, which may lead to a decline in risk-taking
behaviours. Secondary prevention entails limiting the biological impact of the injury (i.e., preven-
tion of secondary cell death). Tertiary prevention does not include traditional prevention but entails
neuro-rehabilitation and symptom management in order to restore a patient’s daily functioning.
The delayed nature of secondary cell death renders this phenomenon an ideal target for mean-
ingful medical intervention in terms of secondary prevention as outlined above. Experimental models
of brain injuries in the 1970s had identified several neuroprotective candidate drugs that could po-
tentially prevent secondary damage in humans following TBI. In combination with the establishment
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Figure 1.1: Schematic of some of the pathophysiological molecular and cellular mechanisms occurring
following traumatic brain injury. Not to scale; schematic created by me.
of the Glasgow Coma Scale (GCS) as standard assessment of severity of brain injuries by visual,
verbal and motor function in patients (Table 1.1) (Teasdale and Jennett, 1974), this fuelled the
initiation of several clinical trials in the 1980s (Maas et al., 2010). Patients could be classified
ranging from mild (GCS score 13-15), moderate (GCS score 9-15), to severe (GCS score <9) in an
internationally standardised manner (Rimel et al., 1982), rendering clinical trials more comparable
between centres. The peak of initiation of randomised controlled trials, both for neuroprotective
agents and therapeutic strategies (such as hypothermia or decompressive craniectomy), was in the
1990s. Unfortunately, the interventions in these clinical trials were largely futile, which resulted in a
reluctance of pharmaceutical companies or individual investigators to undertake financially burden-
some clinical trials, and a decrease of study initiation in the 2000s (Fig. 1.2).
Here and in Table 1.2, I have summarised the therapeutic approaches that were investigated
in phase III randomised controlled clinical trials so far.
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Figure 1.2: Clinical trials in TBI since 1980. Multi-centre phase III RCTs for traumatic brain injury plotted
for initiation and success (defined as benefit over placebo). Modified from Maas et al. (2010).
* 1 RCT initiated in 2014 has not reported results yet.
1.4.1 Therapeutic strategies
Hypothermia
Mild hypothermia - the cooling of the body and brain down to 32 ◦C - emerged as a promising
therapeutic strategy in the 1990s, targeting glutamate release and cytotoxic oedema. This was a
result of several rodent studies reporting improved cognitive and sensorimotor outcome (Bramlett
et al., 1995; Clifton et al., 1991; Dixon et al., 1998), reduced mortality (Clark et al., 1996), decreased
glutamate release (Globus et al., 1995), and reduced neuronal cell death (Dietrich et al., 1994a)
following hypothermia after acute brain injury. Similarly, two small-scale phase II clinical trials in
the 1990s provided encouraging results on an improved outcome of patients treated with mild hy-
pothermia as measured by GCS improvement (Clifton et al., 1993) or disability (Marion et al., 1993)
at three months following injury. Although later results showed that hypothermia may hasten the
recovery rather than provide an overall beneficial effect (as Glasgow Outcome Scale was significantly
improved in patients treated with hypothermia treated with hypothermia at three months, but not
at twelve months, compared to normothermic controls) (Marion et al., 1997), preliminary data from
earlier studies provided enough evidence to initiate a larger scale, phase III randomised controlled
trial (National Acute Brain Injury Study - NABIS). Patients were treated with hypothermia within
eight hours from the initial insult. Hypothermia proved futile in ameliorating outcome, and pa-
tients treated with hypothermia had more hospital days than normothermic controls (Clifton et al.,
2001). Fifty-seven per cent of patients in both groups experienced poor outcome (death, severe
disability, or vegetative state), which can most likely be attributed to the fact that recruited patients
were in a coma to begin with. Nonetheless, hypothermia did not cause any improvement of outcome.
A pre-clinical study published the same year as the NABIS trial investigated the therapeutic
window of hypothermia following acute brain injury in rodents, and found that hypothermia was
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only effective at improving the outcome if applied within 60 minutes of the insult in rats (Markgraf
et al., 2001). This inspired the initiation of a second NABIS hypothermia trial (NABIS:H IIR) with
very early application of hypothermia, setting a tighter therapeutic window (two and a half instead
of eight hours). This trial was terminated as, even when applied within two and a half hours,
hypothermia again proved futile and did not improve poor outcome of patients compared to the
control group (death, severe disability, or vegetative state) (Clifton et al., 2011). Post-hoc analysis
drew attention to potential effectiveness in patients under the age of 18 years. This stood in contrast
to a 2008 trial assessing the effect of hypothermia following TBI in children which had shown a
worsening of clinical outcome and an increase in mortality when treated with hypothermia within
eight hours (Hutchison et al., 2008); however, issues with the study design and chosen endpoints
raised questions about the validity of these prior findings and provided the incentive to evaluate
the outcome on a larger scale (Adelson, 2009). A separate RCT was initiated evaluating the effect
of hypothermia applied within six hours following injury in children and young adults (Cool Kids
study). Similar to previous trials in adults, hypothermia was ineffective at reducing unfavourable
outcomes and the study was prematurely terminated for futility (Adelson et al., 2013).
Decompressive craniectomy
Decompressive craniectomy (DC) following traumatic head injuries was first described by
Kocher in 1901 to alleviate ICP (Kocher, 1901). Interest in the procedure waned over time due to
low success rates, and particularly following a report that DC may actually increase oedema follow-
ing experimental brain injury in dogs up to sevenfold (Cooper et al., 1979). In the 1990s, there
was a resurgence of interest due to new technologies to monitor intracranial pressure and image
the brain, resulting in a number of studies and RCTs published in the 2000s. Initially, the majority
of studies were retrospective reports, which found that although DC was effective at reducing in-
tracranial pressure, it did not have a beneficial effect on the clinical outcome (Münch et al., 2000;
Pompucci et al., 2007; Williams et al., 2009). Interestingly, these studies also found that younger
patients benefited more from DC, suggesting patient age may play a factor deciding the success of
this intervention, which was confirmed by pilot studies reporting early DC in young patients resulted
in a better outcome (Figaji et al., 2003; Taylor et al., 2001).
Later RCTs conducted in adults, or both adults and children, could not prove a beneficial
effect of DC. Cooper et al. (2011) report that while intracranial pressure was significantly lowered
in patients receiving DC compared to standard medical care, DC patients had longer stays in the
intensive care unit and an overall worse outcome. A larger-scale study (RescueICP) published in 2016
showed that DC was effective at reducing mortality, yet increased the occurrence of severe disability
and vegetative state (Hutchinson et al., 2016), which suggests that DC can prevent mortality by
lowering ICP but does not prevent any other secondary damage. This was confirmed by a 2017
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metanalysis reporting that DC is effective at lowering intracranial pressure and may therefore reduce
mortality, but does not affect outcome (Zhang et al., 2017). Therefore, DC may be a useful
therapeutic strategy in the management of derailing intracranial pressure following TBI, but has no
functional benefit over standard care. DC has its own set of complications including brain herniation
through the skull, and trephination, which could require further surgery to treat (Honeybul and Ho,
2011), and therefore the current recommendation for performing DC is only within strict regulations
and justification.
1.4.2 Neuroprotective agents
Over the years, several clinical trials have been targeting a variety of pathomechanisms involved
in secondary damage following TBI by pharmacological intervention. These neuroprotective agents
had often shown great promise in rodent models of TBI, yet failed in the clinic: they either showed
no therapeutic effect compared to placebo, or - in some cases - actually resulted in higher mortality
and therefore these studies had to be prematurely terminated. To date, there is no pharmacological
agent that has shown a superior effect than placebo in any multi-center randomised controlled trial.
Here, I will provide an overview over the most historically prominent candidates for treating TBI.
Steroids
Similar to DC, the initial indication of corticosteroids in TBI in the 1980s was to alleviate
intracranial pressure. RCTs describing ’high-dose’, ’megadose’, and ’ultrahigh’ doses of the widely-
used corticosteroid dexamethasone provided no evidence of any beneficial treatment effect over
placebo (Braakman et al., 1983; Dearden et al., 1986; Gaab et al., 1994). Another study using
the glucocorticoid triamcinolone reported that, while there was no overall treatment benefit, pa-
tients with focal lesions had made a better recovery at one year post injury (Grumme et al., 1995).
Further pre-clinical research investigating neuroinflammation (summarised by Morganti-Kossmann
et al. (2002)) provided the incentive for the largest clinical trial to date in TBI: the MRC CRASH
trial (Corticosteroid Randomisation After Significant Head Injury), applying corticosteroid methyl-
prednisolone. The MRC CRASH trial had to be prematurely terminated after recruiting 10,000
patients (the initial aim was 20,000) due to a significantly higher mortality and increased risk of
severe disability in the treatment group compared to controls (Edwards et al., 2005).
Progesterone, a steroid hormone with many targets, was a promising candidate in treatment for
TBI until 2014. Progesterone was initially discovered as a neuroprotective candidate due to the fact
that females tended to recover better from TBI than males from experimental brain injury (Bramlett
and Dietrich, 2001; Roof et al., 1993). Further pre-clinical research showed that progesterone
attenuated oedema (in males and females) (Roof et al., 1992, 1996), decreased neuroinflammation
and inflammation-associated cytokines (only tested in males) (He et al., 2004; Pettus et al., 2005),
26
and facilitated cognitive recovery while reducing neuronal loss and gliosis (only tested in males)
(Djebaili et al., 2005; Roof et al., 1994; Shear et al., 2002). Consistent with pre-clinical results, two
small-scale phase II RCTs reported improved outcomes in patients treated with progesterone (Wright
et al., 2007; Xiao et al., 2008), which provided the incentive to carry out larger scale phase III studies
(PROtectIII, SYNAPSE), dosing with progesterone began either within four or eight hours following
injury, respectively. The SYNAPSE study reported no clinical benefit of progesterone administration
over placebo within eight hours in a randomised sample of 1195 patients (Skolnick et al., 2014).
The PROtectIII study was terminated before recruiting the initially planned patient sample of 1140
over futility, as it showed no improved outcome following progesterone treatment with four hours
of TBI in 882 patients (Wright et al., 2014). In a secondary study assessing cognitive and motor
functioning such as memory, attention, fine motor coordination, executive function and language
(rather than the usual assessment of reduced mortality and improved Glasgow Outcome Scale) in
the PROtectIII patient group, researchers did not find any improvement compared to placebo, again
suggesting that progesterone did not provide a neuroprotective effect in the clinic (Goldstein et al.,
2017).
NMDA receptor antagonists and other calcium channel inhibitors
Throughout the 1990s and 2000s, several NMDA receptor and calcium channel inhibitors were
tested for neuroprotection through inhibition of excitotoxicity following TBI in a clinical setting,
all of which ultimately failed to elicit an improved outcome. Several pharmaceutical companies,
including Bayer, Novatis, Pfizer, and Parke Davis moved compounds that had previously shown
neuroprotective effects in animal models of TBI forward to the clinic. None of these compounds
managed to prove successful in the clinic. Nimodipine, a calcium channel blocker, initially showed
a reduction in unfavourable outcome (death and vegetative state) at six months (Harders et al.,
1996), but a later study failed to confirm this finding (Vergouwen et al., 2006). Other compounds
targeting excitotoxicity and/or calcium signalling suffered an even worse fate. A RCT assessing
the effect of NMDA receptor antagonist Selfotel in patients with TBI was terminated over safety
concerns following a report of increased mortality in contemporary clinical trials of Selfotel in is-
chaemic stroke patients (Davis et al., 1997, 2000). Although post-hoc analysis revealed that there
was no increased mortality following TBI compared to placebo, there was also no significant treat-
ment benefit (Morris et al., 1999). SNX-111, a presynaptic calcium channel antagonist, showed
a strong neuroprotective effect in an experimental brain injury model (Perez-Pinzon et al., 1997),
but higher mortality in humans compared to placebo following TBI, leading to termination of the
RCT (unpublished, mentioned by Maas et al. (2010)). Similarly, and although not terminated,
treatment with magnesium sulfate (which causes NMDA receptor blockade and calcium channel
inhibition, amongst other mechanisms), resulted in a poorer outcome than treatment with placebo
at six months (Temkin et al., 2007) and was therefore abandoned as a therapeutic strategy. A final
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trial involving a competitive NMDA receptor antagonist (Dexanabinol) failed although the com-
pound showed a highly neuroprotective effect in pre-clinical studies (Maas et al., 2006). No more
clinical trials targeting calcium channels or NMDA receptors have been initiated so far, and it is
generally thought that this therapeutic strategy has failed. This could be due to several reasons,
and some of it is attributed to the fact that NMDA receptors can physiologically promote neuronal
survival; following initial calcium overload immediately after an injury, NMDA receptors may resume
their pro-survival functions (Ikonomidou and Turski, 2002). Therefore, it seems the picture is much
more complex than previously thought, and further research is required to elucidate the molecular
mechanisms underlying secondary cell death.
Free radical scavengers and inhibitors of lipid peroxidation
As a reduction of oxidative stress via administration of SOD had shown promising results in
experimental models of TBI (Kontos and Wei, 1986), clinical trials using a more stable, polyethylene
glycol-conjucated version of SOD (PEG-SOD) were initiated in the 1990s. An initial small phase II
study revealed an improvement of GCS at three and six months following injury compared to placebo
in patients with severe head injury (although not statistically significant) (Muizelaar et al., 1993).
This led to initiation of a phase III trial, which however was unable to demonstrate an improved
outcome (Young et al., 1996), although animal studies conducted around the same time showed
significant neuroprotective effects by elevation of SOD levels (Chan et al., 1995; Mikawa et al.,
1996; Xiong et al., 2005) and PEG-SOD treatment (Hamm et al., 1996). It is likely that the human
trials failed due to the relatively short therapeutic window; pre-clinical research suggested that ROS
bursts predominantly occurred within the first hour following injury (Hall et al., 1993; Smith et al.,
1994). Furthermore, PEG-SOD may have low brain permeability and only affect microvasculature
but not brain parenchyma (Hall et al., 2010).
Based on these limitations, it was concluded that direct targeting of detrimental downstream
effects of free radicals, such as lipid peroxidation, may be a more viable therapeutic option. Lipid
peroxidation is initiated within the first hour following injury (Smith et al., 1994) but persists for
several days following injury (Du et al., 2004). Experimental models of TBI in mice, rats, and
cats had shown a neuroprotective effect of lipid peroxidation inhibitor tirilazad (21-aminosteroid
U74006F) (Dimlich et al., 1990; Hall et al., 1988; McIntosh et al., 1992). A phase III clinical trial
did not show a positive treatment effect compared to placebo (Marshall et al., 1998), although
post-hoc analysis revealed a potential beneficial effect for males with subarachnoid haemorrhage
(SAH), consistent with pre-clinical findings that tirilazad was highly effective for treating SAH (Hall
et al., 1994).
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Current status and future outlook
Following the 1990s peak of clinical trials, trial initiations have significantly decreased, and
none succeeded (Fig. 1.2). The only multi-centre trial of a neuroprotective drug for TBI regis-
tered on clinicaltrials.gov as of February 21st 2019 is a nitric oxide synthase inhibitor (VAS 203,
Ronopterin; NCT02794168). Ronopterin showed promising results and improved patient outcome
in a phase II study (Stover et al., 2014). The phase III trial is currently still recruiting and study
results are expected in June 2019.
What made so many highly promising candidates fail in clinical trials? The main argument
for this is currently the large heterogeneity of patients with traumatic brain injury. No TBI is the
the same as the next - depending on the type of insult, location, patient age, and comorbidities.
In contrast to that, experimental models of traumatic brain injury are carried out in a tightly
regulated manner (Maas et al., 2010). Additionally, endpoint measurements in human clinical
trials may be insensitive to smaller changes. Nonetheless, there is a need for further investigation
of neuroprotective mechanisms following TBI (and other CNS injuries), and innovative models to
investigate the cellular and molecular processes in vivo are required to provide a more detailed picture
of the pathophysiology.
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Table 1.2: Therapeutic approaches to treat TBI. Compounds that have been used in the clinic, their
respective targeted pathomechanism, and reported outcomes in clinical trials.
Therapeutic ap-
proach
Target Outcome in Phase III RCTs
Hypothermia Elevated ICP, glutamate
release
· NABIS study: more hospital days (adults)
(Clifton et al., 2001)
· NABIS:H IIR study: terminated for futility
(adults) (Clifton et al., 2011)
· Cool Kids study: terminated for futility (< 18
years) (Adelson et al., 2013)
Decompressive
craniectomy
Elevated ICP · worse outcome and longer hospital stay (Cooper
et al., 2011)
· RescueICP study: reduced mortality, but in-
creased occurrence of severe disability and veg-
etative state (Hutchinson et al., 2016)
Methylpredni-
solone
neuroinflammation · MRC CRASH study: terminated due to higher
mortality and increased risk of severe disability in
treatment group (Edwards et al., 2005)
Progesterone neuroinflammation,
oedema
· SYNAPSE study: no improved outcome (Skol-
nick et al., 2014)
· ProTECTIII study: terminated for futility
(Wright et al., 2014)
· assessment of cognitive functions in patients of
Wright et al. (2014) no improved cognitive func-
tion (Goldstein et al., 2017)
Selfotel excitotoxicity · terminated over safety concerns (Davis et al.,
1997, 2000)
SNX-111 excitotoxicity · terminated and unpublished, higher mortality
(Maas et al., 2010)
Magnesium sul-
fate




· no improved outcome (Maas et al., 2006)
PEG-SOD oxidative stress · no significant treatment effect (Young et al.,
1996)
Tirilazad lipid peroxidation · no significant treatment effect (Marshall et al.,
1998)
Ronopterin nitric oxide synthase · expected June 2019
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1.5 The zebrafish as a model of successful (CNS) regeneration
The zebrafish (Danio rerio) gained popularity as a model organisms for developmental biology
in the 1990s due to its external and rapid development. Importantly, in contrast to the classical
developmental model (Drosophila melanogaster), the zebrafish is a vertebrate, and is able to shed
light on vertebrate development. George Streisinger is considered the pioneer of zebrafish research.
He hoped to use genetic tools to study vertebrate development using zebrafish, and introduced the
world of molecular and developmental biology to zebrafish in the 1980s (Streisinger et al., 1981).
Following his passing in 1984, the zebrafish was picked up by several other labs, including that of
1995 Nobel Prize Winner Christiane Nüsslein-Volhard. The breakthrough of zebrafish as a laboratory
organism is often thought to be the 1996 special issue of the journal Development, containing 38
zebrafish research papers from four different groups containing the results of a large-scale screen for
genes regulating development analogous to a previous one in Drosophila.
While zebrafish started out as a popular developmental biology model, the sequencing of the
zebrafish genome revealed that the zebrafish shares 70% of genes with humans, and 84% of genes
associated with human disease have a zebrafish counterpart (Howe et al., 2013). In addition to its
extensive use in developmental biology, the zebrafish is capable of scarless healing and complex tissue
regeneration, including regeneration of fin, heart, brain, and spinal cord (Gemberling et al., 2013).
In combination with the fact that zebrafish are more economical to keep than traditional disease
models such as rodents, this renders zebrafish an attractive model organism for many research areas.
1.5.1 Comparison of injury reactions between zebrafish and mammals
While mammalian wound repair is scarless in embryogenesis, scars are left behind in adulthood.
Conversely, adult zebrafish are capable of repair with minimal or no scarring and complex tissue
regeneration (Becker et al., 2004; Petrie et al., 2015; Richardson et al., 2013), which instigated the
investigation of reactions to injury in these animals to identify potential therapeutic targets. Research
showed that zebrafish wound repair recapitulates phases of mammalian wound repair (inflammation,
proliferation, remodelling) (Kroehne et al., 2011; Richardson et al., 2013; Sánchez-Iranzo et al.,
2018). In contrast to mammals, where skin re-epithelialisation (and therefore re-establishment of
a barrier) depends on cell proliferation, skin re-epithelialisation in zebrafish is rapid, transcription-
and proliferation-independent, occurs within one to three hours of wounding, and is achieved by a
thin epidermal layer migrating to cover the wound (Poleo et al., 2001; Richardson et al., 2013).
This suggests that transcription-independent factors as mentioned in Chapter 1.2.1 play a critical
role in adult zebrafish repair and regeneration. Conversely, later steps such as the proliferation of
progenitors require inflammation and potentially even scarring (Hasegawa et al., 2017; Kyritsis et al.,
2012; Richardson et al., 2013; Sánchez-Iranzo et al., 2018). Sánchez-Iranzo et al. (2018) show that
inhibition of fibrosis prevented cardiomyocyte proliferation during cardiac repair. Although fibrosis -
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typically associated with scarring - occurs in this injury model, zebrafish are capable of switching off
pro-fibrotic response to allow successful regeneration both in the heart and skin (Richardson et al.,
2013; Sánchez-Iranzo et al., 2018). Research is currently investigating how successful repair and
regeneration is achieved in zebrafish. It appears likely that macrophage control of wound repair is
crucial to this regenerative success, as absence of this cell type has been shown to impair wound
repair and regeneration in zebrafish (Lai et al., 2017; Petrie et al., 2015; Tsarouchas et al., 2018).
1.5.2 CNS regeneration in zebrafish
Much of the research investigating CNS regeneration in zebrafish has been performed in adult
zebrafish as researchers aimed to identify factors that could initiate a successful and scarless re-
generative response in a mature central nervous system (Becker and Becker, 2008). However, the
zebrafish larva has recently also been established as an attractive model to investigate regeneration
for its amenability to pharmacological and genetic manipulation as well as the ability to perform
time-lapse in vivo imaging to visualise repair processes over time (Hasegawa et al., 2017; Morsch
et al., 2015; Ohnmacht et al., 2016; Tsarouchas et al., 2018; Wehner et al., 2017). Here, I have
summarised the research to date investigating regenerative neurogenesis, axonal outgrowth, and cell
death following CNS trauma in zebrafish.
Absence of bona fide astrocytes: the reason for scarless CNS repair?
Zebrafish lack bona fide astrocytes. As astrocytes form a glial scar following CNS injuries, the
absence of this cell type could potentially explain the scarless response. However, zebrafish possess
radial glia. These cells have been found to directly transform into astrocytes during late mammalian
development (Barry and McDermott, 2005; Voigt, 1989). It is possible that while this step does
not occur in zebrafish, radial glia become specialised to serve astrocyte functions. This is supported
by the fact that subsets of radial glia express reactive astrocyte marker glial fibrillary astrocyte pro-
tein (GFAP) (Lyons et al., 2003), participate in tight junctions (Corbo et al., 2012), or function
as progenitors (Mahler and Driever, 2007) (astrocytes and radial glia have been shown to function
as neural stem cells in the adult mammalian CNS) (Kriegstein and Alvarez-Buylla, 2009). Similar
to reactive astrocytes, radial glia are present following injuries to zebrafish brain (Baumgart et al.,
2012; Kishimoto et al., 2012; Kroehne et al., 2011; März et al., 2011), spinal cord (Goldshmit et al.,
2012; Hui et al., 2010), and optic nerve (Neve et al., 2012), and overexpression of lipocalin-2 (a
mediator of reactive astrocytosis in mammals) results in thickening of GFAP+ radial glia processes
(Lee et al., 2009). Importantly, in contrast to scar-forming astrocytes in the mammalian CNS, radial
glia promote CNS repair by neurogenesis (Baumgart et al., 2012; Kroehne et al., 2011; Kishimoto
et al., 2012; März et al., 2011), guidance of newborn neurons along their processes (Kishimoto et al.,
2012), and may support axon outgrowth following SCI via glial bridges (Goldshmit et al., 2012) al-
though recent time-lapse imaging reveals that axons may find their path independently (Tsarouchas
32
et al., 2018).
Thus, although zebrafish lack astrocytes, they have radial glia which perform similar functions
in their CNS, and it appears unlikely that the absence of scar-forming astrocytes is the main reason
for their regenerative success. However, it may be possible to study radial glia behaviour following
injuries and identify pathways to modify astrocytes in order to push them into a more radial glia-like
phenotype, promoting repair.
Regenerative neurogenesis
While the mammalian brain is capable of adult neurogenesis, this only occurs in discrete re-
gions of progenitor pools (dentate gyrus of the hippocampus, subventricular zone of the lateral
ventricle, and olfactory bulb) (Ming and Song, 2005). Brain injury in mammals leads to an increase
of neurogenesis in these proliferative zones (Dash et al., 2001; Rice et al., 2003; Sun et al., 2005;
Urrea et al., 2007), but the percentage of neurons that can be replaced after brain insult is estimated
to represent only 0.2% of the lost number (Arvidsson et al., 2002), and the evidence for functional
integration of neurons generated in response to injury is conflicting (Arvidsson et al., 2002; Sun
et al., 2007). Furthermore, injury in the mammalian brain was shown to cause aberrant migration
and misplacement of newborn cells in the hippocampus (Ibrahim et al., 2016).
Conversely, zebrafish exhibit constitutive adult neurogenesis in most parts of their brain
(Grandel et al., 2006; Zupanc, 2006), and the extent of proliferation is one to two orders of mag-
nitude higher than in mammals: the number of new cells formed in proliferating zones per day in
the mouse or rat brain correspond to 0.003% to 0.03% of the estimated number of total cells in the
brain (Cameron and McKay, 2001; Herculano-Houzel and Lent, 2005; Lois and Alvarez-Buylla, 1993;
Williams, 2000). In contrast to that, in any given two hour period, 0.2% of total estimated cells
in the fish brain are dividing in proliferating zones (Zupanc and Horschke, 1995). The progenitors
(radial glia) are situated along the ventricle and usually only supply new neurons within one to two
cell diameters of the ventricular surface in the brain (Adolf et al., 2006). Several research groups
have investigated response of neural progenitors following a mechanical brain injury to the adult
zebrafish telencephalon (Baumgart et al., 2012; Kishimoto et al., 2012; Kroehne et al., 2011; März
et al., 2011). This research revealed that newly generated cells can be driven out to the parenchyma
to replenish lost cells in response to brain injury, survive for at least 100 days and express mature
neuronal markers (Baumgart et al., 2012; Kishimoto et al., 2012; Kroehne et al., 2011; März et al.,
2011). Migration of newborn neurons after zebrafish brain injury occurs in an organised manner and
is guided by radial fibers (Kishimoto et al., 2012), which resembles migration of newborn neurons
during of the mammalian cortex (Noctor et al., 2001). Not only the brain, but also the spinal
cord of zebrafish is capable of regenerative neurogenesis. This has been demonstrated following
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mechanical spinal cord injury as well as targeted genetic or pharmacological ablation of spinal cord
motor neurons in zebrafish (Ohnmacht et al., 2016; Reimer et al., 2008).
Identifying pathways that potentiate neurogenesis and increase the permissiveness of newborn
neuron survival following an injury could potentially prove paramount to treatment of human brain
injuries, and research so far has shown that while mammalian regenerative neurogenesis is very
limited to begin with, the newborn neurons that are generated do not survive well (Arvidsson et al.,
2002). Kizil et al. (2012) found that chemokine receptor cxcr5, previously predominantly known to
be involved in B-cell follicle maturation, played a role in conveying the permissiveness of adult neu-
rogenesis. Kishimoto et al. (2012) identified the Notch pathway as a key regulator of neurogenesis
in the telencephalon following an injury. Shimizu et al. (2018) showed that Wnt signalling regulates
the regenerative response of the optic tectum following stab injury. Furthermore, inflammation can
boost proliferation of neural progenitors in zebrafish (Kyritsis et al., 2012). Conversely, inflamma-
tion has previously been shown to be detrimental to mammalian adult neurogenesis (Ekdahl et al.,
2003; Monje et al., 2003), although more recent evidence suggests that polarisation of microglia
may dictate whether neurogenesis is suppressed or enhanced by inflammation (reviewed by Kohman
and Rhodes (2013)).
Similar to mechanical injury, induction of excitotoxic lesion by injection of quinolonic acid into
the zebrafish brain was shown to induce neurogenesis, and newly generated neurons were able to
survive long-term (at least for eight weeks post quinolonic acid application) and form long-distance
projections with synapses in the contralateral hemisphere of the telencephalon (Skaggs et al., 2014).
Interestingly, the regenerative response to brain injury seems to decrease with age, although the
molecular mechanisms underlying this are not yet clear (Edelmann et al., 2013).
Spinal cord regeneration
Zebrafish are capable of functional central nervous system repair in the spinal cord; adult
zebrafish regain the ability to swim within six weeks following spinal cord transection (Becker et al.,
1997). This requires axonal regrowth, and inhibition of axonal crossing of the lesion site by applica-
tion of a mechanical barrier prevents functional recovery (Becker et al., 2004). Studies in the larval
zebrafish have enabled in vivo imaging of the spinal cord repair process. Ohnmacht et al. (2016)
showed that larval zebrafish functionally recover within two days post lesion after spinal cord tran-
section. Recent studies showed that the inflammation, macrophages, and deposition of a permissive
extracellular matrix by deposition of collagen XII are crucial for axonal outgrowth and functional
recovery following larval zebrafish spinal cord injury (Tsarouchas et al., 2018; Wehner et al., 2017).
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Cell death following CNS trauma
A number of papers have investigated cell death following CNS trauma in fish. Zupanc et al.
(1998) assessed apoptotic cell death following cerebellar lesioning in fish by morphological cell anal-
ysis and terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. The
authors showed that TUNEL+ cells appear within five minutes, peak at thirty minutes post injury,
and decrease from two days post lesion to achieve baseline levels around twenty days post lesion.
The authors conclude that apoptotic cell death in the fish brain aids to limit inflammation typically
associated with mammalian brain injury, leads to efficient removal of cells, and may be associated
with the tremendous regenerative potential of fish following CNS injuries (Zupanc et al., 1998).
Three studies have investigated cell death following spinal cord injury. Ohnmacht et al. (2016)
investigated cell death of olig2+ oligodendrocyte-lineage cells in the larval zebrafish spinal cord fol-
lowing injury, and did not detect an increased number of TUNEL+/olig2+ cells following injury.
Tsarouchas et al. (2018) assessed cell death following SCI by TUNEL staining and found an in-
crease one day post lesion, but numbers of TUNEL+ cells were rapidly restored to baseline levels
at two days post lesion. In the adult zebrafish, Hui et al. (2010) quantified cell death by TUNEL
and immunohistochemistry against a key enzyme in the apoptotic cascade (Caspase-3). Both these
markers were reported to occur from six hours post lesion, peak at one day post lesion, and return
to baseline within three days post lesion (Hui et al., 2010). In line with Zupanc et al. (1998), Hui
et al. (2010) suggested that apoptotic cell death may help to control inflammation and promote
debris clearance, key to the regenerative potential of zebrafish.
In the adult telencephalon, Kroehne et al. (2011) found that although numbers of TUNEL+
cells return to baseline levels rapidly (as early as three days after lesioning), cell death is not
spatially confined to the lesion site, which is similar to what is observed in mammalian brain injuries
(Bayly et al., 2006; Pohl et al., 1999). Skaggs et al. (2014) find that excitotoxic lesioning of the
telencephalon by quinolonic acid injection leads to significant cell death. Both quinolonic acid and
vehicle injection caused early cell death at four hours post lesion as monitored by TUNEL. Similar to
Kroehne et al. (2011), the authors found that TUNEL+ cells spread from the injury site throughout
the whole telencephalic hemisphere at one and two days post lesion, although significantly more so
for quinolonic acid that for vehicle, suggesting a role for excitotoxicity in promoting cell death in





There is currently a lack of successful neuroprotective strategies to prevent or limit secondary
neuronal cell death following acute CNS trauma, which has been emphasised by the failure of clin-
ical trials to improve outcomes following TBI (Maas et al., 2010, 2017). In my thesis, I aimed to
elucidate processes that underlie secondary cell death from a new angle: a limitation of the majority
of previous studies investigating mechanisms of secondary cell death and neuroprotection was the
reliance upon static snapshots of the molecular and cellular processes following sacrifice of rodents,
or in vitro models which only provide an incomplete picture of what is happening in vivo (Jeong
et al., 2013). To circumvent these limitations, I aimed to establish a larval zebrafish model of brain
injury. Larval zebrafish offer the key advantages of optical transparency and the availability of a
multitude of transgenic fluorescent reporter lines, which allow for real-time observation of cellular
and molecular processes in vivo. Furthermore, larval zebrafish develop rapidly and by three days post
fertilisation, the optokinetic response is established; by five days, larval zebrafish are able to track
and capture prey, suggesting a rapid maturation of the optic tectum, the largest part of the larval
zebrafish brain (Cooper et al., 2015). Finally, the larval zebrafish has previously been successfully
used to investigate the molecular and cellular mechanisms of spinal cord repair in vivo (Ohnmacht
et al., 2016; Tsarouchas et al., 2018; Wehner et al., 2017).
Although several studies have previously investigated cell death in response to CNS injury in
the zebrafish (Chapter 1.5.2), there is only limited knowledge about the occurrence and dynamics
of primary cell death and secondary cell death (directly caused by mechanical disruption of tissue
injury, versus indirectly caused by biochemical cascades elicited by injury) in these animals. To
address this gap in the literature and assess the suitabiliy of the larval zebrafish to investigate the
mechanisms underlying secondary cell death, I aimed to characterise primary and secondary (direct
and indirect) cell death in response to a mechanical injury to the optic tectum, which was easily
accessible for mechanical manipulation and microscopy due to its superficial position.
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To investigate potentially neuroprotective mechanisms, I then aimed to study early, transcription-
independent wound signalling mechanisms and the immune system. Over the past decade, there
has been mounting evidence of tissue regenerative and potentially neuroprotective functions of mi-
croglia/macrophages. As microglia/macrophages are highly dynamic and plastic cells, thorough
investigation of these cell types requires analysis methods that are capable of detecting these dy-
namic changes; the larval zebrafish model is therefore ideal to investigate the functions of these
cells following injury. Furthermore, as the adaptive immune system only fully matures at four to six
weeks post fertilisation in the zebrafish (Novoa and Figueras, 2012), this enabled me to specifically
investigate the role of the innate immune cells in secondary cell death.
I formulated the following hypotheses for my research:
1. Secondary cell death occurs in larval zebrafish following brain injury, and is mediated by similar
mechanisms as in mammals.
2. Brain injury leads to rapid calcium waves that can influence and induce repair mechanisms by
suppressing excessive cell death, recruiting microglia, and stimulating neurogenesis.
3. Microglia mediate neuroprotection following brain injury.
To test the outlined hypotheses, I set out the following aims for my project:
1. to describe cell death dynamics in response to injury, including distinction between primary
and secondary cell death
2. to identify and describe early signalling pathways, in particular calcium signalling, and its effect
on microglia recruitment, cell death, and neurogenesis
3. to study the role of microglia/macrophages in brain injury: which cells are recruited to the
injury? What is their function once at the injury site? Is their presence beneficial or harmful?
4. to identify microglia/macrophage-derived molecules that could present potential therapeutic





All animals used were maintained under standard conditions (Westerfield, 2007), and experi-
ments were performed in accordance with the British Home Office Regulations. Fish were kept at
the Queen’s Medical Research Institute fish facility on a 14 h light and 10 h dark cycle. Embryos
were raised in E3 at 28.5 ◦C (Westerfield, 2007). If necessary, larvae were raised in E3 containing
0.001% N -Phenylthiourea (Sigma-Aldrich, P7629) to avoid formation of pigment. AB and WIK
strains were used as wild type animals.
3.2 Transgenic fish lines
The following transgenic zebrafish lines were used throughout the course of my research:
Table 3.1: Zebrafish lines. Transgenic and mutant zebrafish lines used over the course of my research.
Name Reference
tg(β-actin:GCaMP6f) Christian Moritz, Francesca Peri, unpub-
lished; see below
tg(mpeg1 :GFP) Ellett et al. (2011)
tg(mpeg1 :mCherry) Ellett et al. (2011)
tg(p2y12 :P2Y12-GFP; mpeg1 :mCherry) Sieger et al. (2012), Ellett et al. (2011)
tg(H2Az :GFP) Pauls et al. (2001)
tg(NBT ::∆LexR-LexOP::secA5-BFP),
referred to as tg(NBT :secA5-BFP)
Mazaheri et al. (2014)
tg(NBT :dsRed) Peri and Nüsslein-Volhard (2008)
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tg(her4.1 :TetA-GBD-p2a-mCherrytud6), re-
ferred to as tg(her4.1 :mCherry)
Knopf et al. (2010)
tg(her4.3 :GFP) Yeo et al. (2007)
tg(elavl3 :kaede) Sato et al. (2006)
tg(mpo:GFP) Renshaw et al. (2006)
irf8st95/st95, referred to as irf8-/- Shiau et al. (2015)
tgBAC(il1b:GFP)SH445, referred to as
il1b:GFP
Ogryzko et al. (2018)
tg(tnfa:eGFP-F) Nguyen-Chi et al. (2015)
3.2.1 Generation of β-actin:GCaMP6f transgenic fish line
The transgenic line β-actin:GCaMP6f was generated by Dr. Christian Moritz in the laboratory of Dr.
Francesca Peri. Briefly, the transgenic line was generated by in by placing the GCaMP6f sequence
(Chen et al., 2013) under the zebrafish β-actin promoter, flanked by Tol2 sites (Kwan et al., 2007).
The construct was injected into one-cell stage embryos together with Tol2 transposase. Larvae from
F2 or subsequent generations were used for this study.
3.3 Mosaic labelling of individual tectal neurons
The plasmid was generated by Ryan Kelly and Dr. David Greenald. To generate the
elavl3 :TdTomato-CAAX plasmid, referred to as elavl3 :memTdTomato, we combined the entry
clones p5E-elavl3 (Don et al., 2017), pME-TdTomato-CAAX (Walton et al., 2015) and p3E-polyA
(Kwan et al., 2007) with the destination vector pDestTol2pA2 (Kwan et al., 2007) using Gateway LR
Clonase II enzyme (Life Technologies) according to manufacturer’s instructions. For mosaic labelling
of tectal neurons, 1 nL of elavl3:memTdTomato plasmid DNA at a concentration of 25 ng/µL was
injected into one cell stage zebrafish embryos, and animals were allowed to develop until four days
post fertilisation.
3.4 Induction of brain injury
Zebrafish larvae at 4 days post fertilisation (dpf) were anaesthetised using bath application of
0.01% Ethyl 3-aminobenzoate methanesulfonate (MS-222) and mounted in 1% low-melting point
agarose (Life Technologies) in E3. The optic tectum was then injured under visual guidance of a
stereomicroscope using a minutien pin (Fine Science Tools) mounted on a micromanipulator (World
Precision Instruments). Larvae were released from the agarose and allowed to recover for varying
amounts of time depending on experimental requirements. If calcium imaging was performed during
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and immediately after injuring, the injury was induced on the stage of a confocal microscope in the
same manner as described above.
3.5 Whole-mount immunostaining of zebrafish larvae
All steps were carried out at room temperature and under gentle agitation unless otherwise speci-
fied. Larvae were euthanised in 0.4% MS-222 at desired timepoint and fixed in 4% paraformaldehyde
(Sigma-Aldrich, 158127) in PBS with 1% DMSO for 12 to 16 h at 4 ◦C. After fixation, larvae were
washed in PBS. If necessary, pigment was removed by incubation in bleaching solution (3% H2O2,
0.5X SSC, 5% formamide) for 30 to 40 min without agitation. Larvae were then permeabilised by ap-
plication of 2 mg/mL collagenase in PBS for 25 min, and subsequently post-fixed in 4% paraformalde-
hyde with 1% DMSO for 30 min (both steps without agitation). Blocking was carried out for 2 h in
blocking buffer (1% normal goat serum, 1% bovine serum albumin, 1% DMSO, 1% Triton X-100,
and 0.01% sodium azide in PBS). Primary antibodies were applied in blocking buffer for 12 to
16 h at 4 ◦C. I used the following primary antibodies: rabbit monoclonal anti-cleaved Caspase-3
(BD Pharmingen, catalogue number 559565; 2 µg/µL); rabbit polyclonal anti-mpo (GeneTex, cat-
alogue number GTX128379-50ul; 6.5 µg/µL); mouse polyclonal anti-4C4 (courtesy of Becker lab,
1:50 [concentration not known]); chicken polyclonal anti-GFP (Abcam, catalogue number ab13970,
25 µg/µL). Larvae were washed in PBS with 1% Triton X-100, and treated with 100 µg/mL RNAse
A in PBS for 30 min at 37 ◦C to remove RNA if nuclear counterstaining with PI was required. They
were then incubated in secondary antibody and, if nuclear counterstaining was required, 1 µg/mL
PI, in blocking buffer for 12 to 16 h at 4 ◦C. The following secondary antibodies were used (all at
4 µg/µL, i.e., 1:500): goat anti-rabbit IgG Alexa Fluor 488 (A11008); goat anti-mouse IgG Alexa
Fluor 488 (A11001) (all by Life Technologies); donkey anti-chicken Alexa Fluor 488 (703-545-155);
donkey anti-mouse Alexa Fluor 647 (715-605-151) (both by Jackson ImmunoResearch). Larvae were
washed in PBS with 1% Triton X-100 and subsequently in PBS before mounting in 1% low melting
point agarose in PBS for confocal imaging.
3.6 Image acquisition
For fixed samples, larvae were prepared as described above, mounted in 1% low melting point
agarose in PBS, and imaged at the Zeiss LSM 710 or 880 laser scanning confocal microscope.
For live confocal imaging, zebrafish larvae were anaesthetised using 0.01% MS-222 and mounted
in 1% low melting point agarose in E3. After a brief waiting period to allow the agarose to settle,
the agarose was covered with embryo medium containing 0.01% MS-222 to prevent desiccation
during imaging. For visualization of necrotic and late apoptotic cells, 1 µg/mL propidium iodide
(PI) were added to the embryo medium. Imaging was conducted on Zeiss LSM 710 or 880 laser
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scanning confocal microscopes. Z-stacks of the optic tectum were acquired with 3.6 to 6 µm intervals
between optical planes to a depth of 100 to 120 µm in fixed or live larvae. For time-lapse imaging of
calcium signalling, images were acquired every 2 s. For timelapse imaging of microglia phagocytic
behaviour, z-stacks of the whole optic tectum were acquired every 6 min. For visualisation of the
rate of cell death in H2A:GFP larvae, z-stacks of the whole optic tectum were acquired every 25 min.
3.7 Image processing and analysis
Cell quantifications were performed manually in Image J (https://imagej.nih.gov/ij) from stacks of
confocal images. PI+ cells, pyknotic nuclei in H2A:GFP animals, Annexin 5+ cells in NBT :secA5-
BFP animals, Annexin A5+/NBT+ in NBT :secA5-BFP; NBT:dsRed animals, and Caspase 3+ cells
were counted across both tectal hemispheres and across all consecutive images in z-stacks of the
optic tectum. Double labelling was only scored if both fluorophores were detected in the same
optical plane. Quantifications were carried out blinded to experimental group.
The diameter of PI+ and PI- at 0 hpi and 6 hpi was measured manually in Image J across both
tectal hemispheres in one optical plane, in at least 10 cells per animal.
For generation of heatmaps illustrating the density of apoptotic cells, pyknotic nuclei were manually
selected in Image J from confocal images of H2A:GFP animals. Their xy coordinates were identified,
and used to generate heatmaps through a custom-written script in MATLAB using a modified
scattercloud function (Eilers and Goeman, 2004). The heatmaps were then overlaid with a masked
outline of the optic tectum in Adobe Illustrator CC 2017.
For quantitative analysis of calcium signalling, time series of confocal images from β-actin:GCaMP6f
animals acquired every 2 s were registered using the StackReg plugin in ImageJ to correct for xy
drift. Two hundred and fifty to 300 regions of interest at a distance of 10 µm were manually
selected in ImageJ, covering the entire cellular layer of one optical slice of the optic tectum, and
δF/F traces and calcium transients for each individual region of interest were calculated using
custom-written MATLAB script (Herrgen et al., 2014). Transients were defined as a δF/F greater
than 4.25 x standard deviation of baseline fluorescence (F), and with a duration of longer than 2
frames. The total number of transients for each larva was calculated by summation of all transients
detected in individual cells.
For generation of heatmaps illustrating the spatial distribution of calcium transients, a matrix
was created based on the location and number of transients in individual tectal cells using the
accumarray function, smoothed by 15 pixels for illustrative purposes, and plotted using the imagesc
function. All steps were performed in MATLAB.
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To quantify the number of microglia, peripheral macrophages, and neutrophils at the site of brain
injury, mpeg1+, p2y12+/mpeg1+, and mpo+ cells were counted in respective transgenic lines
(mpeg1 :GFP, p2y12 :P2Y12-GFP; mpeg1 :mCherry, or mpo:GFP) in a region of interest measuring
200 µm horizontally and 200 µm vertically centered on the injury site across all consecutive images
in z-stacks of the optic tectum. The injury site was visualised by the presence of PI+ primary
necrotic cells. Cells residing on the skin were excluded from quantification.
Tracking of microglial cells within the brain, or of epidermal macrophages on the skin, was carried
out using IMARIS 8.2.1. For this, time-lapse movies of mpeg1 :GFP were visualised in IMARIS,
and individual cells were tracked using an autoregressive motion algorithm under manual supervi-
sion. Speed and net displacement of microglial cell bodies were obtained as outputs of the algorithm.
To determine the frequency of phagocytic events, time-lapse movies of mpeg1 :GFP animals
incubated with PI were visualised in IMARIS, individual mpeg1+ cells were followed over time, and
phagocytic events were identified manually. A phagocytic event was defined as formation of a phago-
cytic cup around PI+ cellular debris followed by movement of engulfed cargo towards the cell body,
or movement of the cell body towards the cargo. The same protocol was used to determine the fre-
quency of phagocytic events in radial glial cells, except that her4.3 :GFP transgenic larvae were used.
All figures were assembled in Adobe Illustrator CC 2017.
3.8 Supplementary movies
Movies were generated from timelapse movies, timestamped
using ImageJ or IMARIS, and labelled in Adobe Photoshop
CC 2015.5. Supplementary movies are referred to in the
text and captions of appropriate Figures, and signposted by
the video camera symbol (i). Supplementary movies can
be found on Dropbox (https://bit.ly/2DIpqg8 or linked by
adjacent QR-code).
3.9 Drug treatments
Pharmacological agents (Table 3.3) were delivered by ventricular injection or bath application. For
injection, the drugs were diluted in calcium-free Ringer’s solution (116 mM NaCl, 2.9 mM KCl,
5 mM HEPES pH 7.2), placed in fine a glass electrode, and delivered to the ventricle under a
stereomicroscope. 0.03% FastGreen FCF (Alfa Aesar, 2353-45-9) were added to the solution to
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visualise it. For bath application, drugs were diluted in E3 medium and pre-incubated for 1 h prior
to the injury unless otherwise stated. The time between injection of compounds and imaging was
kept to a minimum (<5 minutes) unless otherwise stated. I used the following compounds:
Table 3.3: Drugs used for pharmacological manipulation. Drug name, concentration, and mode of
delivery.
Drug name Type Concentration Mode of delivery
D-AP5 NMDA receptor inhibitor 5 mM injection
MK801 3 mM
D-AP5 NMDA receptor inhibitor 10 µM bth application
MK801 100 µM
DNQX AMPA receptor inhibitor 5 mM injection
PPADS pan-P2 receptor inhibitor 20 mM injection





up to 80 mM injection
BAPTA tetrasodium salt extracellular calcium
chelator
177 mM injection
ATP ATP receptor agonist 5 mM injection
L-Glutamate NMDA and AMPA re-
ceptor agonist
9 mM injection
L-Glutamate NMDA and AMPA re-
ceptor agonist
10 µM bath application
O-Phospho-L-Serine mimicks L-phosphatidyl
serine
1 µM bath application
ATP and glutamate (9 mM) were injected on-stage of a confocal microscope to visualise immediate
effects of receptor-binding.
3.9.1 Statistical analysis of drug treatments on calcium wave parameters
Statistical analysis was carried out using Student’s t Test or One-Way ANOVA with Bonferroni post-
hoc test (or corresponding non-parametric tests if data was not normally distributed) as appropriate,
comparing animals treated with vehicle or respective drug from the same day (one drug treatment
occurred per day, or two per day when assessing ATP receptor inhibitors PPADS and iso-PPADS)
in at least two independent experimental days. Power calculations were performed after initial
preliminary data collection of 5 animals to estimate required sample sizes for a power of 80%. Data
is summarised in Fig. 5.3 and portrayed as percentage of vehicle-injected controls.
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3.10 Generation of adgrb1a/b crispants using CRISPR/Cas9-
targeted gene editing
3.10.1 Guide design and injection
For CRISPR/Cas9-mediated disruption of tnfa, I used a guide previously published by Tsarouchas
et al. (2018). The target sequence was 5’-CCCGATGATGGCATTTATTTTGT-3’.
For disruption of BAI1 paralogues adgrb1a and agrb1b, I designed CRISPR guide RNAs for exonic
sequences of adgrb1a (ENSDART00000143118.4) and adgrb1b (ENSDART00000188431.1) to tar-
get BslI restriction enzyme sites. The target sequences were 5’-CAAGGGGGGGCTGCTGGATA-3’
(adgrb1a) and 5’-CCCTCATACGGCGGCTCCGAGTG-3’ (adgrb1b). The injection mix contained
1 µL of each crRNA, 1 µL tracrRNA (all 250 ng/µL), from Merck KGaA, Darmstadt), 0.2 µL Cas9
enzyme (NEB #M0386T), 0.2 µL FastGreen FCF tracer in RNAse free water to 5 µL, and was
injected at the one-cell stage.
3.10.2 DNA extraction and test of guide efficiency via restriction fragment
length polymorphism (RFLP)
The effect of mutagenesis was analysed for each animal by RFLP analysis following imaging.
Briefly, gDNA was extracted by boiling individual larvae for 10 min in 100 µL of 50 mM NaOH, and
DNA was subsequently precipitated by adding 10 µL of 1 M Tris-HCL pH 8.0 and vortexing. PCR





PCR products were digested for 1 h at 55 ◦C using BslI, and fragment length was analysed on a
1.8% agarose gel containing Ethidium Bromide, and subsequently imaged at the UV GelDoc.
3.10.3 Mutation analysis of adgrb1a/b crispants by sequencing
Sequencing and mutation analysis was performed by Dr. Marcus Keatinge. Briefly, to identify and
sequence CRISPR/Cas9-induced mutations, PCR products from eight injected embryos were pooled
and sub-cloned using the Strataclone PCR cloning system (Invitrogen, Catalog #240205). The
ligated plasmid was transformed and 100 colonies sequenced. Finally, sequences were compared to
the respective ENSEMBL transcript IDs.
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3.11 Quantitative real-time PCR
3.11.1 RNA extraction and cDNA synthesis for qRT-PCR
Larvae were euthanised in 0.4% MS-222 if whole body RNA extract was acquired. Tissue was
either processed immediately, or stored in QIAGEN R© RNAlater (QIAGEN R©, # 76104) at 4 ◦C
until processing for a maximum of one week. If samples were stored in RNAlater, RNAlater was
removed prior to RNA extration by washing samples 3 x in sterile PBS. SV Total RNA Isolation kit
(Promega, # Z3100) or RNEasy Micro kit (QIAGEN R©, # 74004) were used for RNA extraction,
and RNA extraction was carried out according to protocol. For whole body RNA samples, ten
larvae were pooled. For RNA samples enriched from heads, fifty heads were cut using surgical
microscissors (3 mm straight blade, FST R© 15000-00) in ice-cold E3 + 0.4% MS-222.
For RNA extraction using SV Total RNA Isolation kit, 175 µL of lysis buffer were added to the
tissue, and samples were triturated using 23 G needles. 350 µL of RNA dilution buffer were added
and samples were incubated at 70 ◦C for 3 min. Samples were centrifuged at 13,000 g for 10 min,
and supernatant was carefully transferred to a new tube. 200 µL of sterile 95% ethanol were
added to the cleared supernatant and mixed by pipetting three to four times. The mix was then
transferred to the SV Total RNA isolation kit spin columns and centrifuged at 13,000 g for 1 min.
The spin column was washed with 600 µL RNA wash buffer, and incubated with DNAse I to digest
genomic DNA at room temperature for 15 min. Column was washed twice (600 and 250 µL) and
RNA was eluted in 25 µL nuclease-free water.
For RNA extraction using QIAGEN R© RNEasy Micro kit, 350 µL of buffer RLT+ containing 1%
β-mercaptoethanol were added to sample, and samples were triturated using 23 G needles. Samples
were centrifuged for 2 min at full speed in Qiagen Qiashredder columns to further lyse cells. Lysate
was then mixed with 350 µL 70% ethanol and placed in QIAGEN R© RNEasy MinElute spin columns,
and centrifuged for 30 s at ≥ 8000 g. Column was subsequently washed with 700 µL buffer RW1 and
500 µL buffer RPE, with 15 s spins at ≥ 8000 g in between. Five hundred µL of 80% ethanol were
added to tubes, and spun for 2 min at ≥ 8000 g. Spin columns were transferred to fresh collection
tubes, and the membrane was dried by centrifuging for 5 min at full speed with an open lid. RNA
was eluted from the column using 14 µL nuclease-free water and centrifugation for 1 min at full speed.
Following both methods, RNA concentration was measured at the NanoDrop One, and RNA was
stored at −80 ◦C until further use. cDNA was synthesised using the iScriptTM cDNA synthesis kit
(Bio-RAD, # 1708890) according to protocol. cDNA samples were stored at −20◦.
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3.11.2 qRT-PCR primer design & validation
Primers (Table 3.5) were designed to a length of 100 to 300 base pairs (bp) us-
ing NCBI Primer Blast, avoiding targets on other annotated Danio rerio mRNAs
(https://www.ncbi.nlm.nih.gov/tools/primer-blast/). Melting temperatures (Tm) were designed
around 60 ◦C, and 3’ self-complementarity value was < 2. Target size was confirmed by running
PCR products on a 1.5% agarose gel.
Table 3.5: Primers used for qRT-PCR. Gene RefSeq numbers, primer sequence, length, melting tempera-
ture (Tm), and GC content.
Gene 5’ - 3’ sequence Product Tm (
◦C) GC Content (%)
length (bp)
actb2 fw ctggcccctagcacaatgaa 199 60.03 55
NM 181601.4 rev gagtcggcgtgaagtggtaa 60.04 55
tnfa fw ccatgcagtgatgcgctttt 166 60.11 50
NM 212859.2 rev gtctgtgcccagtctgtctc 60.04 60
tnfb fw atacacagatgcggtgaggg 196 59.53 55
NM 001024447.1 rev cccgaagaatgttttggcgt 59.40 50
bdnf fw ccaaaggatccgctcagtca 195 59.97 55
NM 131595.2 rev tctgcgatattcgtccgctc 60.04 55
ngfb fw tcaggttacggttgcgtttg 224 59.06 50
NM 199210.1 rev cttcggtcacgtctgcctta 59.76 55
tgfb1a fw tgtacccgcaatccttgacc 169 60.04 55
NM 182873.1 rev ccgactgagaaatcgagcca 59.83 55
il1b fw ggcatgcgggcaatatgaag 116 60.04 55
NM 212844.2 rev tgtagctcattgcaagcgga 60.04 50
il4 fw ggatcctgaatgggaaagggg 211 60.13 57.14
NM 001170740.1 rev cattcccccgaggtcgaaac 60.74 60
il10 fw gaccattctgccaacagctc 102 59.19 55
NM 001020785.2 rev accatatcccgcttgagttcc 59.86 52
adgrb1a fw tgtgtgtccagaacatgggg 259 59.89 55
NM 001020785.2 rev ctcccgaattcgctgcattg 59.97 55
adgrb1b fw aacggagcctgggatgaatg 158 59.19 55
NM 001020785.2 rev cacacggcaatgttgcagaa 59.86 52
To achieve a reaction efficiency of 100%, I optimised primers by performing qRT-PCR reactions
with cDNA dilution curves (at least 5 dilution points). Different primer concentrations were tested
until efficiency was within 6% of 100%. Two technical replicates were run per data point. Graphs
were plotted in GraphPad Prism 7.0 and slope value was determined (shown in Table 3.6). r2
47
values had to be > 0.95 for primer dilution to be considered.
Table 3.6: Primer efficiency following optimisation. Gene target, optimal concentration, slope on cDNA
concentration curve including r2, and Efficiency (E/%) are included in this table.
Target Concentration used slope r2 Efficiency (E) Efficiency (%)
actb2 0.2 µM -3.304 0.9971 2.0075 100.75
tnfa 0.25 µM -3.228 0.9929 2.036 103.6
tnfb 0.1 µM -3.472 0.9751 1.941 94.10
bdnf 0.25 µM -3.357 0.9985 1.986 98.57
ngfb 0.1 µM -3.21 0.9995 2.049 104.89
tgfb1a 0.2 µM -3.216 0.9647 2.0462 104.62
il1b 0.2 µM -3.419 0.9816 1.961 96.10
il4 0.1 µM -3.377 0.9806 1.978 97.75
il10 0.25 µM -3.376 0.9938 1.978 97.76
adgrb1a 1 µM -3.202 0.9631 2.053 105.26
adgrb1b 1 µM -3.234 0.9500 2.038 103.81
3.11.3 Quantitative reverse-transcription PCR (qRT-PCR)
qRT-PCRs were performed on the LightCycler R© 96 Real-Time PCR System (Roche) using the
SsoAdvancedTM Universal SYBR R© Green Mix (BioRad, # 1725271). Reaction mixes were prepared
in LightCycler R© 480 Multiwell Plate 96 (Roche, 04729692001) and then sealed with a foil to prevent
evaporation of reagents. The samples were then spun down on an Eppendorf 5804 plate centrifuge.
The following programme was run:
Step Cycles Temperature Time (s)
Preincubation 1 95 ◦C 300
3-Step Amplification 45 95 ◦C 10
55 ◦C 30
72 ◦C 15
Melting 1 95 ◦C 10
65 ◦C 60
97 celsius 1
Cooling 1 40 ◦C 10
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3.11.4 qPCR analysis
Ct values were extracted from raw data using the LightCycler R© 96 Software by Roche. The ratio
of gene expression compared to a reference gene between conditions was according to the Pfaffl
method (Pfaffl, 2001). Briefly, the following formula was applied:
ratio =
Etarget
∆Cttarget (control - sample)
Ereference∆Ctreference (control - sample)
Values were calculated as mean of two technical replicates. At least four biological replicates were
analysed per condition.
3.12 RNA sequencing
3.12.1 Isolation of transgenically labelled fluorescent cells from larval heads
via FACS
To investigate cell-type specific changes to gene expression following injury, microglia/macrophages
were sorted using Fluorescence Activated Cell Sorting at the Flow Cytometry Facility at the Queen’s
Medical Research Institute, Edinburgh. I used anti-4C4 antibody staining to extract microglia,
the mpeg1 :GFP transgenic line to extract both microglia and macrophages, or wild types as
negative controls. Preparation of the cell suspension for cell sorting was performed as previously
published (Mazzolini et al., 2018). Briefly, larvae were anaesthetised at 2 hpi with 0.4% MS-222,
and transferred to a fresh petri dish containing ice cold E3 with 0.01% MS-222. Heads were cut
using surgical microscissors (3 mm straight blade, FST R©15000-00) and transferred into a cooled
glass dounce homogeniser (1 mL) containing 1 mL medium A (15 mM HEPES, 2 mM D-Glucose in
1 X HBSS).
Once all the heads were collected, medium A was replaced with 1 mL fresh medium A. Heads were
homogenised thirty times using a dounce homogeniser. Two mL of medium A were added to the
cell suspension and ran through a 40 µm cell strainer (Falcon 352340). The cell suspension was
then transferred into 1.5 mL Eppendorf tubes (1 mL each) and centrifuged at 300 g for 10 min at
4 ◦C. The supernatant was discarded using a 5 mL syringe (BD 309647) and 23 G needle (BD
300800). The cell pellet was resuspended with 1 mL of ice cold 22% Percoll and overlayed with
0.5 mL 1X DPBS to build a density gradient. The tubes were centrifuged for 30 min at 950 g
at 4 ◦C. The supernatant containing DPBS, myelin-containing interphase and density medium
was discarded and the cell pellet was washed with 0.5 mL medium A + 2% NGS (300 g for
10 min at 4 ◦C). The cell suspension was transferred through a 35 µm cell strainer cap into 5 mL
FACS tubes (BD 352235) and sorted at FACSAria II at the Flow Facility at the QMRI. The
cell sorting gate was calibrated using wild type larvae undergoing the same protocol. Cells were
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sorted directly into chilled 1.5 mL Eppendorf tubes containing 1 mL of RNAProtect Cell Reagent to
stabilise cellular RNAs. Tubes were stored until RNA extraction at 4 ◦C for a maximum of three days.
Anti-4C4 immunolabelling of microglia was performed as described by Mazzolini et al. (2018).
Unspecific interactions of the Fc receptor with the secondary antibody were prevented by incubation
with 1% anti-CD16/CD32 antibody (Biolegends, # 302013, clone 3G8) prior to each antibody
incubation step. Briefly, cell suspension was incubated in mouse anti-4C4 antibody (1:20) at 4 ◦C
for 30 min following removal of myelin, and washed twice with medium A + 2% NGS. Cell suspension
was then incubated with secondary anti-mouse Alexa Fluor 488 for 30 min at 4 ◦C, washed twice
with medium A + 2% NGS, and placed in FACS tubes as described above.
3.12.2 RNA extraction from FACS sorted cells
Following FACS, cells were were pelleted at 5000 x g for 5 min. The supernatant was aspirated and
RNA was extracted from the cell pellet using the QIAGEN R© RNeasy Plus Micro kit (QIAGEN R©,
# 74034) according to the manufacturer’s instructions. Briefly, the cell pellet was re-suspended in
75 µL Buffer RLT Plus containing 1% β-Mercaptoethanol. The cell suspension was then transferred
to gDNA eliminator columns and centrifuged for 30 s at ≥ 8000 g. The column was discarded. One
volume (350 µL) of ice cold 70% ethanol were added to the flowthrough, mixed well by pipetting,
and immediately transferred to MinElute columns. The samples were spun for 15 s at ≥ 8000 g.
The flow-through was discarded. Seven hundred µL of buffer RW1 were added to the column,
and the samples were centrifuged for 15 s at ≥ 8000 g. The flowthrough was discarded again
and 500 µL of buffer RPE were added. The tubes were centrifuged for 15 s at ≥ 8000 g. Next,
500 µL of 80% added to wash the column and the samples were centrifuged for for 2 min at ≥
8000 x g. To remove any leftover ethanol in the column and dry the membrane before elution,
the column was placed in a fresh 2 mL collection tube and centrifuged for 5 min at full speed
with an open lid. The column was then placed in a fresh 1.5 mL collection tube and the RNA
was eluted by adding 14 µL directly to the membrane and centrifuging the tube for 15 s at full speed.
Quantification of RNA quality and quantity was then carried out at the Labchip GX24 (PerkinElmer)
by Dr. Pamela Brown at the Shared University Research Facility, Queen’s Medical Research Institute,
University of Edinburgh.
3.12.3 cDNA synthesis and isothermal amplification for RNA sequencing
RNA was reverse transcribed and amplified using the NuGEN Ovation R© RNA-Seq System V2 (#
7102-08) according to manufacturer’s instructions with an input of at least 500 ng RNA in 500 µL.
Amplified cDNA was then purified using the QIAGEN R© MinElute R© Reaction Cleanup Kit (# 28204)
and quantified using the NanoDrop One.
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3.12.4 Library preparation, sequencing and bioinformatical analysis of am-
plified cDNA
This part of the methods was carried out by Edinburgh Genomics. Libraries were prepared from
each sample using a manual TruSeq DNA Nano gel free library kit (350 bp insert). The samples
were sequenced on a NovaSeq instrument producing 50PE data (at least 250M + 250M reads).
Bioinformatical quality control and differential analysis
Bioinformatical analysis was carried out by Dr. Katie Emelianova (Edinburgh Genomics).
Trimming
Reads were trimmed using Cutadapt (Martin, 2011) (version cutadapt-1.9.dev2). Reads were
trimmed for quality at the 3’ end using a quality threshold of 30 and for adapter sequences of
the TruSeq DNA Nano kit (AGATCGGAAGAGC). Reads after trimming were required to have a
minimum length of 35.
Reference
The reference used for mapping was the Danio rerio (GRCz10) genome from Ensembl. The anno-
tation used for counting was the standard GTF-format annotation for that reference (annotation
version 84).
Alignment
Reads were aligned to the reference genome using STAR (Dobin et al., 2013) (version 2.5.2b)
specifying paired-end reads and the option −−outSAMtypeBAMUnsorted. All other parameters
were left at default.
Read count by feature
Reads were assigned to features of type exon in the input annotation grouped by gene id in the
reference genome using featureCounts (Liao et al., 2014) (version 1.5.1). featureCounts assigns
counts on a fragment basis as opposed to individual reads such that a fragment is counted where
one or both of its reads are aligned and associated with the specified features. Strandness was set
to reverse and a minimum alignment quality of 10 was specified.
In addition to the counts matrix used in downstream differential analysis, a matrix of Fragments Per
Kilobase of transcript per Million mapped reads (FPKM) values was generated, using the rpkm()
function of edgeR (Robinson et al., 2010) (version 3.20.1) and normalised effective library sizes.
Gene lengths for the FPKM calculation were the number of bases in the exons of each gene (only
counting bases once where they occur in multiple exon annotations). Gene names and other fields
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were derived from input annotation and added to the count/expression matrices.
Count preprocessing
The raw counts table was filtered to remove genes consisting predominantly of near-zero counts,
filtering on counts per million (CPM) to avoid artefacts due to library depth. Specifically, a
row of the expression matrix was required to have values greater than 0.1 in at least 3 samples,
corresponding to the smallest sample group as defined by Group, once any samples were removed
(where applicable).
Reads were normalised using the weighted trimmed mean of M-values method (Robinson and
Oshlack, 2010), passing TMM as the method to the calcNormFactors method of edgeR.
Exploratory analysis
A principal components analysis was undertaken on normalised and filtered expression data to
explore observed patterns with respect to experimental factors. The cumulative proportion of
variance associated with each factor was used to study the level of structure in the data, while
associations between continuous value ranges in principal components and categorical experimental
factors was assessed with an ANOVA test.
Differential analysis
Differential analysis was carried out with edgeR (Robinson et al., 2010) (version 3.20.1) with the
contrasts shown in Table 3.7. Fold changes were estimated as per the default behaviour of edgeR,
to avoid artefacts which occur with empirical calculation.
Table 3.7: Contrasts specified for differential analysis. Any variable specified under blocking was used as
part of an additive model, and accounted for in differential analysis of that contrast.
Variable Group 1 Group 2 Blocking
Group Sham 2 hpi None
Specifically, a small prior count is added to each observation before fitting a model, in proportion to
the library size. Log fold-changes are shrunk towards 0, to a greater degree with genes of low count,
and infinite fold changes are avoided. Statistical assessment of differential expression was carried
out with the quasi-likelihood (QL) F-test using the contrasts shown in Table 3.7. Where specified
in this table, confounding covariates (for example sample pairing, batch effects) were adjusted for
by incorporating them as a blocking factor in an additive model.
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3.12.5 Generation of expression heatmaps
For generation of expression heatmaps, raw counts (fragments per kilobase million, FPKM) were
extracted from the RNA sequencing data for genes of interest using MATLAB. I created expression
matrices containing gene name and counts per million for each sample submitted to RNA sequencing.
Expression heatmaps were then created using the gplots package in R, normalising expression per
gene row. Color scheme was provided by the viridis package.
3.12.6 Gene ontology enrichment analysis
Gene ontology enrichment analysis was carried out using an online tool (https:www.panther.db)
based on the PANTHER Classification system (Mi et al., 2013). The list of genes of interest was
uploaded to the website, alongside with a reference gene list of all detected genes in the RNA
sequencing (i.e., background list). Gene lists were analysed for ’GO Biological process complete’.
Test type performed was Fisher’s exact test with Bonferroni correction for multiple comparisons.
3.13 Statistical methods
All population data are presented as mean ± SEM. Statistical analysis was performed using Prism
7.0 (GraphPad). Briefly, data sets were assessed for normality, and appropriate statistical tests were
carried out as stated in the figure legends.
Analysis was performed blinded to treatment and the power was calculated for significant values.
Randomisation of larvae to treatment was carried out manually by selecting random larvae under
anaesthesia from of petri dishes of 50 larvae. If the power was below 80%, required sample sizes




Mechanical injury induces primary
and secondary cell death in a larval
zebrafish model of brain injury
4.1 Introduction
Traumatic brain injury is a prevalent and pressing global medical issue (Maas et al., 2010, 2017).
It can affect patients of all genders, ages, and backgrounds, and there are no targeted treatments
available to alleviate the consequences. TBI is a major cause of death in young adults, and
lifelong disabilities are common in survivors - it is estimated that 5.3 million people in the US and
7.7 million people in the EU are living with TBI-related disabilities (Langlois and Sattin, 2005;
Tagliaferri et al., 2006), and over half the population will have one or more TBIs in their lifetime
(Maas et al., 2017).
TBI leads to significant neuronal loss via primary cell death (directly caused by mechanical injury)
and secondary cell death (elicited by biochemical cascades initiated by the injury). Secondary (or
delayed) cell death occurs both in experimental models of TBI (Beer et al., 2000; Clark et al., 2000;
Keane et al., 2001) and in human patients (Clark et al., 1999), and is related to a poorer cognitive
status after brain injuries (Miñambres et al., 2008; Nathoo et al., 2004; Yakovlev et al., 1997).
Despite intensive research efforts to elucidate the molecular mechanisms of TBI and identify neuro-
protective strategies, there are no therapeutic approaches or neuroprotective drugs that have shown
benefit over placebo in multi-centre clinical trials so far (Maas et al., 2010, 2017). While this may be
a reflection of poor study design and insensitive end point measurements (Maas et al., 2010), it also
highlights the fact that potentially more dynamic models of brain injury may be needed to capture
and understand the molecular processes underlying secondary cell death following brain injury in vivo.
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The first aim of my thesis was to establish such a model in order to investigate neuroprotective
strategies following TBI. For this purpose, I developed a robust and simple assay to reliably induce
cell death in larval zebrafish by lesioning the brain with a fine metal pin. I introduced the injury
in the optic tectum (OT), the largest subdivision of the larval zebrafish brain (Cooper et al.,
2015). The OT is easily accessible to micromanipulation and microscopy due to its superficial
positioning in the brain and already has a clearly defined and highly structured architecture at
4 days post fertilisation (Scott and Baier, 2009), which is the timepoint I aimed to carry out
my analysis at. In comparison with rodent and larger animal experimental models, the larval
zebrafish had several advantages: more economic husbandry, the ability to easily perform in vivo
timelapse imaging facilitated by a multitude of transgenic fluorescent reporter lines, and the ease
of pharmacological and genetic manipulation to tease apart molecular and cellular mechanisms
contributing to secondary cell death.
Initially, I needed to describe the dynamics of cell death following TBI, and more specifically, how
they relate to what is observed in human patients and other experimental models. I employed several
tools to analyse cell death following brain injury:
• propidium iodide (PI):
PI is a nuclei acid dye that can only enter cells with a compromised membrane (Kroemer et al.,
2009), therefore it can be used in bath application to visualise necrotic (and late apoptotic)
cell death.
• nuclear condensation (in H2A:GFP transgenic larvae):
Nuclear condensation (pyknosis) is a hallmark of late apoptosis (Kroemer et al., 2009; Ober-
hammer et al., 1994; Toné et al., 2007), therefore I employed a green fluorescent protein
(GFP)-tagged histone to visualise apoptotic cells.
• Annexin 5 (in NBT:secA5-BFP transgenic larvae):
Annexin 5 can bind phosphatidyl serine (PS) exposed on early apoptotic cells (Balasubrama-
nian and Schroit, 2003; Segawa and Nagata, 2015). I used a transgenic line in which a blue
fluorescent protein (BFP)-tagged version of Annexin 5 is secreted by neurons and therefore
apoptotic cells (both neurons and other cells exposing PS) appear BFP+.
• cleaved Caspase-3 (via immunostaining):
To quantify activation of Caspase-3, a key enzyme in the execution of apoptosis (Porter and
Jänicke, 1999; Wyllie, 1997), I performed an immunostaining against cleaved Caspase-3 in
fixed larvae.
In this chapter, I will lay out the description of the mechanical injury assay developed at the start of
my project. As I later aimed to investigate calcium waves occuring immediately following injury, it
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was of advantage that the assay could both be carried out on a stereomicroscope and on a confocal
microscope. I investigated primary and secondary cell death dynamics, and performed repeated in
vivo imaging to further describe this novel assay. The work described in this chapter will lay the
foundation for further experiments and the selection of timepoints for endpoint analyses described
in later chapters of this thesis.
4.2 Description of injury
I induced a mechanical brain injury by penetrating the optic tectum of 4 dpf larval zebrafish using
a minutien pin under visual guidance under a microscope. The minutien pin was mounted on a
micromanipulator for precise and reproducible delivery of the injury. For induction of the injury,
the larvae were immobilized in a dorsal orientation in 1% low melting point agarose. The optic
tectum is the largest part of the larval zebrafish brain and lies superficially on the dorsal side of
the zebrafish brain, therefore making it easily accessible to mechanical injury and microscopy. A
schematic and brightfield images of this are shown in Fig. 4.1 A and B.
The larvae recovered well from the injury once released of the agarose and placed in fresh medium,
and showed little mortality over 24 h (<1%). Occasionally, blood vessels were ruptured during the
injury leading to ventricular haemorrhage (< 2%). Larvae exhibiting ventricular haemorrhage after
injury were excluded from later quantifications of cell death to exclude any potential confounding
effects of haemorrhage on cell death. A quantification of adverse effects over 1075 larvae in 6
biological replicates is shown in Fig. 4.1 C.
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Figure 4.1: Description of the injury assay. (A) Schematic of the dorsal view of the larval zebrafish outlining
forebrain (FB), optic tectum (OT), and hindbrain (HB). The site of injury is indicated by a drawing of the
needle. (B) Representative brightfield images of a larva before and during injury. (C) Quantification of
fractions of normal larvae, larvae with haemorrhage, and dead larvae following injury in 6 different biological
replicates with a total n of 1075.
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4.3 Dynamics of cell death: primary necrotic and secondary
apoptotic cell death
I aimed to assess the dynamics of cell death following mechanical injury. Using H2A:GFP transgenic
animals (Pauls et al., 2001) allowed me to visualise pyknotic nuclei of apoptotic cells (Kroemer
et al., 2009). In combination with the presence of PI, labelling necrotic and late apoptotic cells
(Kroemer et al., 2009), this enabled me to visualise injury-induced necrosis and apoptosis in
real-time.
Mechanical injury resulted in a sharp increase of PI+ cells at 0 hpi (Fig. 4.2). The lack of pyknosis
(Fig. 4.3; diameter of PI+ cells at 0 hpi: 4.7 ± 0.3 µm; diameter of PI- cells at 0 hpi: 4.9 ±
0.1 µm; n = 5 animals; p > 0.999 in Mann-Whitney test), as well as their rapid appearance
identified these PI+ cells as necrotic cells. Quantification of PI+ cells over time revealed that
these necrotic cells were rapidly removed from the tissue (Fig. 4.2), with a significant drop
evident as early as one hour post injury (1 hpi). Conversely, in vivo imaging with H2A:GFP larvae
showed that pyknotic nuclei were not present immediately after the injury, but appeared around
1 hpi, where they originated at the injury site, and peaked at 6 hpi, where they spread to both
hemispheres (Fig. 4.4 D). This occurrence of delayed apoptotic cell death in regions distant from
the original injury site was reminiscent of findings following mammalian brain injury, where cell
death is observed at regions remote from the original injury site (Rink et al., 1995). The peak
of pyknotic nuclei at 6 hpi was accompanied by a small secondary peak of PI+ cells. However,
PI+ cells at 6 hpi had a significantly smaller diameter than healthy nuclei (Fig. 4.3; diameter
of PI+ at 6 hpi: 2.2 ± 0.1 µm; diameter of PI- healthy nuclei at 6 hpi: 4.8 ± 0.2 µm; n ≥ 5
animals; p ≤ 0.005 in Mann-Whitney test), which suggested these PI+ cells were late apoptotic cells.
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Figure 4.2: Mechanical injury leads to rapid cell death as monitored by of PI uptake. (A) Mechanical
injury results in a prompt uptake of PI. Scale bar, 50 µm. (B) Quantification of PI+ cells after mechanical
injury. Dashed line indicates time of injury. n ≥ 6 animals per experimental group.
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Figure 4.3: PI+ cells display morphological characteristics of necrosis immediately after injury, and of
apoptosis hours later. (A, B) The diameter of PI+ cells (arrowheads) is not significantly different from
viable cell nuclei (H2A:GFP) at 0 hpi. Scale bar, 10 µm. Values are the average of at least 10 PI+ and
H2A:GFP+ cells in one optical section per animal. n = 5; p > 0.999 in Mann-Whitney Test. (C, D) At 6
hpi, the diameter of PI+ cells (arrowheads) is significantly smaller than that of viable cell nuclei. Scale bar,
10 µm. Values are the average of at least 10 PI+ and H2A:GFP+ cells in one optical section per animal. n
≥ 5; p ≤ 0.005 in Mann-Whitney Test.
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Figure 4.4: Mechanical brain injury leads to delayed nuclear condensation peaking at 6 hpi. (A)
Overview and close-ups of tectum in H2A:GFP transgenic animals before, and at 0, 6, and 24 hpi. Scale
bar, 50 or 5 µm, respectively. (B) Close-up of a pyknotic nucleus with the Fire LUT (ImageJ), showing
the distinct difference in size and intensity of pyknotic nuclei compared with surrounding normal nuclei.
Scale bar, 5 µm. (C) Quantification of pyknotic nuclei present in entire tectum following injury. Dotted
vertical line indicates time of injury. n ≥ 6 animals per timepoint. (D) Heat map illustrating the spread
of secondary cell death throughout the tectum in the hours following injury. XY coordinates of pyknotic
nuclei from representative animals at varying timepoints following injury were plotted in 2D using the Matlab
Scattercloud function.
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Interestingly, I also observed PI uptake in the cell bodies of radial glia and microglia/macrophages
following injury (Fig. 4.5). The continued presence of PI+ radial glia and microglia/macrophages
for up to 48 hpi suggested these cells were neither necrotic nor apoptotic, and PI may have en-
tered via a mechanism other than disrupted membrane integrity due to cell death. In the case of
macrophages/microglia (Fig. 4.5 B), it was likely that PI inside these cells originated from necrotic
cells they had previously engulfed. In radial glia (Fig. 4.5 A), I hypothesised that the emergence
of PI+ cells was the result of opening of pore-forming ion channels. ATP-dependent P2X subtype
receptors have previously been shown form large ion channel pores in glial cells following CNS injury
(James and Butt, 2002). To investigate whether this was the case in radial glia following brain
injury, I injected pan-P2X receptor inhibitor iso-PPADS or vehicle into the ventricle of larvae prior
to injury. Using iso-PPADS, I was able to completely abolish PI labelling of radial glia in all an-
imals (n = 6 per group, Fig. 4.5C) at 6 hpi, suggesting P2X receptors play a crucial role in dye
uptake, potentially through P2X receptor-dependent pore formation. Conversely, I did not observe
a significant effect on PI labelling of microglia/macrophages using iso-PPADS.
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Figure 4.5: Cells with radial glial and microglial morphology take up PI, but survive long after the
injury. (A) Cells with radial glial morphology at 6 hpi and 48 hpi do not appear condensed, but have PI
in their cytoplasm. Arrowheads are pointing towards cell bodies of radial glia. Scale bar, 15 µm. (B) At
6 hpi, large aggregations of PI+ debris were often present. Based on the size of these aggregates (larger
than normal neurons), these are likely microglia that have taken up PI+ cells but not yet degraded them. At
48 hpi, some microglia and their processes appear PI+. Arrowheads are pointing to microglial cell bodies.
Scale bar, 15 µm. (C) Ventricular injection of P2X subtype receptor inhibitor iso-PPADS ablates radial glial
uptake of PI (6/6 animals). Images shown taken at 6 hpi in either vehicle (Calcium-free Ringer solution) or
iso-PPADS injected larvae bathed in propidium iodide. Scale bar, 15 µm.
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In vivo imaging in H2A:GFP transgenic animals in the presence of PI had suggested that both
necrosis and apoptosis occurred following mechanical brain injury in larval zebrafish with distinct
temporal patterns (Fig. 4.2, Fig. 4.4). To strengthen this evidence, I employed two additional
approaches for the detection of apoptosis in the brain: in vivo imaging of the transgenic line
NBT :secA5-BFP (Mazaheri et al., 2014), and immunohistochemistry against cleaved Caspase-3, a
key enzyme in the apoptotic caspase cascade (Wyllie, 1997). Both markers of apoptosis exhibited
a peak of positive cells at 6 hpi (Fig. 4.6), whereas levels were similar to baseline at 0 hpi and 24
hpi, recapitulating data from H2A:GFP transgenic larvae.
Figure 4.6: Occurrence of apoptosis following brain injury is confirmed in an apoptosis reporter line and
through Caspase-3 immunostaining. (A) Apoptotic cell death takes place in the hours after mechanical
injury as shown by an increase in the number of cells externalising phosphatidylserine. Scale bar, 50 µm.
(B) Immunostaining for cleaved Caspase-3 shows a delayed increase in apoptosis after injury. 50 µm. (C)
Quantification of Annexin 5+ cells. n 12 animals per experimental group. *, p < 0.05 in two-way ANOVA.
(D) Quantification of cleaved Caspase-3+ cells. n 6 animals per experimental group. *, p < 0.05 in two-way
ANOVA.
The data presented so far suggested that both (early) necrosis and (delayed) apoptosis occur
in response to mechanical injury. However, it did not provide any insight on whether cells were
dying due to primary cell death (direct mechanical disruption) or secondary cell death (indirect
biochemical changes). I hypothesised that PI+ cells appearing at the injury site promptly died
due to direct structural damage; to test this, we followed individual neurons after injury. We
generated a construct to express a membrane-tagged TdTomato under the neuronal promoter
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elavl3. Injection of the elavl3 :memTdTomato construct into one cell stage H2A:GFP embryos
resulted in mosaic expression at 4 dpf. We followed both cells at the prospective injury site as well
as in the contralateral hemisphere, and identified whether they were structurally damaged by the
injury. We observed direct structural damage at 0 hpi, and subsequent removal until 6 hpi, in 28
neurons residing at the injury site (Fig. 4.7 A, B; n = 15 animals). This finding suggested that
these cells die through primary cell death.
Conversely, the delayed appearance of pyknotic nuclei (and other markers of apoptosis) (Fig. 4.4,
Fig. 4.6) raised the question whether these cells did were structurally injured, but not enough
to kill them immediately, and underwent delayed primary cell death; or whether they escaped
mechanical damage and were killed by an indirect mechanism such as excitotoxicity or oxidative
stress, which would be considered secondary cell death. We followed 56 neurons in 15 animals
at least 50 µm from the injury site (both ipsi- and contra-lateral), and found that they did not
exhibit structural damage. Most of these cells survive until 6 hpi (Fig. 4.7 C, D), but we detected
cell death at 6 hpi in a small proportion (Fig. 4.7 E, F; n = 5 cells in 15 animals), characterised
by nuclear pyknosis and disrupted dendritic morphology. The absence of structural damage at 0
hpi followed by cell death at 6 hpi strongly suggested that these cells underwent secondary cell death.
Finally, as I was predominantly interested in neuronal protection and survival, I aimed to confirm that
the cells dying from the injury were, as in mammalian models of brain injury, predominantly neurons.
To elucidate whether this was the case and to further characterise my injury model, I cross-bred the
transgenic line NBT :secA5-BFP labelling apoptotic cells using neuronal reporter lines NBT :dsRed
(Fig. 4.8 A-C) or elavl3 :kaede (Fig. 4.8 D-F). I imaged the same animals before injury and at 6 hpi,
and quantified double positive cells (Annexin 5-BFP+/dsRed+, or Annexin 5-BFP+/kaede+). This
revealed that most cells both before and at 6 hpi were double positive for Annexin 5-BFP and dsRed
or Annexin 5-BFP and kaede, although the total number of double positive increased following injury
(Fig. 4.8). This data confirmed that, as in mammalian models, the majority of dying cells in the
zebrafish brain following injury were neurons.
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Figure 4.7: In vivo imaging of individual tectal neurons shows that both primary and secondary cell
death occur after brain injury. (A, C, E) Confocal images of the optic tectum of H2A:GFP transgenic
animals. A small number of tectal neurons in the ipsilateral (A) or contralateral (C, E) hemisphere were
mosaically labelled through injection of elavl3 :memTdTomato plasmid DNA. Scale bars, 50 µm (B, D, F)
Close-up of neurons indicated in (A), (C) and (E). White arrow indicates pyknotic nucleus. Scale bars,
10 µm.
Data obtained and analysed by Dr. Leah Herrgen.
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Figure 4.8: The majority of apoptotic cells are neurons. (A, B) Most apoptotic cells in control animals
(A) and in injured animals at 6 hpi (B) colocalise with a neuronal marker NBT (arrowheads). Scale bars,
10 µm. (C, D) Most apoptotic cells in control animals (C) and in injured animals at 6 hpi (D) colocalise
with a neuronal marker elavl3 (arrowheads). Scale bars, 10 µm. (E) Quantification of Annexin 5-BFP+ and
dsRed+/Annexin 5-BFP+ cells in control and injured animals. n = 6 animals per experimental group. (F)




Secondary cell death is a phenomenon following CNS insults such as TBI widely studied in
experimental rodent models. Although some zebrafish models of CNS injuries have investigated
cell death (Morsch et al., 2015; Ohnmacht et al., 2016; Skaggs et al., 2014; Tsarouchas et al.,
2018; Zupanc et al., 1998), no study enquired whether cells die through primary or secondary cell
death. The data presented in this chapter are therefore, to my knowledge, the first to describe the
cell death dynamics, including distinction between primary and secondary cell death, following a
mechanical brain injury in larval zebrafish in vivo.
Using in vivo imaging of zebrafish larvae with several markers of necrotic and apoptotic cell death
allowed me to monitor and quantify cell death in real-time, and to distinguish between primary
necrotic and secondary apoptotic cell death. To thoroughly investigate necrosis and apoptosis
following brain injury, I used four different markers: propidium iodide uptake (necrosis/secondary
necrosis), nuclear pyknosis, phosphatidyl serine exposure and activation of Caspase-3 via cleavage
(all apoptosis). With respect to the apoptosis markers, the processes that are being detected
occur during different phases of apoptotic cell death and therefore do not share the same absolute
numbers of apoptotic cells. Apoptosis usually is initiated by effector caspases, frequently caspase-3,
which can activate multiple different downstream processes to orchestrate cell suicide (Porter and
Jänicke, 1999; Wyllie, 1997). Caspase-3 is therefore one of the earliest markers of a subset of cells
undergoing apoptosis, which I was able to detect via immunostaining (Fig. 4.6 A, C). There is
also a parallel, caspase-independent apoptosis-inducing pathway by release of apoptosis-inducing
factor (AIF) following mitochondrial membrane potential depolarisation (Susin et al., 1999), which
identifies a subset of apoptotic cells that would not be labelled by Caspase-3. Zebrafish are
known to express homologues of AIF, and although I did not specifically investigate this mode
of cell death following my injury assay, it is possible that cells undergoing apoptosis via the AIF
pathway were present following injury in larval zebrafish. Downstream of Caspase-3, cells rapidly
externalise phosphatidyl serine (PS) as an ’eat me’ signal for phagocytes in an energy-dependent
manner (Balasubramanian and Schroit, 2003; Segawa and Nagata, 2015), which I was able to
visualise using a BFP-tagged Annexin 5 (Fig. 4.6 B, D). Later in the process of apoptosis, both
caspase-dependent and -independent, chromatin is tightly packed and nuclear pyknosis is observed
(Oberhammer et al., 1994; Toné et al., 2007), which I could trace using a GFP-tagged histone
variant to assess nuclear morphology (Fig. 4.4).
The fact that these markers label cells during different stages of apoptosis explains the differences
in absolute (baseline) numbers. There is a high amount of developmental apoptosis in the 4 dpf
zebrafish brain. As cleaved Caspase-3 and Annexin 5 label early apoptotic cells, cells positive for
either of these have not had a chance yet to be phagocytosed, resulting in a higher steady-state
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number (Fig. 4.6). There is, however, a low baseline level of cells with condensed nuclei or PI+
cells, as these cells are in the late stages of apoptosis (or necrotic) and have usually already been
removed and digested by microglia before they reach this stage.
Why is it of interest to distinguish between different modes of cell death? Cells undergoing
necrotic or apoptotic cell death create different milieus for their surrounding cells, and elicit
different immune responses upon phagocytic clearance (Green et al., 2016). Necrosis is cell death
mediated by cell membrane rupture, energy failure, or other ways that noxious stimuli - such as
mechanical injury - can damage cells. Intracellular contents are passively released and spill over in
the environment (Peter et al., 2010), potentially exacerbating cell death in the surroundings. In
terms of phagocytic clearance, this poses a challenge as not only the necrotic cell corpses have to be
cleared, but also the toxic intracellular contents that have been spilled (Peter et al., 2010). Finally,
necrosis generally leads to an inflammatory response, for example through release of chromatin
protein HMGB1 (Scaffidi et al., 2002), and the release of pro-inflammatory cytokines by phagocytes.
Conversely, apoptotic cell death results in an anti-inflammatory environment for the surviving
neighbouring cells. To explain why apoptosis and necrosis are so different, one can take a look
at development: apoptosis is a crucial cellular process during development and morphogenesis
(reviewed by Meier et al. (2000)), and occurs frequently. Even in adulthood, it is estimated that
one million adult human cells undergo apoptosis every second (Ravichandran, 2010). Yet, it is
rare to observe an apoptotic cell in healthy tissue (Hochreiter-Hufford and Ravichandran, 2013),
which demonstrates the efficiency of the phagocytic system in detecting and clearing apoptotic
cells. However, it also highlights the fact that the apoptotic cell response is immunologically silent,
otherwise chronic inflammation would reign in our bodies. Apoptotic cells release a number of ’find
me’ signals to attract phagocytes and organise their own clearance, such as the nucleotides ATP
and UTP (Elliott et al., 2009) and certain lipids (Gude et al., 2008; Lauber et al., 2003), amongst
other factors (reviewed by Ravichandran (2011)). The advertisement of cell death may occur even
before apoptosis is completed (Hoeppner et al., 2001), and the release of ATP to alert immune cells
during apoptosis was found to be energy-dependent (Elliott et al., 2009), illustrating that it cannot
occur once the cell is fully dead. A distinction between necrotic and apoptotic cell death appears to
be the amount of ’find me’ signals released: while in apoptotic cells only roughly 0.01% of ATP are
released in an energy-dependent manner (Elliott et al., 2009), necrotic cells release large amounts
of it (as mentioned above, intracellular contents are passively spilled due to membrane disruption).
While apoptosis is carefully orchestrated and involves a series of cellular cascades aimed at neatly
packing intracellular substances into apoptotic bodies, necrosis was generally seen as a descent into
chaos although it is now appreciated that organised forms of necrosis do exist (Bournazou et al.,
2009; Festjens et al., 2006; Golstein and Kroemer, 2007). Furthermore, in contrast to engulfment
of necrotic material which induces inflammation, engulfment of apoptotic material (also called
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efferocytosis) dampens the immune response (Elliott and Ravichandran, 2010; Henson, 2005), and
was shown to suppress the release of pro-inflammatory cytokines by monocytes in vitro (Kim et al.,
2004a; Voll et al., 1997). Finally, apoptotic cells can also modulate the phagocyte recruitment
via release of ’keep out’ factors: apoptotic cells were found to release lactoferrin, which repels
neutrophils from an injury site (Bournazou et al., 2009).
Mechanical forces induce a wave of primary necrotic cell death in many injuries including TBI
(Lenzlinger et al., 2001; Liou et al., 2003; Lou et al., 1998; Stoica and Faden, 2010). Consistent
with previous findings, I observed the occurrence of primary necrotic cell death in my zebrafish
model of mechanical brain injury (Fig. 4.2, Fig. 4.7). To my surprise, the majority of these
necrotic PI+ cells disappeared within one hour as observed by repeated in vivo imaging in the
hours following injury (Fig. 4.2), although there was a slight increase of PI+ cells at 6 hpi. This
secondary peak in PI+ cells was most likely linked to the increased presence of late apoptotic cells,
which is supported by the fact that PI+ cells at 6 hpi often have pyknotic nuclei and hence a
significantly decreased diameter compared to healthy surrounding nuclei (Fig. 4.3).
In addition to PI+ late apoptotic cells, I also observed PI+ cells with microglial and radial glial
morphology (Fig. 4.5). These cells did not appear to be necrotic and were present in the tectum for
up to 48 hpi during repeated live imaging, arguing against the fact that they were undergoing cell
death. It had previously been shown that CNS injury can lead to large pore formation in glial cells
following ATP-dependent stimulation of P2X receptors (James and Butt, 2002), and these P2X
receptors can allow diffusion of molecules of up to 900 Da (Steinberg et al., 1987; Virginio et al.,
1999; Yan et al., 2008). PI has a molecular weight of 668 Da, therefore could potentially enter cells
via P2X-dependent pores. To investigate whether pore formation occurred in radial glia following
injury, I applied iso-PPADS, a P2X receptor subtype specific inhibitor. This treatment completely
abolished PI uptake in radial glia (Fig. 4.5), suggesting the formation of a P2X receptor-dependent
large pore following brain injury. Previous research has shown that P2X receptors are involved
in a variety of pathways: inducing cell death or proliferation (Adinolfi et al., 2005), including
proliferation of neural progenitors (Pearson et al., 2005), or driving inflammation in a variety of
cells, including glial cells (Albalawi et al., 2017; Monif et al., 2009). Whether any of these occur in
the larval zebrafish remains to be elucidated.
Necrosis and apoptosis can modulate repair mechanisms by either enhancing or suppressing
inflammation, therefore the decision of a cell whether to undergo necrosis or apoptosis may be a
crucial factor for the functional outcome following brain injuries. Zupanc et al. (1998) and Hui
et al. (2010) showed that apoptosis is the predominant mode of cell death in zebrafish following
brain or spinal cord injury, respectively. Conversely, my data reveal the occurrence of both necrotic
and apoptotic cell death. Importantly, these occur as distinct waves, and primary necrotic cell
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death is elicited by structural damage and PI+ cells are only found at the injury site (Fig. 4.2,
Fig. 4.7), while secondary apoptotic cell death is elicited by indirect mechanisms and occurs both
at the injury site and remotely (Fig. 4.4, Fig. 4.7). In mammals, necrotic cell death is observed
as early as 10 minutes following experimental TBI in rodents (Cortez et al., 1989; Dietrich et al.,
1994b; Hicks et al., 1996; Sutton et al., 1993), and is the predominant mode of cell death during
acute TBI in humans (Graham et al., 1989). However, unlike in zebrafish, where primary necrotic
cells are only found at the injury site and are furthermore rapidly removed (Fig. 4.2), necrosis after
TBI in mammals is found in regions distant from the original injury site and can be detected for
several weeks following injury (Cortez et al., 1989; Sato et al., 2001; Zhou et al., 2012). Similarly,
although neuronal apoptosis is initiated early after injury - with first cells being detected around
12 to 72 hours post injury in mammalian models (Rink et al., 1995) -, and peaks around 24 hours
in mammalian models (Conti et al., 1998) or 25 to 48 hours human patients (Smith et al., 2000),
apoptotic cells persist for weeks to months in the brain (Clark et al., 1999; Williams et al., 2001).
This suggests that while zebrafish recapitulate typical characteristics of primary and secondary cell
death detected in mammals, they are able to limit both necrotic and apoptotic cell death, and can
return to baseline numbers of dead cells in the brain rapidly. Since clearance of debris (including
corpses of dead cells) is a crucial step for the further repair process (Neumann et al., 2009), the
rapid clearance of both primary and secondary cell death may explain enhanced regenerative success
of zebrafish compared to mammals. Swift removal of dead cells could potentially be fast-tracked by
transcription-independent mechanisms (Kotwal et al., 2015); in the next chapters, I will therefore
investigate the early reactions to injury, including transcription-independent mechanisms, such
as calcium waves, and microglial responses, to investigate how a rapid clearance of dead cells is
achieved in the zebrafish.
To summarise, the data presented in this chapter demonstrate that zebrafish experience two
waves of neuronal cell death following mechanical brain injury, and exhibit the same markers of
necrotic and apoptotic cell death as previously found in experimental models of brain injury and
TBI patients. Although primary necrotic cells following mechanical brain injury are cleared within
an hour, I could still observe the occurrence of secondary cell death. The mechanisms underlying
secondary cell death are only incompletely understood, but could include the release of toxic
intracellular substances by primary necrotic cells and a progressive network dysfunction resulting in
excessive synaptic glutamate release, amongst other pathological processes. I observed secondary
apoptotic cell death as early as 1 hpi, with a progressive increase until 6 hpi. As previously observed
in other experimental models of TBI and TBI patients (Bayly et al., 2006; Liou et al., 2003; Mukhin
et al., 1998; Stoica and Faden, 2010), secondary cell death occurs both at the injury site and at a
distance from the original injury site (Fig. 4.4, Fig. 4.7), providing another layer of evidence of the
suitability of the larval zebrafish model to investigate the cellular and molecular processes following
mechanical brain injury.
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Although zebrafish appear to be much more efficient at removing both primary and secondary dead
cells than mammals following CNS injury, the fact that they replicated the occurrence of secondary
cell death encouraged me to use the larval zebrafish for the investigation of potential neuroprotective
strategies decreasing or inhibiting secondary cell death. I was interested in two particular strands of
investigation:
• immediate, transcription-independent signalling mechanisms, and their role in suppression of
excessive cell death, immune cell recruitment, and neurogenesis
• the role of microglia/macrophage functions, such as phagocytosis and secretion of cytokines
and other factors, in secondary cell death




Description of calcium signalling
following mechanical brain injury in
larval zebrafish
5.1 Introduction
In any organism, uni- or multicellular, rapid detection of wounds is crucial for survival. Early detection
of wounds via transcription-independent damage signals such as calcium, reactive oxygen species, or
ATP is often not only a key part of initiating the wound repair response, but can be a deciding step
for the later regenerative success (Love et al., 2013; Yoo et al., 2012). One of the most prominent
and conserved damage signals in nature, ranging from plants to mammals, is calcium signalling.
Calcium is a key messenger molecule for conveying a multitude of intra- and intercellular signals,
including wounding. Calcium waves are a conserved wounding signal and have been described in a
variety of different organisms, including Drosophila melanogaster (Antunes et al., 2013), Xenopus
laevis (Clark et al., 2009; Herrgen et al., 2014), Caenorhabitis elegans (Xu and Chisholm, 2011), cow
(cell culture) (Chifflet et al., 2012; Klepeis et al., 2001), human (cell culture) (Shabir and Southgate,
2008), and zebrafish (Sieger et al., 2012; Yoo et al., 2012). Calcium waves occur within seconds
from injury. They inform surrounding cells about the injury and can fast-track wound healing by
initiating repair mechanisms such as wound closure (Antunes et al., 2013; Xu and Chisholm, 2011),
expulsion of dead cells (Herrgen et al., 2014), or rapid leukocyte recruitment (Sieger et al., 2012;
Razzell et al., 2013). Therefore, calcium waves are a critical first step of the wound healing process.
I had three distinct hypotheses regarding the effects of calcium waves following injury in the larval
zebrafish, and how they could confer neuroprotection or contribute to repair:
1. PI+ primary necrotic cells following mechanical injury to the larval zebrafish brain are largely
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cleared away within one to two hours post injury (Fig. 4.2). Sieger et al. (2012) had previously
shown that calcium waves recruit microglia following laser injury of the larval zebrafish optic
tectum. Therefore, I hypothesised that mechanical injury elicts calcium waves that recruit
microglia. Microglia then aid in the repair process by phagocytosis of necrotic cells, and may
therefore play a neuroprotective role by preventing spillage of toxic intracellular substances by
necrotic cells.
2. Justet et al. (2016) had shown previously that calcium waves can suppress excessive apoptosis
following injury, which suggested early calcium waves following an injury could therefore confer
neuroprotection; I aimed to assess whether this was the case by inhibiting early calcium waves
and assessing the extent of cell death at later timepoints (particularly 6 hpi, as this was the
peak of secondary cell death in my injury assay).
3. Finally, calcium waves have been described as a signal preceding neurogenesis in neural pro-
genitors (Weissman et al., 2004); therefore, they could instruct regenerative neurogenesis in
response to injury.
I aimed to investigate these hypotheses using the genetically encoded reporter GCaMP6f in the
β-actin:GCaMP6f transgenic line. First, I intended to describe calcium waves occurring after
mechanical injury. For interference with calcium waves, I aimed to identify upstream mechanisms
by injection of pharmacological inhibitors of mechanisms previously shown to elicit calcium waves
(ATP, glutamate, mechanosensitive channels, gap junctions) and subsequent assessment of calcium
waves (Antunes et al., 2013; Herrgen et al., 2014; Razzell et al., 2013; Sieger et al., 2012). As
a readout of the downstream mechanisms, I aimed to assess microglial recruitment to the injury
using the transgenic line mpeg1 :GFP, quantify pyknotic nuclei during the peak of secondary cell
death at 6 hpi in H2A:GFP larvae, and investigate proliferation of radial glia in response to injury
following inhibition of early calcium waves.
In the context of brain injury, sustained calcium signalling has furthermore been linked to glutamate
excitotoxicity and neuronal death (Choi, 1985, 1988; Lipton and Rosenberg, 1994). Therefore, in
addition to investigating calcium waves within seconds of injury, I aimed to study calcium signalling
dynamics in the minutes to hours following injury, and how this relates to cell death. Therefore,
I performed time-lapse imaging of the β-actin:GCaMP6f reporter line, and aimed to interfere with
NMDA receptors, which have previously been implicated in excitotoxicity and secondary cell death
(Faden et al., 1989), to assess the effect on NMDA receptor mediated calcium signalling and death
following injury.
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5.2 Early calcium signalling
5.2.1 Description of calcium waves immediately following injury
I first assessed whether calcium waves occurred in the first seconds after mechanical brain injury of
the larval zebrafish. I induced a mechanical injury in transgenic β-actin:GCaMP6f larvae on stage
of a confocal microscope while acquiring images every 2 s. Injuring of the brain lead to a rapid
increase of GCaMP6f fluorescence (5.1 B, Movie S2), indicating an increase of intracellular calcium
occurred. Ensuring that calcium waves were specific to neuronal injury (which results in presence
of PI+) and could not be elicited by compression of the brain which did not cause neuronal necrosis
(data not shown), I performed the same assay without eliciting neuronal cell death (i.e., compression
of one hemisphere instead of penetration of the tissue). Compression of one tectal hemisphere
for 5 s did not cause an increase in GCaMP6f fluorescence in the brain (5.1 A, Movie S1, 5/5
animals) while eliciting calcium waves in the skin (white arrowheads, Fig. 5.1 A). This was consis-
tent with cell death-related injury-induced signalling eliciting the observed calcium waves in the brain.
Next, I assessed the spatial dynamics of calcium waves. Directly surrounding the initial injury
site, I observed a strong and rapid increase of GCaMP6f fluorescence in cell bodies immediately
surrounding the injury site (pointed out by magenta circle in 5.1 B, 6 s). The predominant cell
type in the optic tectum are neurons (Scott and Baier, 2009), therefore I hypothesised that these
cells were neurons. I also observed a distinct pattern of activation in cells lining the ventricle
and spreading throughout most of these cells in the optic tectum (arrows in 5.1 B, 20 s). This
activation pattern resembled progenitors lining the ventricle of the tectum, so I hypothesised these
cells could be radial glia. To confirm this hypothesis, I cross-bred the calcium reporter line with
animals expressing fluorescent reporters in neurons (NBT :dsRed) or radial glia (her4.3 :mCherry)
and repeated the experiment. Using double transgenic larvae, I was able to confirm that these initial
waves indeed occurred in cells expressing neuronal and radial glial markers (Fig. 5.2). Interestingly,
the calcium wave in radial glia appeared with a slight delay - four seconds on average - compared
to the neuronal wave, suggesting potentially different mechanisms of calcium release underlying
these two waves.
I had so far described two distinct immediate calcium waves following injury:
• Neuronal wave surrounding the immediate injury site
• Radial glial wave spanning the progenitors both close and remote to the injury site
It was unclear what elicited these early calcium waves, and whether or how these waves could play
a role in instructing repair mechanisms. Therefore, I next aimed to dissect the pharmacology of
how these calcium waves were elicited, in order to later potentially perturb them. For this purpose,
I next performed quantitative analysis of wave areas and intensities for both neuronal and radial
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Figure 5.1: Injury, but not compression of the brain leads to long-range calcium waves. (A, B)
Representative images taken −10 s, 6 s, or 20 s after compression (A) or mechanical injury (B) of the
optic tectum in β-actin:GCaMP6f transgenic larvae. Magenta arrowhead in (A) shows site of compression.
Arrowheads in (A) (+ 6 s) show sites of calcium activation in the skin. Magenta circle in (B) highlights cell
body activation surrounding injury site (+6 s), arrowheads show potential activation of radial glial cells (+
20 s).
i Figures correspond to supplementary movies S1 (compression, A), and S2 (injury, B).
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Figure 5.2: Calcium waves occur in cells expressing neuronal and radial glial markers. Crossbreeding of
β-actin:GCaMP6s animals with neuronal and radial glial marker animals revealed that calcium waves occur
in NBT+ cells expressing dsRed (A, arrowheads), and her4.3+ cells expressing mCherry lining the ventricle
(B, arrowheads). These waves are spatially and temporally overlapping, but radial glial waves occur slightly
later than neuronal waves. Scale bar, 20 µm.
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glial waves using a MATLAB script (modified version of script used by Herrgen et al. (2014)) in
combination with pharmacological perturbation of signalling. This enabled me to use the calcium
wave as a readout of which receptors are activated following injury and result in calcium waves.
5.2.2 Signalling leading to early calcium waves following brain injury
Previous studies in Xenopus laevis and zebrafish identified ATP and L-glutamate among the earliest
factors released following brain injuries, and were both shown to elicit calcium waves (Herrgen et al.,
2014; Sieger et al., 2012). Mechanosensitive TRPM3 channels and gap junctions had been shown
to mediate either initiation or propagation of calcium waves in response to injury (Antunes et al.,
2013; Herrgen et al., 2014; Liu et al., 2010; Weissman et al., 2004). To identify which of these
pathways are active following mechanical brain injury in larval zebrafish, I injected pharmacological
inhibitors of NMDA receptors, AMPA receptors, P2 receptors, TRPM3 receptors, and gap junctions
into the ventricle of the fish 10 minutes before injury and then quantified the area and intensity of
neuronal and radial glial calcium wave, as well as the velocity of the calcium wave.
NMDA receptors
After injection of the NMDA receptor mix MK801 and AP5 (previously used by Sieger et al. (2012)),
the neuronal wave was undetectable (Fig. 5.3 B, I, Movie S3), and the radial glial wave area was
slightly reduced (Fig. 5.3 B, J, Movie S3; n = 6 animals; *, p = 0.0363 in Student’s t test). The
radial glial wave intensity remained unchanged. This data suggests a crucial role for the NMDA
receptor signalling in the initiation of the early neuronal wave surrounding the injury site, and a
minor role in the propagation of the radial glia wave. The velocity of the overall calcium wave
remained unchanged.
AMPA receptors
Injection of DNQX, an AMPA receptor inhibitor, resulted in a 40% reduction of the neuronal wave
area and intensity (Fig. 5.3 C, I, J, Movie S3; n = 14 animals; **, p = 0.0035 in Mann-Whitney,
and 0.0065 in Student’s t test, respectively). All other factors were not significantly altered (ns for
radial glia wave intensity, area, and wave velocity). This data suggested that AMPA receptors play
a role in neuronal wave propagation.
ATP signalling
To investigate the role of P2 receptor-mediated ATP signalling on the initiation or propagation of
calcium waves following injury, I injected PPADS (pan-P2 receptor inhibitor) (Charlton et al., 1996;
Connolly, 1995) and iso-PPADS (P2X receptor subtype inhibitor) (Connolly, 1995) in the ventricle
prior to injury. I was presented with the opposite effect of glutamate receptor inhibitors: following
ventricular injection of either PPADS or iso-PPADS, the radial glial calcium wave was absent (Fig.
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5.3 C, D, K, L, Movie S3; n = 6 or 5 animals, respectively; **, p ≤ 0.01 in Kruskal-Wallis-Test with
Dunn’s Post-Test). Treatment with PPADS but not iso-PPADS led to a significant decrease of the
neuronal wave intensity compared to vehicle (Fig. 5.3 C, I; **, p = 0.0038 in One-Way ANOVA with
Bonferroni Post-Test), however, neuronal wave area or wave velocity remained unchanged (Fig. 5.3
J, M). This suggested that P2 receptors were crucial for radial glia wave initiation. P2Y receptors
may contribute to calcium release in neurons following injury.
Stretch-activated calcium channels
Injection of Ononetin, a TRPM3 antagonist, into the ventricle prior to injury caused a significant
decrease of the neuronal wave intensity compared to vehicle (36%; Fig. 5.3 F, I, Movie S3; n = 11
animals; **, p = 0.0038 in Student’s t test). All other factors remained unchanged (Fig. 5.3 J-M).
TRPM3 channels may therefore play a role in the neuronal calcium wave initiation or propagation.
Gap junctions
To decrease gap junction permeability, I used two different inhibitors: carbenoxolone (CBX) and
flufenamic acid (FFA). Injection of CBX did not affect any parameters I measured compared to
vehicle (Fig. 5.3 G, I-M, Movie S3; n = 6; all parameters ns compared to vehicle in Student’s t
test). Injection of FFA significantly decreased the area of the neuronal wave compared to vehicle
(65% reduction; Fig. 5.3 H, J; **, p = 0.001 in Student’s t test), while leaving other parameters
unaffected (Fig. 5.3 J-M). This suggested a role for a subset of gap junctions in propagation of the
neuronal calcium wave immediately after injury. Alternatively, this could be due to non-gap junction-
mediated effects of FFA; although FFA is commonly used as a gap junction inhibitor (Harks et al.,
2001; Herrgen et al., 2014; Srinivas and Spray, 2003), it can also modulate ATP release and a wide
variety of other ion channels (Braet et al., 2003; Guinamard et al., 2013; Stout et al., 2002).
Activation of calcium signalling via injection of ATP and L-Glutamate
Using pharmacological inhibitors, I had shown that several signalling pathways played a role in
eliciting calcium waves following injury, in particular glutamate and ATP. To confirm that these
molecules are sufficient to induce calcium waves as the data in Fig. 5.3 suggested, I injected ATP
and L-glutamate into the brain ventricle of β-actin:GCaMP6f larvae on the stage of a microscope
while imaging at a temporal resolution of 2 s (Fig. 5.4). Injection of vehicle (calcium-free Ringer’s
solution) did not cause a change in GCaMP6f fluorescence. ATP injection resulted an increase in
calcium in radial glia close to the ventricle (6/6 animals). L-gutamate injection elicited calcium
release mainly in neuronal cell bodies and axons in the neuropil (6/6 animals), but it cannot be
excluded that also radial glia are amongst the cells that show calcium signalling upon glutamate. My
data does not suggest so, however, as no cells in proximity of the ventricle were reactive. Injection
of pregnenolone sulfate, a TRPM3 agonist, did not lead to any change in calcium signalling.
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Figure 5.3: Pharmacological inhibitors reveal a key role for NMDA receptors in the neuronal calcium
wave in response to injury, while ATP receptors are crucial for the glial wave. (A-H) Representative
images for each treatment (Vehicle, MK801+AP5, DNQX, PPADS, iso-PPADS, Ononetin, CBX, and FFA)
at 10 s following injury. Scale bar, 50 µm. (I) Quantification of neuronal wave intensity as percentage
of vehicle-injected controls on the same day. (J) Quantification of neuronal wave area as percentage of
vehicle-injected controls on the same day. (K) Quantification of radial glial wave intensity as percentage
of vehicle-injected controls on the same day. (L) Quantification of radial glial wave area as percentage of
vehicle-injected controls on the same day. (M) Quantification of calcium wave velocity as percentage of
vehicle-injected controls on the same day. **, p ≤ 0.01; *, p ≤ 0.05 in Student’s t Test. MK-801/AP5, n
= 6; DNQX, n = 14; PPADS, n = 6; iso-PPADS, n = 5; Ononetin, n = 11; CBX, n = 6; FFA, n = 6.
i Figure corresponds to supplementary movie S3.
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Figure 5.4: Injection of ATP or Glutamate leads to calcium waves similar to observed after injury.
Pregnenolone sulfate, an activator of TRPM3 channels, lead to no changes in calcium activity. Images
taken 6 s after injection of calcium-free Ringer solution (vehicle), 5 mM ATP, 10 mM L-Glutamate, 0.45 mM
Pregnenolone Sulfate in β-actin:GCaMP6f larvae.
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5.2.3 Downstream effects of early calcium signalling
Next, I aimed to elucidate the downstream effects of early calcium signalling. As Sieger et al.
(2012) had previously shown that calcium waves can recruit microglia following laser injury in the
zebrafish brain, I was interested in microglia recruitment. Furthermore, Justet et al. (2016) had
shown that early calcium waves can inhibit excessive apoptosis following an injury, and I aimed
to assess cell death at 6 hpi injury. I attempted to inhibit calcium waves using pharmacological
inhibitors I had previously identified (Fig. 5.3), and I tested how long the inhibiting effects
of MK801 + AP5 and PPADS lasted. To do so, I injected the drugs into the ventricle and
performed injuries after varying amounts of time to see whether inhibition of the calcium waves
subsided over time. Using this approach, I found that MK801 + AP5 inhibited a neuronal
calcium wave for at least 1 hpi (Fig. 5.5 A), therefore suggesting that this treatment was not
temporally specific enough for this purpose, although n numbers in this experiment were low. As
preliminary experiments did not appear promising, I decided to abandon this potential strategy
of inhibiting early calcium waves. Additionally, inhibition of NMDA receptors to could result
in neuronal survival or death potentially unrelated to early calcium waves (see Chapter 5.3).
PPADS inhibited the radial glial wave significantly between 10 and 40 min (Fig. 5.5 B). However,
blocking ATP receptors could result in downstream effects other than inhibition of the radial glial
calcium wave following injury: in particular, microglia/macrophages have previously been shown
to use ATP-P2 receptor signalling to as a chemotactic cue. Using mpeg1 :GFP transgenic larvae
labelling macrophage-lineage cells including macrophages and microglia cells with GFP, I found
that using PPADS significantly decreased the number of mpeg1+ cells at the site of brain injury
at 2 hpi, but it was unclear whether this was directly mediated by calcium waves, or by ATP
receptors on microglia sensing damaged cells, or whether there was some cross-talk between the
two signalling mechanisms. With the tools I had at hand, I was unable to tease these effects apart.
However, I was able to confirm that PPADS treatment did not cause cell death of mpeg1 :GFP+
cells, as the number was unaltered between control (vehicle) and PPADS-treated larvae (Fig. 5.5 D).
I then attempted to use the intracellular calcium chelator BAPTA-AM to inhibit both neuronal and
glial early calcium signalling following injury. While BAPTA-AM injection resulted in a significant
reduction of calcium waves following injury (Fig. 5.6 A), the low solubility of BAPTA-AM in water
required that it was dissolved in Pluronic F-127 (20% solution in DMSO, referred to as Pluronic
/ DMSO), which lead to alteration of microglia/macrophage morphology and number at 2 h post
injection (Fig. 5.6 B), although this was not quantified. Furthermore, BAPTA-AM has been shown
to cause delayed neuronal necrosis in cortical cultures (Wie et al., 2001). It was likely that injection
of BAPTA-AM, as well as Pluronic / DMSO without BAPTA-AM, led to toxicity and I therefore
decided not to follow up on this strategy.
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Figure 5.5: MK801+AP5 inhibition of calcium signalling lasts for at least 1 h, while PPADS lasts
for less than 40 min and reduces recruitment of mpeg1+ cells to the injury site. (A) Treatment
with MK801+AP5 (ventricular injection) significantly reduces neuronal wave intensity for at least 60 min
following injury. *, p ≤ 0.05 in Kruskal-Wallis Test with Dunn’s post-test. n ≥ 3 animals / group. (B)
Treatment with PPADS (ventricular injection) inhibits radial glial wave area for less than 40 min. **, p
≤ 0.01 in Kruskal-Wallis Test with Dunn’s post-test. n ≥ 4 animals / group. (C) Injection of PPADS
leads to a significant reduction in the number of mpeg1+ cells at the site of brain injury at 2 hpi, but did
not lead to a decrease in the overall number of mpeg1+ cells in tectum and skin (D) (i.e., does not cause
microglia/macrophage cell death).
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Figure 5.6: Ventricular injection of BAPTA-AM 2 h prior to injury leads to significant reduction of
neuronal and glial waves but solvent causes microglia/macrophage changes. (A) Quantification of
calcium wave parameters as % of control values. **, p ≤ 0.01 in Student’s t-Test or Mann-Whitney Test,
respectively. n ≥ 6 animals / group. (B) Representative images of mpeg1:GFP transgenic larvae 2 h post
injection of Ca2+-free Ringer’s, Pluronic/DMSO, and BAPTA-AM (in Pluronic/DMSO), including zoom on
mpeg1+ cells on the right hand side. BAPTA-AM appears to cause a reduction in number of mpeg1+ cells
(not quantified) and more amoeboid morphology. Scale bars, 50 µm (left), 15 µm (right).
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Figure 5.7: Ventricular injection of BAPTA tetrasodium salt leads to significant reduction to neuronal
and radial glial wave area but not intensity. Quantification of neuronal and radial glial wave intensity and
area relative to control values. **, p ≤ 0.01 in Student’s t-Test. n ≥ 5 animals / group.
Finally, I attempted the use of BAPTA tetrasodium salt, an extracellular calcium chelator, to inhibit
calcium signalling in the immediate phase following injury. BAPTA tetrasodium salt did cause a
significant decrease in the area of the neuronal and glial wave, but not the intensity (Fig. 5.7). I
did not follow up on this approach and decided to instead focus on the role of persistent calcium
signalling and microglia/macrophages on secondary cell death.
5.3 Excitotoxicity following mechanical brain injury in larval
zebrafish
Following initial calcium waves in response to a mechanical injury of the optic tectum, we were
able to quantify a sustained increase in single-cell calcium transients for at least 6 hpi (Fig. 5.8
A-F). We were interested whether neurons, or microglia/macrophages, or both increased their
calcium activity; increased neuronal calcium transients have been linked to excitotoxicity (Randall
and Thayer, 1992), while increased microglia/macrophage transients are a sign of their activation
(Bader et al., 1994; Eichhoff et al., 2011; Pozner et al., 2015). To investigate whether neurons
and microglia/macrophages increased their calcium activity, we cross-bred the β-actin:GCaMP6f
reporter line with NBT :dsRed animals, or mpeg1:mCherry animals, and quantified the number of
transients in double positive cells. Both neurons and microglia/macrophages exhibited significantly
increased calcium transients following injury over at least a 30 min window of observation (Fig. 5.8
F); we did not assess radial glial calcium transients, although it is possible that these cells also
significantly increased their calcium transient activity.
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Figure 5.8: Calcium transients are significantly increased for at least 6 hpi, and are increased in both
neurons and microglia/macrophages. (A, B) Live imaging of calcium dynamics in the optic tectum of
β-actin:GCaMP6f larvae in a sham animal (A) and an injured animal at 0 hpi (B). White arrows indicate
individual tectal cells. Scale bars, 20 µm.(C, D) Calcium traces from the individual tectal cells highlighted
in (A) and (B). (E) Quantification of calcium transients in the whole tectum over 30 min from indicated
time. **, p <0.01 in Two-Way ANOVA. n = 6 / group. (F) Quantification of calcium transients in sham
or injured animals (0 hpi) in NBT :dsRed or mpeg1 :mCherry+ cells. **, p <0.01 in One-Way ANOVA. n ≥
6 / group. Data in (E) and (F) collected and analysed by Laura Pons.
Using in vivo timelapse imaging in β-actin:GCaMP6f larvae for 1 h (between 2 and 3 hpi) followed
by fixation, nuclear staining, and imaging of nuclei in the same optical plane as previous calcium
imaging, I identified a high density of pyknotic nuclei in regions of high calcium activity as reflected
by single-cell transients (Fig. 5.9). Therefore, I demonstrated a spatiotemporal correlation of
calcium activity and cell death; this was interesting, as previous studies in rodents had linked
increased calcium activity with excitotoxic cell death (Randall and Thayer, 1992; Young, 1992).
However, calcium activity could also be found in regions with low densities of pyknotic nuclei.
This could be caused by a number of factors. First, cell death could occur in a delayed manner
relative to calcium transients and we had not studied the timescale of the calcium transient-cell
death axis. Second, a certain threshold of calcium may be required to induce cell death. Third,
calcium signalling could also reflect the occurrence of other cellular pathways, as calcium has not
exclusively been linked to cell death but also a variety of other processes, such as migration or gene
expression (reviewed by Berridge et al. (2003)).
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Figure 5.9: Pyknotic cell death occurs in regions of high calcium activity. Heatmaps of calcium transients
and pyknotic nuclei in 6 larvae. Calcium transients were quantified between 2-3 h post injury, while pyknotic
nuclei were quantified at 3 h post injury.
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To investigate whether the sustained calcium activity we observed following injury was elicited
by glutamate and mediated by NMDA receptors and could therefore represent excitotoxicity as
previously described in mammalian models of central nervous system injuries (Faden et al., 1989;
Randall and Thayer, 1992), I bathed larvae in the NMDA receptor inhibitor mix MK801 + AP5
and quantified the number of calcium transients following injury. Application of MK801 + AP5
abolished the significant increase of calcium transients following injury that was observed in
untreated larvae both at 0 and 6 hpi (Fig. 5.10 A, B). Furthermore, treatment with MK801 and
AP5 significantly decreased the number of pyknotic nuclei in H2A:GFP larvae 6 h post injury (Fig.
5.10 C, D), while not affecting the number of PI+ cells at 0 hpi (Fig. 5.10 E, F). This provided
further evidence that PI+ cells at 0 hpi die through primary cell death, while pyknotic nuclei at
6 hpi die through secondary cell death, and suggested that NMDA receptor-mediated calcium
signalling could play a role in secondary cell death. The fact that NMDA receptor application only
partially inhibited secondary cell death suggested that, as in mammals, other mechanisms may play
a role in mediating secondary cell death, such as oxidative stress.
Finally, I assessed whether glutamate could be used to exacerbate secondary cell death. Therefore,
I increased glutamate levels via bath application of L-glutamate as previously used by McCutcheon
et al. (2016) and quantified number of pyknotic nuclei at 6 hpi. Treatment with L-glutamate
following injury led to a significant increase of pyknotic nuclei, therefore providing further evidence
that excitotoxicity is - at least in part - responsible for secondary cell death in our brain injury model.
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Figure 5.10: Treatment with NMDA receptor antagonists MK801 and AP5 abolishes injury-induced
sustained increase in calcium signalling and reduces secondary cell death at 6 hpi. Treatment with
NMDA receptor inhibitor mix MK801 and AP5 significantly reduced calcium transients both immediately
(A), and at 6 hpi (B) while not affecting transients in sham animals. **, p ≤ 0.01 in Two-Way ANOVA.
n ≥ 6 animals / group. (C) Representative close-up images of vehicle- or MK801+AP5-treated H2A:GFP
larvae at 6 hpi. Arrowheads are pointing at pyknotic nuclei. Scale bar, 25 µm. Experiment performed and
images acquired by Laura Pons. (D) Representative close-up images of vehicle- or MK801+AP5-treated
larvae stained with PI at 0 hpi. Arrowheads are pointing at PI+ cells. Scale bar, 20 µm. (E) Quantification
of pyknotic nuclei in whole tectum of vehicle- or MK801+AP5-treated H2A:GFP larvae (sham or 6 hpi). **,
p ≤ 0.01 in Two-Way ANOVA. n = 6 animals / group. (F) Quantification of PI+ cells in whole tectum of
vehicle- or MK801+AP5-treated animals (sham or 0 hpi). ns in Two-Way ANOVA. n ≥ 6 animals / group.
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Figure 5.11: Treatment with NMDA receptor agonist L-glutamate causes a significant increase of
secondary cell death at 6 hpi. (A) Representative close-up images of vehicle- or L-Glutamate-treated
H2A:GFP larvae at 6 hpi. Arrows are pointing at pyknotic nuclei. Scale bar, 25 µm. (B) Quantification of
pyknotic nuclei in whole tectum of vehicle- or L-glutamate-treated H2A:GFP larvae (sham or 6 hpi). **, p
≤ 0.01 in Two-Way ANOVA. n = 6 animals / group.
5.4 Discussion
The idea that an early calcium signal plays a crucial role in injury repair is not new. One of
the first observations that wound healing is inhibited in the absence of calcium signalling was
made by Stanisstreet in the Xenopus embryo ectoderm in 1982 (Stanisstreet, 1982). Since then,
injury-induced calcium waves have been studied in a variety of organisms and tissue contexts.
Similarly, sustained increases in calcium signalling, called glutamate excitotoxicity, following CNS
injuries have been studied for several decades (Faden et al., 1989; Katayama et al., 1990).
In this chapter, I have described the investigation of calcium signalling following larval zebrafish brain
injury both within seconds (early), and within minutes to hours (sustained responses). Working with
larval zebrafish equipped me with tools to visualise injury-induced calcium signalling. Although phar-
macological perturbation of early calcium waves was complicated by a lack of specific (particularly
temporal) inhibitors without toxicity, this platform potentially allows for easy perturbation of sig-
nalling mechanisms upstream of calcium waves and the effects on downstream readouts such as
microglial recruitment or cell death in real-time.
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5.4.1 Early calcium signalling
I was able to provide evidence for distinct pathways eliciting calcium signalling after acute mechani-
cal brain injury in larval zebrafish. Several receptors were activated by injury of neural tissue, leading
to calcium waves in specific cell types: the first cells to increase intracellular calcium surrounding
the injury site were neurons (starting within zero to two seconds of injury and lasting until fourteen
seconds post injury on average) upon glutamate receptor activation (both NMDA and AMPA
receptors, although NMDA receptors appear to be the predominant type; NMDA receptor inhibition
was able to completely abolish the neuronal calcium wave, and may therefore act upstream of AMPA
receptors) (Fig. 5.3 B, C, I, J). Similarly, I was able to increase calcium in neurons by ventricular
injection of L-glutamate (Fig, 5.4). Increases of calcium in neuronal cell bodies immediately
following injury were aided by activation of P2Y subtype ATP receptors (Fig. 5.3 D, E, K, L,
Movie S3), as well as TRPM3 mechanosensitive channels (Fig. 5.3 F, I, J, Movie S3). However,
injection of P2 receptor agonist ATP or TRMP3 agonist ononetin were unable to elicit a significant
calcium increase in cells with neuronal morphology (Fig. 5.4). Finally, gap junctions may in part
play a role in propagation of the neuronal calcium wave. Inhibition of connexin 43 channels via
carbenoxolone (CBX) did not cause any effect on the parameters I measured, whereas application
of a different type of gap junction inhibitor, flufenamic acid (FFA), significantly decreased neuronal
wave area (Fig. 5.3 J, Movie S3). This finding needs to be interpreted with caution: although
FFA has previously been used as a reversible gap junction inhibitor (Harks et al., 2001; Herrgen
et al., 2014; Srinivas and Spray, 2003), it is now known that FFA can also modulate the release
of ATP and glutamate via connexin 43 gap junctions (Braet et al., 2003; Stout et al., 2002),
and is a promiscuous modulator of calcium, chloride, sodium, and TRPM3 mechanosensitive ion
channels (reviewed by Guinamard et al. (2013)). Therefore, it could be the case that FFA modulates
the neuronal calcium wave propagation via modulation of ion channels and ATP or glutamate release.
Activation of neuronal cells following injury was closely followed by an intracellular increase of
calcium in radial glia (starting from four seconds and lasting up to thirty seconds post injury)
elicited by ATP signalling via the P2X receptor subtype (Fig. 5.2, Fig. 5.3 D, E, K, L, Movie
S3). Application of pan-P2 receptor inhibitor PPADS, or P2X receptor subtype-specific inhibitor
iso-PPADS, completely abolished radial glial calcium signalling following injury (Fig. 5.3, Movie
S3); I did not assess the effect of P2Y subtype receptor inhibitors, although these have previously
been used in the investigation of calcium waves (Kulick and von Kügelgen, 2002; Suplat et al.,
2007; Tovell and Sanderson, 2008). In line with the finding that P2 receptors were able to inhibit
radial glial calcium waves following injury, ventricular injection of ATP (a P2 receptor agonist) led
to a rapid increase of GCaMP6f fluorescence in radial glia (Fig. 5.4). No other pharmacological
inhibitor I tested, including glutamate receptor inhibitors, mechanosensitive channel inhibitors,
or gap junction inhibitors, had an effect on the radial glial calcium wave (Fig. 5.3 J). This was
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surprising, as previous research had shown that calcium waves in radial glia can be inhibited by
application of carbenoxolone in vitro, targeting connexin 43 channels (Weissman et al., 2004).
Nonetheless, the data suggested that ATP is the predominant signalling mode for glial cells
following brain injury in the larval zebrafish.
The findings described in this chapter are consistent with previous observations that injuring of
neural tissue leads to calcium waves (Herrgen et al., 2014; Kanemaru et al., 2013; Kraft et al.,
2017; Sieger et al., 2012; Vargas et al., 2015). However, it was unclear whether these calcium
wave were a passive reaction to release of ATP and glutamate from dying neurons, or whether they
could instruct reparative and regenerative downstream processes in the immediate phase following
brain injury (or both). Previous research has shown that calcium waves can exert (neuro)protective
functions, for example by inhibiting excessive apoptosis following an injury (Justet et al., 2016;
Kanemaru et al., 2013), but also via other cellular mechanisms such as actin remodelling, rapid
wound closure, and expulsion of dead cells from intact tissue (Herrgen et al., 2014; Minns et al.,
2016). Furthermore, calcium waves have been reported to attract microglia to sites of brain injury
(Sieger et al., 2012). Sieger et al. (2012) showed that calcium waves and ATP are required to
recruit microglia to a site of neuronal injury in the 3 dpf zebrafish tectum, which I confirmed with
my experiments in the 4 dpf zebrafish tectum. I was furthermore able to reproduce the prior finding
that ATP is required for microglia recruitment to an injury site (Fig. 5.5 C) (Davalos et al., 2005;
Honda et al., 2001; Ohsawa et al., 2007), although the effect was small using the P2 receptor
inhibitor PPADS, which is most likely attributed to the fact that PPADS inhibition of P2 recep-
tors is only temporary (Fig. 5.5 B), and other factors may contribute to the recruitment of microglia.
My attempts to employ calcium chelators to specifically block immediate calcium signalling
following injury were not successful (Fig. 5.6 and 5.7). However, there appears to be a consensus in
the literature that an early calcium wave following (neuronal) injury is benign rather than cytotoxic
(Herrgen et al., 2014; Justet et al., 2016; Kanemaru et al., 2013; Vargas et al., 2015), although
further research into this is required to understand the exact role of it in this mechanical injury
assay. This will hopefully be enabled by more precise tools to spatially and temporally inhibit
calcium signalling in the future.
In addition to recruitment of leukocytes and potential inhibition of excessive apoptosis, calcium
waves in radial glia may play a role in regulating regenerative neurogenesis in response to injury. In
the optic tectum of the larval zebrafish, radial glia lining the ventricle are progenitor cells. Although
developmental neurogenesis in the optic tectum decreases after two to three days post fertilisation
(Wullimann and Knipp, 2000), these cells retain the capacity to produce new neurons throughout
the whole life of the zebrafish and can therefore be reactivated by injury - a calcium wave could be
one of these signals to prime radial glia for proliferation. My finding that ATP acts on radial glia
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to produce calcium waves following injury is particularly exciting as a previous study has reported
that ATP can induce calcium waves which then increase proliferation of rat radial glia in vitro
(Weissman et al., 2004). ATP has also been shown to be a positive regulator of neural stem cell
proliferation in rodents in vivo (Cao et al., 2013; Gampe et al., 2015), while calcium waves have
been shown to be an effector of proliferation (Justet et al., 2016; Kraft et al., 2017) although a
link through ATP was not addressed in these studies.
The detailed investigation into the link between ATP, calcium, and radial glial proliferation was
hampered by technical issues: I was unable to specifically inhibit calcium signalling only in radial
glia immediately following the injury. Although PPADS and iso-PPADS were able to completely
inhibit the radial glial calcium wave, these drugs are not specific inhibitors for P2 receptors on radial
glia and also inhibited recruitment of microglia (Fig. 5.5 D), which have previously been shown to
play a role in modulating progenitor proliferation in a brain injury model of adult zebrafish (Kyritsis
et al., 2012). I could therefore not discern whether reactivation following injury was a direct or
indirect effect of calcium waves, mediated by radial glial calcium waves or mediated by microglia,
respectively. There are, however, two other approaches I propose to investigate a link between radial
glial proliferation and calcium signalling:
• Use of BACCS (blue light-activated calcium channels):
Rather than specifically inhibiting calcium in radial glia following an injury, with BACCS I
could elicit calcium signalling specifically in radial glia using blue light. There are several
different versions of BACCS with different response dynamics (i.e., rapid or slow calcium
response, slow or fast recovery) that could be employed (described by Ishii et al. (2015)). A
proposed experiment could be to inject BACCS constructs under a radial glial promoter such
as her4.3 into β-actin:GCaMP6f larvae to create mosaic expression in single radial glia, and
expose these cells to light to elicit a calcium response. At certain timepoints (e.g. 1 day post
blue light), proliferation could be assessed using a BrdU pulse experiment and compared to
non-activated cells. This experiment would require thorough planning and trouble-shooting,
but could provide more causal information on the link of radial glial calcium activity and
proliferation.
• Use of the CaMPARI (Calcium Modulated Photoactivatable Ratiometic Integrator) system:
Although initial calcium waves may initiate neurogenesis (Weissman et al., 2004), persistent
or rhythmic calcium bursts may play a role in further execution of proliferation as previously
shown (Johansen et al., 2017; Owens and Kriegstein, 1998; Pearson et al., 2005; Resende
et al., 2010a,b; Somasundaram et al., 2014). It would prove challenging to continuously
image the activity pattern of radial glia in order to detect calcium oscillations, and then assess
proliferation, which occurs a few days later (2 days post injury in the larval zebrafish spinal cord
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(Ohnmacht et al., 2016); 2 to 3 days post injury in our injury model, unpublished data, Leah
Herrgen). Employing CaMPARI (developed by Fosque et al. (2015)) could provide a solution
to this problem. This genetically encoded calcium indicator undergoes irreversible green-to-red
photoconversion when calcium is active and the cell is irradiated with UV light of a wavelength
of 400 nm, therefore providing a snapshot of activity. This system has previously been shown
to elicit efficient photoconversion, and has been employed in freely-moving zebrafish and
flies (Fosque et al., 2015). CaMPARI could be expressed under a radial glial promoter in
larval zebrafish, and the larvae could be exposed to photoconverting light at certain times
following the injury while freely moving, and proliferation could be assessed with a BrdU pulse
experiment in the same larvae. This would require some trouble-shooting and timepoints would
need to be carefully chosen. Although this experiment would not provide causal information,
it could provide a correlative insight between radial glial calcium activity at a given timepoint
and later proliferation.
5.4.2 Sustained calcium transients
Following initial calcium waves, the optic tectum showed an increased calcium transient frequency
compared to controls for at least 6 hours post injury (Fig. 5.8 A). Our data of cross-breeding of
β-actin:GCaMP6f and NBT :dsRed fish showed that neurons increase their transients following
injury (Fig. 5.8 B). Similarly, calcium activity was increased in microglia/macrophages as timelapse
imaging of double transgenic β-actin:GCaMP6f; mpeg1 :mCherry larvae revealed (Fig. 5.8 B).
Previous work has shown that microglia display an increase of calcium transients when activated
(Bader et al., 1994; Eichhoff et al., 2011; Pozner et al., 2015). Future work could involve studying
double transgenic β-actin:GCaMP6f; mpeg1 :mCherry larvae in more detail to investigate how
calcium transients in microglia/macrophages are temporally related to cellular functions in response
to zebrafish brain injury injury in vivo (such as migration or phagocytosis), as previous work
has shown calcium transients in microglia induce migration in vitro (Bader et al., 1994) and
phagocytosis in vivo (Koizumi et al., 2007).
Investigating neuronal calcium activity following injury, I observed that secondary cell death
predominantly occurred in regions that had previously also shown a high number of calcium
transients (Fig. 5.9). This suggested that these regions potentially experienced a cytotoxic calcium
overload. This phenomenon following CNS injuries is commonly referred to as excitotoxicity and
has been extensively studied in experimental models of CNS injuries. Previous research had shown
that the glutamate-NMDA receptor pathway is responsible for increased calcium activity following
brain injury (Faden et al., 1989; Randall and Thayer, 1992); I employed NMDA receptor antagonist
mix MK801 and AP5 to decrease calcium signalling following injury (Fig. 5.10), which lead to
a significant reduction of pyknotic nuclei at 6 hpi but not PI+ cells at 0 hpi (Fig. 5.10), showing
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Figure 5.12: Schematic of factors eliciting early and sustained calcium signalling following mechanic
injury. Magenta and green ellipses depict dead or healthy neurons, respectively, and mechanisms inducing
early and sustained calcium signalling following injury are illustrated.
that, as in rodent models, the NMDA receptor pathway mediated secondary cell death in larval
zebrafish. Similarly, supplying external L-glutamate via bath application following the injury (which
was previously shown to cause apoptotic cell death after 24 hours in a larval zebrafish model of
excitotoxicity by McCutcheon et al. (2016)), led to a significant increase of pyknotic at 6 hpi in
injured but not sham animals (Fig. 5.11). The discrepancy between my results (a lack of cell
death in sham animals following L-glutamate treatment) and what McCutcheon et al. (2016)
published (apoptotic cell death in what would be ’sham’ animals in my assay) can be explained by
the different timescales; I only applied L-glutamate for 6 hours, while McCutcheon et al. (2016)
left the larvae in L-glutamate for 24 hours. In combination, my dataset strongly suggests that
sustained neuronal calcium transients following injury in larval zebrafish are excitotoxic, and that
the occurrence of glutamate excitotoxicity eliciting secondary cell death appears to be conserved
between zebrafish and rodents following brain injury .
To summarise, this dataset provides novel information on calcium signalling events following me-
chanical brain injury in the larval zebrafish, and is useful for several reasons:
1. It confirms and expands data on early calcium waves and their upstream signalling mechanisms
following injury (summarised in Fig. 5.12).
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2. It shows that excitotoxicity is a conserved neurotoxic mechanism following brain injury in larval
zebrafish.
3. It could provide the basis to a novel study investigating calcium signalling in relation to radial
glia behaviour, including physiological and injury-induced (regenerative) neurogenesis.
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Chapter 6
Rapid clearance of debris by
microglia limits secondary neuronal
cell death
6.1 Introduction
Microglia are the resident macrophages of the brain. They are involved in brain development
and responsible for surveillance of the brain, protection from pathogen invasion, and removal of
cellular debris and apoptotic cells (Cunningham et al., 2013; Paolicelli et al., 2011; Pont-Lezica
et al., 2014; Schafer et al., 2012; Sierra et al., 2010; Stevens et al., 2007; Squarzoni et al., 2014;
Ueno et al., 2013). In the context of injury, the role of microglia and peripheral macrophages has
been ambiguous: initially, many studies found a detrimental role of neuroinflammation mediated
by microglia and macrophages in neuronal survival following brain injuries (Festoff et al., 2006;
Li et al., 2013; Wirenfeldt et al., 2005). Conversely, other studies suggest that, depending
on their polarisation, microglia/macrophages can be critical for tissue repair and mediate neuro-
protection (Chamak et al., 1994; Szalay et al., 2016; Tsarouchas et al., 2018; Yin et al., 2003, 2006).
Microglia are made aware of injuries by ATP released in the environment as a DAMP (Davalos et al.,
2005) and calcium waves (Sieger et al., 2012). Sieger et al. (2012) demonstrated that microglia
are rapidly recruited to brain injuries in larval zebrafish and engulf debris. Whether phagocytosis
is beneficial or detrimental is subject of an ongoing debate (Sierra et al., 2013). Several previous
studies suggest a neurotoxic role for microglial phagocytosis following neuronal injuries due to
phagocytosis of stressed-but-viable neurons, exacerbating tissue loss (Fricker et al., 2012a,b; Neher
et al., 2011, 2013). Furthermore, phagocytosis can result in generation of superoxide anions, also
known as respiratory burst (Minakami and Sumimotoa, 2006), which may exacerbate oxidative
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stress in response to injury. Consistent with this, microglial phagocytosis has previously been shown
to cause ROS production and neuronal death in vitro (Claude et al., 2013; Wilms et al., 2003).
On the other hand, phagocytosis removes debris that may otherwise spill toxic intracellular factors
(Green et al., 2016; Wolf et al., 2017), and can promote a more anti-inflammatory polarisation of
microglia (Fadok et al., 1998; Wolf et al., 2017).
Here, I aimed to assess microglial recruitment and phagocytosis in the larval zebrafish. Although
previous studies in rodents had used 2-photon imaging of microglia/macrophages to assess
microglial behaviour in response to injury or disease in vivo (Davalos et al., 2005; Locatelli et al.,
2018; Pozner et al., 2015; Roth et al., 2014), this is much more challenging than in larval zebrafish
which are easily amenable to live imaging. Using in vivo imaging in larval zebrafish enabled me to
easily assess dynamic changes in microglial behaviour in response to injury. Furthermore, in contrast
to mammals, zebrafish are able to rapidly decrease both primary and secondary cell death (Fig.
4.2, Fig. 4.4), and therefore microglial responses may differ from mammalian models; identification
of the mechanisms that render zebrafish microglia neuroprotective could provide a valuable tool for
treatment of brain injuries.
In the upcoming chapter, I will describe the work I undertook to investigate microglia/macrophages
in my injury assay. As I hypothesised that microglia/macrophages could act neuroprotective, in
particular through rapid phagocytosis of debris, I first assessed microglia/macrophage recruitment
and phagocytosis in response to injury using timelapse in vivo imaging, and then aimed to inhibit
phagocytosis using pharmacological and genetic perturbation of phagocytic receptors. I also em-
ployed the irf8-/- mutant line lacking microglia and macrophages (Shiau et al., 2015) to investigate
the effect of complete absence of these cells on secondary cell death, and compared cytokine levels
in these mutants with wild type animals using quantitative reverse-transcription PCR (qRT-PCR).
6.2 Recruitment of microglia/macrophages
I started off my investigation into immune cell function by assessing recruitment of microglia and
macrophages. For this purpose, I employed the mpeg1 :GFP transgenic line, labelling all macrophages
including microglia. I performed in vivo imaging before, 0, 1, and 2 hpi in the same animals. mpeg1+
cells within the brain rapidly migrated to the brain injury site (Fig. 6.1), suggesting a recruitment
via transcription-independent mechanisms as previously shown (Fig. 5.5 C, Sieger et al. (2012)).
Additionally, mpeg1+ cells present on the skin were rapidly recruited to the site of skin injury. The
adjacent quantification only shows mpeg1+ cells inside brain, as the exact number of cells at the
site of skin injury was often difficult to determine due to the dense positioning of the cells and
interaction of processes, and moreover my primary interest was neuronal repair.
I performed timelapse imaging before and within the first two hours after injury to gain a more
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Figure 6.1: Cells expressing the microglia/macrophage marker mpeg1 migrate to the site of injury.
Images taken before, 1, and 2 hours post injury from the same animal. PI is indicating presence of dead cells.
Scale bar, 50 µm In the lower right panel: quantification of mpeg1+ cells at site of brain injury, excluding
cells on the skin. n = 6 animals.
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Figure 6.2: mpeg1+ cells change their behaviour from sedentary surveillance to responsive migration
in the first two hours following injury. (A) Traces visualizing mpeg1+ cell body movement before and 2
hpi. (B) Quantification of average mpeg1+ cell body migration speed. **, p = 0.0011 in paired t test; n
= 8 animals. (C) Quantification of average mpeg1+ cell net displacement before and after injury. **, p =
0.0001 in paired t test; n = 8 animals.
i Figure corresponds to movies S4 (A, before) and S5 (B, injured).
dynamic understanding of mpeg1+ cell recruitment. The first mpeg1+ cells migrated to the
injury site within five minutes of injury. Using the 3D-rendering software IMARIS, I was able to
trace microglia/macrophages, and measure the migration speed and net displacement before and
after injury. Traces are visualised in Fig. 6.2 and in supplementary movies S4 and S5. mpeg1+
cells significantly increased their average migration speed following injury, from 0.55 µm/min to
1.125 µm/min (**, p = 0.0011 in paired t test before - after injury; n = 8 animals). Similarly,
net displacement of mpeg1+ cells was significantly increased from 9.30 µm to 33 µm following
injury (**, p = 0.0001 in paired t test before - after injury; n = 8). This data therefore revealed
a significant behavioural response of mpeg1+ cells within two hours of injury from (resting)
surveillance to migration to the injury site.
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6.3 Microglia, but not peripheral macrophages, are present
within injured brain
I had so far used the number of mpeg1+ cells at the site of brain injury to quantify mi-
croglia/macrophage recruitment. However, this transgenic line does not reveal whether these cells
were brain-resident microglia or peripheral ’invading’ macrophages from the skin or other regions of
the body following injury. As it had previously been described that microglia and macrophages can
have very distinct injury-induced signatures and inflammatory responses, I wanted to assess if there
was a predominant cell type at the site of brain injury, or if there was heterogeneous recruitment of
both microglia and peripheral macrophages.
To address this question, I followed two approaches: first, I performed repeated in vivo imaging of
the double transgenic line Tg(p2y12 :P2Y12-GFP; mpeg1 :mCherry), in which all macrophages are la-
belled red with mCherry and microglia additionally express GFP, allowing me to distinguish between
the two cell types. Imaging these animals before, 0, 1, 2 and 6 hpi revealed that virtually all mpeg1+
cells at the site of brain injury expressed the well-established microglial marker P2Y12 (Bennett et al.,
2016; Butovsky et al., 2014; Mildner et al., 2017), and were therefore probably microglia (Fig. 6.3
A, D). The second approach I used was to perform a double immunostaining against the microglial
marker 4C4 (Becker et al., 2004) and GFP on the transgenic mpeg1 :GFP background at 6 hpi. This
showed that most cells present at the brain injury site were immunoreactive for 4C4 (Fig. 6.3 B, E),
while they were predominantly 4C4- in the trunk of the fish apart from in the spinal cord (Fig. 6.3 C).
I was intrigued by the fact that macrophages did not appear to enter the brain in our injury model,
seeing as they were the predominant type of immune cell present in spinal cord lesions of larval
zebrafish (Tsarouchas et al., 2018), and infiltration of monocyte-derived macrophages (MDMs) is
frequently observed following mammalian brain injuries (Gyoneva et al., 2015). To explore whether
microglia/macrophages ever transition between skin to brain or brain to skin following injury in our
model, I re-investigated the timelapses I acquired for Fig. 6.2. As the skin is autofluorescent in
zebrafish, this allowed me to easily observe if any cells were transitioning between skin and brain
in the 2 hours following injury. I observed very few occasions where macrophages or microglia
were ’trespassing’ into each other’s territories within this two hour period. Fig. 6.4 shows a
representative image of a skin macrophage being recruited to the site of injury, but stopping at the
skin injury and not entering the brain within the window of observation. This is reflected by the
quantification in Fig. 6.4.
Finally, I aimed to assess recruitment of neutrophils; in mammals, neutrophils are some of the
earliest immune cells to arrive at the injury site, and are additionally recruited by activated microglia
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Figure 6.3: Virtually all macrophages recruited to the injury site express microglial markers P2Y12
or 4C4. A Representative images of mpeg1 :mCherry;p2y12:P2Y12-GFP transgenic larvae at 6 hpi. Yellow
arrows indicate microglia (P2Y12
+/mpeg1+ or mpeg1-), blue arrows indicate immune cells on skin (P2Y12
+
or P2Y12
-/mpeg1+). Scale bar, 40 µm. (B) Images of the brain injury site acquired at 6 hpi. Orange
arrows point to microglia (4C4+/GFP+ or GFP-), blue arrow points to macrophages (4C4-/GFP+). Scale
bar, 25 µm. (C) Images acquired from the spinal cord showing microglial cell (orange arrow; 4C4+/GFP+)
in spinal cord region and macrophages (blue arrow; 4C4-/GFP+) in rest of the trunk. Scale bar, 25 µm.
(D) Quantification of microglia and macrophages at the injury site in mpeg1 :mCherry;p2y12:P2Y12-GFP
transgenic larvae. n = 6 animals per experimental group. (E) Quantification of microglia and macrophages
at the injury site using immunohistochemistry agains 4C4. n = 9.
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Figure 6.4: Traces visualising past cell body displacement of skin macrophages which do not enter
the brain. Traces showing past cell body displacement of mpeg1 :GFP+ cell within 2 hpi. Quantification of
immune cell transitions during 2 h after injury. n = 7 animals per experimental group.
Figure 6.5: Very few neutrophils are recruited to the brain injury. Representative images of mpo:GFP
transgenic larvae before, 1, 2, or 6 hpi. Magenta arrow indicates injury site. Scale bar, 50 µm. Adjacent:
quantification of mpo+ cells at the site of injury (skin or brain).
(Carlos et al., 1997; Oehmichen et al., 2003). In the larval zebrafish spinal cord, neutrophils are
abundantly recruited to the injury site within a few hours (Tsarouchas et al., 2018). To investigate
neutrophil recruitment in our brain injury model, I performed repeated in vivo imaging using a
transgenic neutrophil reporter line (mpo:GFP). This showed that neutrophils were present in much
lower numbers than microglia or macrophages in the head, and only few cells were recruited to
the skin injury site. Moreover, very few cells (and at most times none at all) were present inside
the brain, suggesting that in the larval zebrafish brain, neutrophils play only a minor role in wound
repair.
6.4 Comparison of wild type and irf8-/- larvae
Given that microglia were highly reactive to the injury, I wanted to investigate the role of these cells
following injury, particularly their contribution to cell death. I employed a comparison between wild
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type animals and irf8-/- mutants (Shiau et al., 2015), lacking all microglia (and macrophages) until
at least 6 days post fertilisation. These animals survive until fertile adulthood and have no gross
morphological defects, although they have an increased number of neutrophils (Shiau et al., 2015).
6.4.1 Cell death
Using PI bath application for in vivo imaging, I assessed the extent of cell death in these animals
following injury. I observed a significant increase of PI+ cells at 6 hours post injury compared to
wild type animals, which usually have managed to decrease necrotic PI+ cell levels significantly at
this point (Fig. 6.6 A, B).
To assess apoptosis in response to injury, I quantified the number of pyknotic nuclei and cleaved
Caspase-3+ cells comparing wild type animals with irf8-/- mutants. Both of these cell death
markers were already significantly increased in uninjured irf8-/- mutants at 4 dpf (Fig. 6.6 C-E),
which is most likely due to a lack of clearance of developmentally apoptotic cells in the absence of
microglia (Casano et al., 2016; Xu et al., 2016). Although the baseline levels of pyknotic nuclei and
Caspase-3+ cells were higher than in wild type animals, the difference between baseline numbers
and numbers at 6 hpi was higher in irf8-/- mutants than in wild types. Therefore, the number of
dead cells was enhanced following injury in microglia- and macrophage-less animals compared to
wild type animals. However, the data in Fig. 6.6 represent a steady state; the numbers provide
no information on whether the enhanced number of cells positive for cell death markers in irf8-/-
larvae at 6 hpi was due to a lack of collection and degradation of dead cells in the hours leading
up to 6 hpi (and therefore increased accumulation of dead cells compared to wild type animals), or
due to an exacerbation of secondary cell death elicited by enhanced neurotoxicity in the absence of
microglia/macrophages.
Interestingly, the numbers of Caspase-3+ cells were not significantly different from uninjured animals
at 24 hpi (Fig. 6.6 F), while pyknotic nuclei were (Fig. 6.6 D). As these two markers label different
phases of apoptotic cell death (early for Caspase-3, late for nuclear pyknosis), this could indicate
that Caspase-3+ cells present at 6 hpi stay around to become pyknotic (and Caspase-3-) later instead
of being removed. Conversely, nuclear pyknosis - a marker for late apoptosis - remained high at 24
hpi, which can potentially be explained by a lack of clearance, and the progression of early apoptotic
(Caspase-3+) cells to later stages of apoptosis. Nonetheless, the number of pyknotic nuclei also did
not increase. Likewise, the number of PI+ cells reached baseline levels at 24 hpi, which suggested
there may be a capacity, although limited, to remove dead cells even in irf8-/- larvae. This is
likely achieved by phagocytosis through neutrophils (Esmann et al., 2010), or could be mediated by
other mechanisms mediated by neighbouring cells such as macropinocytosis (Henson, 2005), and
expulsion of dead cells via tissue contractions (Herrgen et al., 2014). It is somewhat curious that
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Figure 6.6: irf8-/- mutants lacking microglia and macrophages exhibit increased numbers of (secondary)
cell death following brain injury. (A) Representative images of a wild type and irf8-/- animal at 6 hpi labelled
with PI bath application. Scale bar, 50 µm. (B) Quantification of PI+ cells following injury. Significance
relates to wild type animals of respective treatment. **, p ≤ 0.01 in Two-Way ANOVA. (C) Representative
images of pyknotic nuclei in a wild type and irf8-/- animal at 6 hpi. Scale bar, 50 µm. (D) Quantification of
pyknotic nuclei following injury. Significance relates to sham animals of respective genotype. **, p ≤ 0.01
in Two-Way ANOVA. (E) Representative images of cleaved Caspase-3 immunostaining in a wild type and
irf8-/- animal at 6 hpi. Scale bar, 50 µm. (F) Quantification of cleaved Caspase-3+ cells following injury.
Significance relates to wild type animals of respective treatment. *, p ≤ 0.05; **, p ≤ 0.01 in Two-Way
ANOVA.
PI+ cells return to baseline levels between 6 and 24 hpi while pyknotic nuclei do not; this may be
explained by the fact that the abovementioned factors (phagocytosis by neutrophils, expulsion via
tissue remodeling, etc.) may be sufficient to remove PI+ cells present at 6 hpi, but cannot keep
up efficient clearance, and cannot prevent cells that are in early apoptotic stages (Caspase-3+) at
6 hpi to progress to later stages characterised by nuclear pyknosis, which results in accumulation of
pyknotic nuclei at 24 hpi.
6.4.2 Neutrophil recruitment
irf8 is a key transcription factor regulating macrophage versus neutrophil fate in development, and
irf8-/- mutants have excess neutrophils during embryogenesis (Shiau et al., 2015). Neutrophils are
a major source of reactive oxygen species, and can create inflammatory environments detrimental
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to neuronal survival. To assess neutrophil recruitment and to test whether irf8-/- mutants have an
increased presence of neutrophils in the brain upon injury, I performed an immunostaining against
myeloid peroxidase (mpo). This showed that there was an increased presence of neutrophils in the
brain of irf8-/- animals compared to wild types. In uninjured wild type animals, I rarely observed
neutrophils in the brain, whereas I observed an average of 3.3 ± 0.6 neutrophils in uninjured irf8-/-
larvae. Upon injury, the number of neutrophils in the brain significantly increased in irf8-/- larvae
(51 ± 6.5 neutrophils at 6 hpi; 30 ± 1.5 at 24 hpi; **, p ≤ 0.01 compared to sham for both
timepoints in two-way ANOVA with Bonferroni Post-Test), but not in wild type animals (1.3 ± 0.4
at 6 hpi; 0.75 ± 0.25 at 24 hpi; ns compared to sham for both timepoints in Two-Way ANOVA
with Bonferroni Post-test). This showed that in the absence of microglia, neutrophil presence is
increased in the uninjured brain, and is further enhanced upon injuring.
Figure 6.7: Myeloid peroxidase (mpo) immunoreactive cells in are found in the tectum of irf8-/-, but
not wild type animals, and are increased at 6 hours post injury. Scale bar, 50 µm. Quantification of
mpo+ cells at site of injury (brain and skin) before, 6, 24, and 48 hpi. Significance relates to wild type sham
animals. **, p ≤ 0.01 in Two-Way ANOVA with Bonferroni Post-Test. n ≥ 5 animals / timepoint.
As previous research has shown that neutrophils can play a neurotoxic role following TBI in mammals
(Allen et al., 2012), it is possible that the enhanced neutrophil number played a role in exacerbation
of secondary cell death in irf8-/- animals, for example by generation of ROS.
6.4.3 Caveats of using irf8-/- mutants to discern microglia/macrophage
effects on cell death
I attempted to gain an initial insight in the role of microglia in secondary cell death using the
irf8-/- mutant lacking this cell population. A major caveat of this mutant line is that irf8-/- animals
had higher baseline levels of pyknotic nuclei and Caspase-3+ cells than wild type animals even
before injury; this is presumably caused by a failure to clear developmental apoptosis due to the
lack of microglia in these animals (Casano et al., 2016; Xu et al., 2016). However, irf8-/- mutants
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did not exhibit higher number of PI+ cells than wild types prior to injury. As PI can label both
necrotic and late apoptotic cells (both having lost their membrane integrity), this suggested that
although high numbers of apoptotic cells were present in uninjured irf8-/- brains, these were able
to contain their membrane integrity under normal conditions. Timelapse imaging using irf8-/-
larvae revealed that within minutes of the injury, many of these cells lose their membrane integrity
and become PI+ (data not shown). Although developmental apoptosis is a physiological process
that occurs to control for a surplus of generated neurons in the brain (Yamaguchi and Miura,
2015), the loss of membrane integrity of these cells results in the spillage of toxic intracellular
factors and could have a considerable impact on secondary cell death. Mechanical injury may have
caused the large number of already present apoptotic cells in irf8-/- larvae to rapidly experience
energy deficiency, for example via mitochondrial dysfunction which is well-documented following
brain injuries (Hiebert et al., 2015), and lose their membrane integrity to undergo secondary necrosis.
Furthermore, the number of neutrophils in the brain of irf8-/- mutants was significantly increased
compared to wild types in response to injury (Fig. 6.7). Although irf8-/- mutants are known to
have an expanded neutrophil population, there were only approximately 3 neutrophils in the brain
of uninjured mutants. Conversely, in response to injury, there was a substantial recruitment of
neutrophils (Fig. 6.7). Microglia may therefore, as previously suggested, be required to prevent
neutrophil infiltration to the brain in response to an injury (Neumann et al., 2008). Whether this
has any influence on cell death - for example via increased reactive oxygen species production - is
not clear from my experimental data. However, the fact that wild type animals exhibit considerable
amounts of secondary cell death despite the absence of neutrophil infiltration suggests that other
mechanisms, such as excitotoxicity (Fig. 5.3, Fig. 5.10, Fig. 5.11), play a prominent role in
mediating secondary cell death in our model.
For the purpose of investigating the role of microglia on cell death following injury, irf8-/- mutants
exhibited the major caveat of a high baseline number of apoptotic cells as outline above. In combi-
nation with excess neutrophils, this made it difficult to discern whether the increased cell death at 6
hpi was the result of the loss of membrane integrity in apoptotic cells in irf8-/- mutants, the lack of
microglia, or the expanded neutrophil populations (or a combination of all three, or other factors).
I therefore went on to investigate microglial functions in response to injury, such as production of
cytokines or phagocytosis.
6.4.4 Profile of cytokines and neurotrophic factors
To discern the contribution of microglia/macrophages to the inflammatory - or trophic - environment
following injury, I then assessed the profiles of cytokines and neurotrophic factors following brain
injury in wild type and irf8-/- animals. I chose to assess levels of several pro- and anti-inflammatory
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cytokines as well as trophic factors that had previously been studied in CNS trauma and could
potentially modulate secondary cell death and CNS repair (Fan et al., 1995; Kamm et al., 2006;
Kinoshita et al., 2002; Knoblach et al., 1999; Shohami et al., 1994; Tsarouchas et al., 2018).
qRT-PCR from larval heads at distinct points following injury (1, 2, and 6 hpi) revealed that a lack
of microglia/macrophages significantly altered levels of several cytokines. In wild type animals, tnfa,
il1b, il10, bdnf, and ngfb were quickly and significantly upregulated following injury (within 1-2 hpi)
(Fig. 6.8). This failed to happen in irf8-/- mutants, where levels remained unaltered. Conversely,
irf8-/- mutants exhibited increased transcript levels of tgfb1a and il4 (though not significantly for
the latter one).
As I performed qRT-PCR on cDNA extracted from whole heads, I could not determine the cellular
source of transcripts. While many of the studied transcripts are probably of microglial origin following
brain injury, they can also be produced by other cells such as neurons or neutrophils (Ziebell and
Morganti-Kossmann, 2010), and the increase of tgfb1a and il4 in irf8-/- animals indicates that also
in the larval zebrafish, cells other than microglia/macrophages are capable of cytokine upregulation
following brain injury. Therefore, I aimed to investigate the cellular sources of some of the studied
transcripts; this was enabled by transgenic reporter lines for il1b and tnfa. To investigate the
cellular sources of il1b and tnfa, I performed in vivo imaging with the transgenic lines il1b:GFP
and tnfa:eGFP-F. This revealed that il1b and tnfa were present in cells with microglial/macrophage
morphology in the brain or on the skin, respectively (Fig. 6.9), and explained the lack of il1b or tnfa
expression in irf8-/- mutants following injury. Due to a lack of time, I did not cross these lines to the
mpeg1 :mCherry reporter line to confirm this finding, but based on morphology I was confident that
these cells were indeed microglia/macrophages. Ramified cells with microglial morphology appeared
to express high levels of il1b already at baseline, and GFP fluorescence under the il1b promoter
remained high until 6 hpi, although the cellular morphology changed: cells became more amoeboid
or rounded, which has been linked to more activated and phagocytic polarisations (Fig. 6.9 B)
(Loane and Kumar, 2016; Nimmerjahn et al., 2005). For tnfa:eGFP-F, expression was interestingly
detected within the brain at 2 hpi but on the skin at 6 hpi (Fig. 6.9 C, labelled with arrowheads).
Based on my data that microglia and macrophages do not usually cross between brain an skin (Fig.
6.4), this indicates there may be a different temporal regulation of tnfa expression following injury
between microglia and macrophages.
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Figure 6.8: Changes in cytokine and neurotrophic factor transcript levels elicited by injury are altered
in irf8-/- mutants. Relative quantification of mRNA transcript levels via qRT-PCR. Significance was deter-
mined via Two-Way ANOVA and relates to sham values of respective genotype. *, p ≤ 0.05; **, p ≤ 0.01.
Per replicate, the heads of 50 animals were pooled. n ≥ 3 per timepoint.
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Figure 6.9: Cells with microglia and macrophage morphology express il1b and tnfa. (A) Images taken
from il1b:GFP transgenic larvae either in control animals, or 2 or 6 hpi. (B) Close-ups of images in (A);
location in tectum indicated by dashed boxes in (A). Notice the change of morphology of cells expressing
il1b at 6 hpi (C) Representative images acquired using the tnfa:eGFP-F transgenic line.
.
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6.5 Inhibition of pro-inflammatory cytokine Tnfa results in a
reduction of secondary cell death
As I aimed to assess the role of microglia in secondary cell death, I made use of the CRISPR/Cas9
system to target tnfa, which I had shown to be present in cells with microglial morphology two hours
after brain injury (Fig. 6.9 C). Targeting tnfa using a guide previously published by Tsarouchas et al.
(2018), I detected a reduction in secondary cell death following brain injury at 6 hpi in H2A:GFP
larvae (Fig. 6.10). Previous research in rodents had shown an ambiguous role for TNFα following
brain injury - being neurotoxic or -protective depending on receptor subtype distribution (Bruce
et al., 1996; Jara et al., 2007; Longhi et al., 2013; Talley et al., 1995). My data suggested that
Tnfa serves a predominantly neurotoxic role following brain injury in larval zebrafish.
Figure 6.10: tnfa crispants exhibit a reduction in secondary cell death following brain injury. (A)
Representative close-up images of injury site in uninjected or tnfa crispant transgenic H2A:GFP larvae at
6 hpi. Arrowheads point to pyknotic nuclei. Scale bar, 25 µm. (B) Quantification of pyknotic nuclei in
uninjected or tnfa crispant animals either uninjured (sham) or 6 hpi. *, p ≤ 0.05 in Two-Way ANOVA; n ≥
9 per group.
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6.6 Microglia/macrophages increase rate of phagocytosis fol-
lowing injury
In addition to production of cytokines and trophic factors, the ability to phagocytose particles,
including pathogens or cellular debris, is a key function of microglia/macrophages. This is mediated
by recognition of PAMPs and DAMPs. In previous experiments, I had observed phagocytosis of
PI+ debris by mpeg1+ cells following injury (Fig. 6.1). Furthermore, double transgenic animals
labelling microglia/macrophages and neurons (mpeg1 :GFP;NBT :dsRed) revealed the presence of
dead neurons inside mpeg1+ cells following injury (Fig. 6.11). As primary necrotic cell death can
elicit secondary cell death via a variety of molecular mechanisms, for example by spillage of toxic
intracellular factors, I hypothesised that phagocytosis could be beneficial in order to contain noxious
intracellular substances released from necrotic cells. I therefore next aimed to quantify and perturb
phagocytosis in order to draw conclusions on its effect following brain injury.
Figure 6.11: Orthogonal view of neurons (ma-
genta) in mpeg1+ cell (green) at 2 hours post
injury. Scale bar, 10 µm
To investigate whether microglia increased their phagocytic activity following injury, I performed
timelapse imaging for 48 min before an injury, and then for 48 min after injury (starting from 0.5 h
post injury), acquiring a stack of the whole optic tectum every 6 min. I used the mpeg1 :GFP
transgenic line to visualise microglia/macrophages and bath application of PI to stain dead cells,
and performed quantification using the 3D software IMARIS. Quantification of phagocytic events
before and after injury revealed a significant increase of phagocytosis of PI+ cells following injury
from no observed events before to 1.23 ± 0.4 per 48 min after injury (**, p ≤ 0.01 in Mann-Whitney
Test) (Fig. 6.12 A-C). However, due to the lack of PI+ cells in the optic tectum of sham animals
at 4 days post fertilisation, this dataset was only minimally informative. Therefore, I also quantified
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overall phagocytosis. To this end, I quantified engulfments of both PI+ and PI- cells (most likely
early apoptotic cells which are abundantly engulfed by microglia in 3 and 4 dpf zebrafish (Casano
et al., 2016; Mazaheri et al., 2014)), which could occur either by cell rear movement (ball-chain
formation followed by movement of the microglial cell towards the PI+/- cargo with subsequent
engulfment and visualisation of PI+/- cell inside the microglial cell), or phagocytic branch retraction
(formation of ball-chain around PI+/- cell followed by retraction and visualisation of PI+/- cell inside
microglia) as previously described (Mazaheri et al., 2014) (Fig. 6.12 E). This data confirmed that
overall phagocytosis was indeed increased at 0.5 hpi. Before injury, 0.61 ± 0.22 phagocytic events
could be observed on average per mpeg1+ cell in the brain within 48 min. At 0.5 hours post injury,
this was significantly increased to 2.21 ± 0.37 per 48 min (**, p ≤ 0.01, n = 8 animals) (Fig. 6.12
D-F, Movies S6 and S7). Therefore, I demonstrated that in addition to changes in cell migration
and displacement (Fig. 6.2), mpeg1+ cells also changed their phagocytic activity in response to
injury.
Figure 6.12: Phagocytosis is significantly increased upon injury. (A, B) Representative images of time-
lapses of mpeg1 :GFP animals stained with PI either before or 0.5 h after injury. Scale bar, 15 µm. (C)
Quantification of average phagocytic events of PI+ cells per mpeg1+ cell per 48 minutes. **, p ≤ 0.01 in
Mann-Whitney Test. n ≥ 8 animals / group. (D, E) Representative images phagocytosis in mpeg1 :GFP
animals either before (D) or 0.5 h after injury (E). Representative mpeg1 :GFP+ cell in (D) is engulfing PI-
cargo, while mpeg1 :GFP+ cell in (E) has already engulfed PI+ cargo and is currently engulfing PI- cargo.
Scale bar, 15 µm. (F) Quantification of average phagocytic events per mpeg1+ cell per 48 minutes. **, p
≤ 0.01 in Mann-Whitney Test. n = 8 animals / group.
i Figure corresponds to movies S6 (A, before) and S7 (B, 0.5 hpi).
To determine whether radial glia, which reportedly possess phagocytic capacity (Amaya et al., 2015;
Nacher et al., 1999; Springer and Wilson, 1989), participate in phagocytosis following injury, I per-
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formed timelapse imaging of her4.3 :GFP larvae bathed in PI. In contrast to microglia/macrophages,
her4.3+ positive radial glia appeared static following the injury and I did not observe any PI+ cells
within radial glia or radial glia processes both in sham or injured animals. This, in addition to the
fact that peripheral macrophages or neutrophils did not enter the brain following injury, suggested
that microglia are the predominant phagocytes following brain injury in larval zebrafish.
Figure 6.13: No internalised PI+ cells or debris can be seen in her4.3+ radial glia in sham or injured
animals. Scale bar, 25 µm. ns in Mann-Whitney test; n = 6 animals / group
6.7 Inhibition of phagocytosis leads to an increase of sec-
ondary cell death
As I hypothesised that rapid phagocytosis of dead cells in the injured tectum could prevent an
exacerbation of secondary cell death, I expected inhibition of phagocytosis would lead to an ele-
vated number of pyknotic nuclei at 6 hpi. To achieve an inhibition of phagocytosis, I employed
two approaches; both involved interference with the phosphatidyl serine (PS) receptors to prevent
microglial recognition of necrotic and apoptotic cells.
6.7.1 Pharmacological inhibition of phagocytosis via bath application of
L-SOP
For a pharmacological, acute inhibition of phagocytosis, I treated injured and sham larvae with 1 µM
of O-Phospho-L-Serine, further referred to as L-SOP, with a pre-incubation of 1 h prior to injury
to allow for sufficient uptake into the brain. L-SOP mimicks PS, which is a molecule exposed on
necrotic (energy-independent) and apoptotic (energy-dependent) cells and is an important molecule
recognised by microglial and macrophage receptors prior to phagocytosis (Bratton et al., 1997;
Brouckaert et al., 2004; Krysko et al., 2004; Li et al., 2015; Segawa and Nagata, 2015). L-SOP
saturates these receptors, therefore ’blinding’ microglia to apoptotic cells, and has previously been
shown to decrease the phagocytic uptake of apoptotic neurons by microglia in the zebrafish retina
in vivo and rat cell culture in vitro (Bailey et al., 2010; Witting et al., 2000).
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Figure 6.14: Phagocytosis of PI+ cells is significantly decreased after treatment with L-SOP. Repre-
sentative images of timelapses of vehicle- (A) or L-SOP-treated (B) animals following injury. Scale bar,
15 µm. (C) Quantification of average PI+ phagocytic events per mpeg1+ cell per 48 minutes. **, p ≤ 0.01
in Student’s t-Test. n ≥ 6 animals / group.
i Subfigure (B) corresponds to supplementary movie S8.
I treated animals with vehicle or L-SOP and quantified phagocytic events in a given time frame as
previously. L-SOP treatment significantly decreased, but did not completely abolish, phagocytosis
of PI+ cells between 0.5 hpi and 1.15 hpi (Fig. 6.14). Compared to an average of 1.23 ± 0.12
phagocytic events per mpeg1+ cell per 45 minutes in vehicle treated animals, L-SOP treated
animals only displayed 0.35 ± 0.05 (**, p ≤ 0.01 in Student’s t-test)), exhibiting a 72% reduction
of phagocytic events.
To rule out that L-SOP affected microglial reactivity to the injury, I quantified recruitment of
mpeg1+ cells to the lesion site in larvae treated either with vehicle or L-SOP. There was no
significant difference of recruitment of mpeg1 :GFP+ cells between the two groups (Fig. 6.15 A).
Furthermore, as L-SOP has been shown to act as a group III metabotropic glutamate receptor
agonist in vitro (Koulen et al., 1999), I wanted to assess whether L-SOP modified calcium dynamics
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Figure 6.15: Effect of L-SOP treatment on recruitment of mpeg1:GFP+ cells towards the site of brain
injury (A), and effect on calcium transients in uninjured and injured β-actin:GCaMP6f larvae (B).
L-SOP had no significant effect on either of these two parameters. (A) ns for all timepoints in Two-Way
ANOVA. (B) ns in Two-Way ANOVA.
in our model. I therefore quantified calcium transients in β-actin:GCaMP6f larvae treated with
L-SOP or vehicle, which revealed that L-SOP did not significantly alter calcium dynamics in either
sham or injured animals (Fig. 6.15 B).
To assess whether a reduction of phagocytosis affected secondary cell death, I treated H2A:GFP
animals with L-SOP and quantified the number of pyknotic nuclei at 6 hpi. L-SOP treatment
significantly increased the number of pyknotic nuclei at 6 hpi in injured, but not in sham animals
(Fig. 6.16 A, C), which suggested that inhibition of phagocytosis did not result in increased cell
death under baseline conditions. However, while this increase of pyknotic nuclei at 6 hpi was
consistent with an overall neuroprotective effect of microglia, it could also be a direct result of
reduced phagocytic clearance of dead cells resulting in accumulation of pyknotic nuclei over time.
To exclude this possibility, I therefore performed timelapse imaging of H2A:GFP larvae between 4.5
and 5 hpi and quantified the number of newly appearing pyknotic nuclei, which provided me with a
direct measure of the rate of secondary cell death. The number of newly appearing pyknotic nuclei
- and therefore, the rate of secondary cell death -, was significantly increased in larvae treated with
1 µM L-SOP compared to vehicle-treated larvae (Fig. 6.16 B, D), which suggested a neuroprotective
role for phagocytosis following brain injury.
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Figure 6.16: Microglial phagocytosis limits secondary cell death. (A) Representative images of vehicle-
or L-SOP-treated animals at 6 hpi. Scale bar, 25 µm. (B) Representative images of two timepoints of
timelapse of vehicle- or L-SOP-treated animals between 4.5 and 5 hpi. Scale bar, 25 µm. (C) Quantification
of pyknotic nuclei in sham or injured animals treated with vehicle or L-SOP. **, p ≤ 0.01 in Two-Way
ANOVA. n ≥ 6 animals / group. (D) Quantification of newly appearing pyknotic nuclei in sham or injured
animals treated with vehicle or L-SOP. **, p ≤ 0.01 in Two-Way ANOVA. n ≥ 6 animals / group.
119
6.7.2 Genetic manipulation of phagocytosis using CRISPR/Cas9 targeted
mutation of adgrb1a/b
To confirm my findings obtained by pharmacological inhibition of phagocytosis, I employed a second,
genetic approach to disrupt PS recognition. Using CRISPR/Cas9-mediated gene editing, I targeted
PS receptor BAI1 that has previously been shown to mediate engulfment of dead cells both in mam-
mals (Park et al., 2007a) and zebrafish (Mazaheri et al., 2014). Zebrafish possess two paralogues
of BAI1 (Harty et al., 2015), named adgrb1a and adgrb1b. Injection of guide RNAs with the Cas9
enzyme into one cell stage zebrafish embryos has been shown to efficiently generate mutations in
a high number of cells and allows for study of gene function in the F0 generation, which we call
crispants (Jao et al., 2013). To disrupt function of the two zebrafish BAI1 paralogues, I injected
guide RNAs targeting exon 1 of adgrb1a and exon 4 of adgrb1b in one cell embryos, which indeed
resulted in efficient disruption of these two genes as shown by loss of endonuclease restriction sites
(Fig. 6.17 A). Importantly, disruption of these genes also resulted in a transcript level reduction of
more than 50% for both genes (Fig. 6.17 B). Finally, we also confirmed mutation by sequencing of
genomic DNA, which revealed a 54% mutation rate in adgrb1a (Fig. 6.18), and a 93% mutation
rate in adgrb1b (Fig. 6.19).
Figure 6.17: CRISPR-guided mutation of adgrb1a and adgrb1b causes loss of endonuclease restriction
site and reduction of transcript levels. (A) Representative gel image following PCR product digestion
with BslI in uninjected controls and crispants. (B) qRT-PCR analysis of relative expression of adgrb1a and
adgrb1b transcript levels in whole larval bodies at 4 dpf. **, p ≤ 0.01 in One-Way ANOVA compared to
uninjected controls; 10 animals pooled per sample; n = 4.
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Figure 6.18: Mutations in adgrb1a transcripts revealed by sequencing. First line shows wild type se-
quence, with guide RNA target sequence underlined and highlighted protospacer adjacent motive (PAM)
site. Insertions are highlighted with purple, while deletions are represented by -. Total number of inserted
or deleted bases and frequency of each mutation shown next to each sequence.
Figure 6.19: Mutations in adgrb1b transcripts revealed by sequencing. First line shows wild type sequence,
with guide RNA target sequence underlined and highlighted PAM site. Insertions are highlighted, with
purple while deletions are represented by -. Total number of inserted or deleted bases and frequency of each
mutation shown next to each sequence.
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Figure 6.20: Phagocytosis of PI+ cells is significantly decreased after CRISPR/Cas9 targeted mutation
of zebrafish paralogues of PS receptor BAI1. Representative images of timelapses of uninjected (A) or
crispant animals (B) following injury. Scale bar, 15 µm. (C) Quantification of PI+ cells being engulfed per
mpeg1+ cell in 48 minutes. **, p ≤ 0.01 in Two-Way ANOVA. n ≥ 6 animals / group. (D) Quantification
of mpeg1 :GFP+ cells at the site of brain injury before, 0, 1, 2, and 6 hpi. ns for all timepoints in Two-Way
ANOVA. n ≥ 9 animals / group.
i Subfigure (B) corresponds to supplementary movie S8.
Similar to pharmacological manipulation of PS receptors, genetic mutation of adgrb1a and adgrb1b
resulted in a significant decrease of phagocytosis of PI+ cells as observed by timelapse imaging of
mpeg1 :GFP transgenic larvae following injury bathed in PI (as above) (Fig. 6.20), while leaving
microglial recruitment to the injury site intact (Fig. 6.20 D).
Importantly, genetic manipulation of adgrb1a and adgrb1b led to an increased number of pyknotic
nuclei at 6 hpi (Fig. 6.21 A, C), and resulted in an increased rate of secondary cell death between 4.5
and 5 hpi as previously observed with L-SOP (Fig. 6.21 B, D). The fact that both pharmacological
and genetic disruption of PS-mediated phagocytosis yielded similar results in terms of phagocytosis
and cell death confirmed that these methods are useful to disrupt microglial phagocytic behaviour,
and furthermore provided evidence that microglial phagocytosis exerts a net neuroprotective effect.
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Figure 6.21: Inhibition of microglial phagocytosis through genetic manipulation of adgrb1a and adgrb1b
significantly increases number of pyknotic nuclei at 6 hpi, and increases the rate of secondary cell
death. (A) Representative images of uninjected or adgrb1a/b crispant animals at 6 hpi. Scale bar, 25 µm.
(B) Representative images of two timepoints of timelapse of uninjected or adgrb1a/b crispant animals
between 4.5 and 5 hpi. Scale bar, 25 µm. (C) Quantification of pyknotic nuclei in sham or injured uninjected
or crispant animals. **, p ≤ 0.01 in Two-Way ANOVA. n ≥ 6 animals / group. (D) Quantification of
pyknotic nuclei in sham or injured uninjected or crispant animals. **, p ≤ 0.01 in Two-Way ANOVA. n ≥
6 animals / group.
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6.8 Discussion
In this chapter, I presented my work on the role of microglia/macrophages in secondary cell death
following brain injury, with particular focus on phagocytosis. My data shows that microglia react
to the injury rapidly - the first microglia arrive at the site of injury within 5 min, and are the
predominant phagocytic cell at the site of injury (Fig. 6.3). Microglia phagocytose PI+ cells and
cellular debris (Fig. 6.12), and by inhibiting phagocytosis either via L-SOP or genetic mutation of
phagocytosis receptor BAI1, I was able to demonstrate that phagocytosis can limit secondary cell
death (Fig. 6.16, Fig. 6.21).
It was surprising to observe virtually no macrophages or neutrophils entering the brain following
injury in wild type larvae. Recruitment of peripheral immune cells is commonly observed following
mammalian TBI (Carlos et al., 1997; Clark et al., 1994; Foley et al., 2009; Hsieh et al., 2014; Roth
et al., 2014). Even in another larval zebrafish CNS injury assay (spinal cord injury), neutrophils and
macrophages arrive early and abundantly (Tsarouchas et al., 2018), while microglia only arrive at the
site of injury at 24 to 48 hpi, although this is unsurprising as there are no or only very few resident
microglia in the spinal cord in 4 dpf larval zebrafish (Tsarouchas et al., 2018). Using microglia,
macrophage, and neutrophil markers (P2Y12 expression and 4C4 immunoreactivity, mpeg1 :GFP
immune cell tracing, and myeloperoxidase expression, respectively) I detected that neither peripheral
macrophages nor neutrophils were present in the brain following injury (Fig. 6.3, Fig. 6.7, Fig. 6.5).
In irf8-/- mutants, which lack microglia/macrophages and have an expanded neutrophil population,
there is a significant neutrophil response to injury (Fig. 6.7). While both optic tectum and spinal cord
are part of the CNS, a possible explanation for the different composition of immune cells observed
at the injury site by Tsarouchas et al. (2018) and my data is the different (cellular) environment of
the lesion site. Microglia are abundant in the optic tectum at 4 dpf, while they are not in the spinal
cord at 3 dpf (Tsarouchas et al. (2018); Fig. 6.3). Although microglia are able to recruit neutrophils
to sites of brain injury (Carlos et al., 1997), they have also been shown to be capable of reducing
neutrophil infiltration following neuronal injury in mammalian brain slices (Neumann et al., 2008).
Likewise, macrophages residing at the wound have been shown to repel approaching neutrophils
following tail fin injury in zebrafish (Tauzin et al., 2014). Whether microglia participate in repulsion
of peripheral macrophages and neutrophils, or whether there is a lack of chemoattractant factors
for these cells following larval zebrafish brain injury remains to be determined.
6.8.1 Alterations in the whole head transcription levels of cytokines and
trophic factors
Brain injury led to a rapid increase in transcript levels of both pro- and anti-inflammatory cytokines.
As early as 1 h post injury, several cytokines and trophic factors - including tnfa, il10, and bdnf -
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were significantly upregulated in wild type animals. Perhaps unsurprisingly, the lack of microglia
in irf8-/- mutants abolished the injury-induced changes in many cytokines following brain injury
(Fig. 6.8); nonetheless, tgfb1a and il4 were upregulated in irf8-/- mutants, which suggested that
microglia are not the main cellular source of these cytokines in response to injury.
Quantitative reverse-transcription PCR from whole heads revealed that tnfa, a typical pro-
inflammatory cytokine, was rapidly upregulated following injury (Fig. 6.8). Using a transgenic
reporter line revealed that tnfa:eGFP-F+ cells were initially detected in the brain (at 2 hpi); these
cells were likely a subset of microglia (Fig. 6.9). Interestingly, at 6 hpi, mainly cells on the skin
expressed GFP under the tnfa promoter. Based on my previous finding that immune cells do
not commonly trespass following brain injury in larval zebrafish (Fig. 6.4), this suggests that
different populations of microglia/macrophages induce tnfa expression at different time points
following injury. TNFα has been reported to confer both neurotoxicity and neuroprotection in
models of brain injury: deletion of TNFα in mice was shown to significantly improve behavioural
recovery in a rodent model of brain injury (Bermpohl et al., 2007), but genetic deletion of
TNF receptors increased the lesion volume in another study (Bruce et al., 1996); furthermore,
TNFα restricted cell death following oxidative stress elicited by NO (Turrin, 2006). A more
recent study reported that different subtypes of TNF receptors can modulate the effect of TNF:
deletion of the p55 TNF receptor resulted in attentuation of lesion volume and cognitive deficit,
while deletion of p75 TNF receptor significantly worsened neuronal injury and cognitive outcome
following experimental TBI in rodents (Longhi et al., 2013). This suggests that the effect of TNFα
may depend on the temporal and cellular distribution of TNF receptors. Zebrafish possess TNF
receptor homologues which carry out functions similar to mammalian TNF receptors (promote cell
survival or induce apoptosis, amongst other functions) (Espin et al., 2013). In my injury assay,
genetic mutation of tnfa resulted in a 30% reduction of pyknotic nuclei at 6 hpi (Fig. 6.10).
Based on previous in vivo imaging data showing early induction of tnfa in cells with microglial
morphology, this suggested that Tnfa from a microglial source may act neurotoxic although my
manipulation was neither temporally nor spatially restricted, so this needs to be interpreted with
caution. As there is no detailed cellular expression atlas of tnfa and its receptors during zebrafish
development, I cannot speculate on the action of Tnfa on certain cell types. Furthermore, it is
unclear whether Tnfa acts directly on neurons to promote neurotoxicity, or indirectly on microglia
to promote a more neurotoxic or pro-inflammatory polarisation in zebrafish. To summarise,
although my data provide a first overall insight on the role of Tnfa in secondary cell death in
zebrafish, much needs to be done to investigate its specific role and to assess translatability
to mammalian systems. Zebrafish microglia or neurons could react to Tnfa differently than
their mammalian counterparts, for instance by differential receptor expression and downstream
pathways. A more thorough understanding could be achieved by a detailed study of Tnf receptor
expression in zebrafish using double colour in situ hybridisation for Tnf receptors and neuronal or
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microglial markers, or by cell-type specific CRISPR/Cas9 knockout of Tnf or its respective receptors.
il1b is another pro-inflammatory cytokine commonly upregulated following experimental brain
injury (Liu et al., 1993; Lu et al., 2005). Consistent with this, I found significant upregulation
of il1b following injury to the larval zebrafish brain using qRT-PCR (Fig. 6.8), and detected il1b
expression in cells with microglial morphology using the genetic fluorescent reporter line (il1b:GFP).
IL-1β is mainly thought to be released by activated microglia, however, it has previously been
detected in development and may be a glial growth factor (Dziegielewska et al., 2000; Giulian et al.,
1988). In the context of brain injury, il1b has been found to cause neuronal apoptosis (Holmin
and Mathiesen, 2000; Lu et al., 2005). Wong et al. (2018) recently found that deletion of the IL-1
receptor IL-1R1 specifically on neurons or endothelial cells was able to reduce infarct size following
ischaemic insult in mice, while global knockout of IL-1R1 had no effect on the overall infarct size.
This suggested a neuroprotective effect of IL-1 receptor 1 mediated signalling on other cell types,
such as microglia (Wong et al., 2018). The endogenous inhibitor of the IL-1β signalling pathway,
IL-1 receptor antagonist (IL-1ra), has furthermore been found to mitigate the neurotoxic effects
of IL-1β in experimental models of brain injury (Relton and Rothwell, 1992; Sun et al., 2017b;
Toulmond and Rothwell, 1995), and higher serum levels are associated with better patient outcome
(Hutchison et al., 2008). Interestingly, endogenous IL-1ra that could act neuroprotective against
excitotoxic insults in glial-neuronal co-cultures was found to be produced by microglia, but not
other glial cell types in vitro (Pinteaux et al., 2006). A recombinant human IL-1ra has qualified for
safety and bioavailability in a phase II clinical trial for TBI (Helmy et al., 2014), but no phase III
studies have been initiated yet.
Importantly, although wild type animals significantly upregulated several pro-inflammatory cytokines
upon injury, I also detected increased expression of the anti-inflammatory cytokine il10 and the
trophic factors bdnf and ngfb (Fig. 6.8). IL-10 has been shown to confer neuroprotection in a
multitude of CNS injury models: traumatic brain injury (Knoblach and Faden, 1998), spinal cord
injury (Brewer et al., 1999), and focal stroke (Spera et al., 1998). It is predominantly produced by
microglia, and can provide either direct neuroprotection via neuronal IL-10 receptors (Zhou et al.,
2009b,a) or by indirect autocrine actions on microglia such as dampening an excessive inflammatory
response that may exacerbate neuronal death (Cianciulli et al., 2015; Park et al., 2007b). Similarly,
BDNF has been shown to exert neuroprotection (Chen et al., 2007; Wu et al., 2008), potentially
due to enhancing microglial phagocytosis (Jiang et al., 2011), and there is evidence to suggest a
neuroprotective role for NGF (Fantacci et al., 2013; Philips et al., 2001).
Intriguingly, I detected significantly increased expression of the anti-inflammatory factor tgfb1 in
irf8-/- but not wild type animals. While microglia are thought to be the predominant source of
tgfb1a (Lindholm et al., 1992), neurons have also been suggested to produce it in response to
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neuronal injury (Yamashita et al., 1999). Therefore, injured neurons could be the the cellular
source of tgfb1a in irf8-/- mutants. Data on TGF-β, the tgfb1a homologue in rodents and humans,
following brain injury is conflicting - one study found that higher serum TGF-β levels correlated to
a better patient outcome at 90 days following injury, suggesting a neuroprotective effect (Taylor
et al., 2017), while another found antagonism of TGF-β signalling led to decreased apoptosis in a
murine model of brain injury (Patel et al., 2017). The main action of TGF-β following brain injury
is thought to be via microglial modulation (Taylor et al., 2017), but in irf8-/- mutants these cells
are absent. TGF-β is, however, also an effective neutrophil chemoattractant (Brandes et al., 1991;
Fava et al., 1991; Reibman et al., 1991), which may explain the high numbers of neutrophils at the
injury site in irf8-/- mutants; microglia may therefore prevent neutrophil infiltration by suppression
of tgfb1a expression. However, it is likely that several other factors may contributed to neutrophil
recruitment, such as reactive oxygen species (Niethammer et al., 2009).
This expression dataset - demonstrating increases in both pro- and anti-inflammatory cytokines as
well as trophic factors - highlighted once more the complexity of molecular processes occurring
following brain injury. However, I used whole head cDNA and so far only study candidate gene
expression, which did not allow for discovery of novel, previously unknown genes involved in microglial
function in response to injury. To investigate injury-induced changes in microglia in more detail, I
therefore employed an RNA-sequencing approach from sorted mpeg1 :GFP+ cells (see Chapter 7).
6.8.2 Microglial phagocytosis mediates neuroprotection
Microglia increased their phagocytic activity rapidly following injury, as observed by engulfment of
PI+ or PI- cells via cell rear movement or phagocytic branch retraction (Fig. 6.12). Coupling of
microglial phagocytosis to cellular apoptosis has been quantified in other types of noxious brain
injury, such as excitotoxicity in hippocampal slice cultures and LPS injection in the hippocampus
(Abiega et al., 2016), but dynamic in vivo observations involving timelapse movies following injury
and quantification of phagocytic are so far sparse (Morsch et al., 2015).
Which factors may regulate microglial attraction and phagocytosis? As previously observed (Fig.
5.5, Sieger et al. (2012)), ATP is an important chemoattractant for microglia in zebrafish in vivo,
which is in line with several other in vitro and in vivo studies in rodents (Abiega et al., 2016;
Davalos et al., 2005; Nimmerjahn et al., 2005; Ohsawa et al., 2007). Microglia can furthermore
be activated via ATP stimulation, with one example being TNFα expression two to three hours
after exposure to high levels of ATP (Inoue et al., 1998); this was similar to what I observed in
vivo (Fig. 6.9). However, exposure to high levels of ATP for extended periods of time (longer than
30 minutes), or neuronal hyperactivity as experienced during seizures, have been shown to impair
microglial phagocytosis (Abiega et al., 2016; Fang et al., 2009). This is mediated, in part, by an
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impairment to sense microgradients in ATP (Abiega et al., 2016). However, in my model I found
that microglia were able to rapidly detect the injury site and increase their phagocytic capacity in
response to the presence of PI+ cells (Fig. 6.1, Fig. 6.12). This suggested that zebrafish microglial
phagocytosis may be resilient to harmful stimuli, and investigation of these cells could reveal novel
strategies to enhance phagocytosis - and thereby neuroprotection - following TBI.
By employing a pharmacological inhibitor of phagocytosis and genetic manipulation of the PS
receptor BAI1 (adgrb1a/adgrb1b), I discovered that phagocytosis of debris by microglia had
a neuroprotective effect: the number of pyknotic nuclei was significantly increased with both
treatments at 6 hpi (Fig. 6.16 A, C; Fig. 6.21 A, C). This effect extended beyond collection of
apoptotic cells to decrease the number of apoptotic cells present at 6 hpi: when phagocytosis was
inhibited, the rate at which new pyknotic cells appeared (i.e., secondary cell death occurred), was
increased (Fig. 6.16 B, D; Fig. 6.21 B, D).
Neuroprotection via phagocytosis could occur through several mechanisms. It could be mediated via
a direct effect of phagocytosis, such as containing toxic intracellular substances (Green et al., 2016;
Wolf et al., 2017). One example of phagocytosis limiting secondary cell death is the Royal College
of Surgeons (RCS) rat model of inherited retinal dystrophy (D’Cruz, 2000). Retinal degeneration
was found to be caused by loss of MerTK, a phagocytosis receptor, on retinal pigment epithelium
cells, whereby accumulation of primary cellular debris and spillage of intracellular factors lead to
secondary retinal cell death. Cuenca et al. (2013) showed that neuronal cell loss in this model could
be rescued via boosting phagocytosis. Microglia-mediated neuroprotection could also be caused by
indirect effect, such as upregulation of anti-inflammatory or neuroprotective microglial transcripts
following phagocytosis (Fadok et al., 1998; Wolf et al., 2017). Phagocytosis via PS recognition
(as inhibited by both L-SOP and BAI1 receptor mutation) has been shown to cause a general
anti-inflammatory profile and dampen inflammation, which is a mechanism often hijacked by cancer
cells to decrease macrophage-mediated cell death, but also generally observed during efferocytosis,
the removal of apoptotic cells (Birge et al., 2016; Fadok et al., 1998; Kim et al., 2004a). Similarly,
phagocytosis of myelin has been shown to cause an anti-inflammatory microglial phenotype (Liu
et al., 2006); TNFα, a pro-inflammatory cytokine, can increase phagocytosis of myelin, but inhibits
this conversion to a protective phenotype (Kroner et al., 2014), adding further complexity to the
interplay of cytokines and phagocytosis following injury.
Zebrafish microglia appear to be efficient phagocytes that can correctly target dying cells (Fig.
6.12). Here, my data show that rapid phagocytosis of cellular debris via a PS receptor-mediated
mechanism is essential to prevent the exacerbation of secondary cell death following brain injury
in larval zebrafish. Genes and pathways that render microglia in the zebrafish effective phagocytes
in response to an injury, and thereby limit the occurrence of secondary cell death, could represent
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attractive therapeutic targets for human TBI to improve the outcome of brain injuries and limit
secondary cell death. These genes or pathways should ideally be specific to microglia and be
targetable using small molecules that can easily penetrate the BBB for maximum therapeutic effect.
However, more research will need to be carried out in order to identify such potential therapeutic









In vivo timelapse imaging had provided me with an insight into dynamic changes in microglial
behaviour following injury, in particular migration and phagocytosis (Fig. 6.2, Fig. 6.12), and
revealed a neuroprotective role for microglia via rapid phagocytosis of cellular debris (Fig. 6.16,
Fig. 6.21). Candidate-driven analysis had revealed the upregulation of transcripts which had
previously been shown to have pro- or anti-inflammatory or neurotrophic functions in response
to injury (Fig. 6.8) (Basu et al., 2002; Chen et al., 2007; Cianciulli et al., 2015; Fantacci et al.,
2013; Ferreira et al., 2014; Holmin and Mathiesen, 2000; Knoblach and Faden, 1998; Philips et al.,
2001; Wu et al., 2008). However, I obtained this expression data from RNA extracted from whole
larval heads following injury and it provided no information on the cellular source of transcripts.
Furthermore, while there were some transgenic reporter lines to study the cellular sources of
cytokines (tnfa:eGFP-F and il-1β:GFP), this was not the case for all genes of interest. Finally,
a candidate-driven approach did not allow for the unbiased identification of novel injury-induced
transcripts that could potentially confer a neuroprotective function. Therefore, I aimed to assess
transcriptomic alterations in microglia by performing RNA sequencing. With this dataset, I hoped
to elucidate genes modulating microglial polarisation and behaviour (e.g., phagocytosis), as well as
secreted factors with the potential to directly influence neuronal survival.
The work in this chapter was carried out in collaboration with the Queen’s Medical Research Insti-
tute Flow Cytometry Facility and Edinburgh Genomics to perform fluorescence-activated cell sorting
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(FACS), and bulk RNA sequencing, respectively. My qRT-PCR results from whole heads revealed
that transcript levels change rapidly in response to injury, with changes in some transcript levels be-
ing detected as early as one to two hours post injury (Fig. 6.8). Furthermore, as an early microglial
phagocytic response was crucial for conferring neuroprotection and limiting secondary cell death
(Fig. 6.16, Fig. 6.21), I chose to extract RNA from sorted microglia at two hours post injury, al-
lowing me to study early injury-induced changes in these cells that may confer later neuroprotection.
With the work in this chapter, I aimed to characterise injury-induced transcriptomic changes in
microglia/macrophages by bulk RNA sequencing from sorted cells. I had so far shown a neuro-
protective role for microglial phagocytosis; this could potentially be enhanced by understanding
the pathways that elicit such a phagocytic and neuroprotective phenotype. Furthermore, RNA
sequencing could identify whether microglia/macrophages produce any secreted molecules that
might directly influence neuronal survival in response to injury. Therefore, RNA sequencing could
elucidate transcripts that are directly or indirectly neuroprotective.
7.2 Sample preparation: cell yield, RNA quantity/quality and
cDNA amplification results
To collect the microglial population of interest, I initially aimed to extract 4C4+ cells from larval
heads as previously achieved by Mazzolini et al. (2018). Larvae were mounted, injured, released,
and allowed to recover for 2 h. Following this, I decapitated larvae and subsequently followed the
fluorescence-activated cell sorting (FACS) protocol published by Mazzolini et al. (2018). Briefly, the
protocol entailed the generation of a single-cell suspension by mechanical homogenisation, removal
of myelin using a 22% Percoll gradient, Fc block to prevent unspecific binding of antibodies to the
Fc receptor, antibody staining, and resuspension of cells in a glucose-rich medium containing 2%
normal goat serum to prevent formation of cell clusters (Mazzolini et al., 2018). All steps were
carried out at 4 ◦C on ice to prevent (or minimise) changes in transcript levels during processing.
Due to time constraints - the mounting, injuring, and releasing of larvae took roughly one hour per
100 animals -, I was only able to process a maximum of 400 larvae per day (a maximum of 200
larvae per group (sham or injury)). Conversely, Mazzolini et al. (2018) used a minimum of 600
larval heads per group. The percentage of retrieved 4C4+ cells was low (approximately 0.9% of live
cells, Fig. 7.1). As a comparison, I repeated this experiment in mpeg1:GFP larvae, removing the
steps of Fc blocking and antibody staining and instead sorting for the transgenically expressed GFP,
which retrieved 2% of live cells from heads (Fig. 7.1 A). The low number of recovered 4C4+ cells
resulted in a very low RNA yield compared to mpeg1 :GFP+ cells (Table 7.1 B). Interestingly, the
RNA yield for the two groups was not proportionate to cell yield. This could have been a result of
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fluctuations in the presence of ambient RNAses during RNA extraction, or due to an increased loss
of cells in the 4C4 group following pelleting after FACS (after which cell number is not assessed
anymore) compared to the mpeg1 :GFP group.
For bulk RNA sequencing, Edinburgh Genomics required a minimum input of 1.1 µg RNA. Even
with the slightly higher cell and RNA yield following mpeg1 :GFP+ sorting (Table 7.1), this was
still two to three orders of magnitude larger than what I received following FACS-RNA extraction.
Therefore, I was required to use a commercial kit for reverse transcription of the RNA and
subsequent isothermal amplification of the cDNA. Based on the recommendation of Edinburgh
Genomics, we purchased the NuGEN Ovation R© RNA-Seq System V2. The minimum input for this
system was 500 pg in 5 µL, equivalent to an RNA concentration of 100 pg/µL. My injury assay
was not scaleable and I could not pool more than 200 heads per treatment per experimental day;
as the values for 4C4+ cells and subsequent RNA were below the minimum requirements even for
the amplification kit, this approach was therefore not feasible for generating sufficient amounts of
RNA/cDNA for bulk RNA sequencing. Therefore, I decided to proceed using the transgenic line
mpeg1 :GFP, which provided me with higher cell and RNA yields, but had the significant limitation
that it was not specific to microglia and extracted both microglia and macrophages in the head
region and would therefore make the biological validation following sequencing more complex.
Furthermore, whole head imaging - including the ventral side - revealed that mpeg1 :GFP transgenic
larvae had about 150 mpeg1+ cells in the cardiac region, which were not present in 4C4 cells (Fig.
7.2). Based on this data, I carefully excluded the cardiac region during decapitation of larvae for
future steps.
mpeg1 :GFP+ cells were sorted directly into QIAGEN R© RNAProtect Cell Reagent to prevent changes
to the transcriptome following FACS, and were stored at 4 ◦C for a maximum of four days until RNA
extraction using the QIAGEN R© RNEasy Micro Kit. Samples were eluted in 14 µL of nuclease-
free water, and RNA quantity and quality was analysed using the LabChip GX24 by Dr. Pamela
Brown. Following RNA quantity and quality analysis, RNA was reverse transcribed and amplified
for RNA sequencing using the NuGEN Ovation R© RNA-Seq System V2. The minimum input for this
amplification reaction were 500 pg (in 5 µL), which I exceeded (Table. 7.2). Quality and quantity of
cDNA was then assessed by Edinburgh Genomics prior to library preparation. Gel bands of cDNA
supplied to Edinburgh Genomics are shown in Fig. 7.3. A summary of all results prior to RNA
sequencing is shown in Table 7.2.
133
Figure 7.1: Representative plots of side scatter (SSC) to GFP intensity from FACS reports sorting
for 4C4 or mpeg1:GFP. (A) SSC against GFP intensity for 4C4+ cell sorting. White asterisk indicates
population of cells unspecifically stained by the secondary antibody (as determined by no secondary control).
(B) Population report. Only 0.9% of live cells are GFP+. (C) SSC against GFP intensity for mpeg1 :GFP
sorting. (D) Population report. 2.1% of live cells are GFP+.
Table 7.1: Cell and RNA yields using different markers for fluorescence activated cell sorting. Values
for antibody-dependent sorting of 4C4+ microglial cells, or sorting using the mpeg1 :GFP) transgenic line.
RNA amounts were determined on the the LabChip GX24.
Cell type Cell yield RNA concentration Total RNA extracted (14 µL)
Microglia (4C4+) 3 919 24 pg/µL 336 pg
Microglia/macrophages
(mpeg1 :GFP+)
22 000 500 pg/µL 7 ng
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Figure 7.2: Quantification of mpeg1+ and 4C4+ cells in the whole larval head. Acquired from dorsal or
ventral imaging of the whole head in mpeg1 :GFP transgenic larvae and anti-4C4 immunostained larvae.
Figure 7.3: Quality control gel of cDNA following Amplification using NuGEN R© Ovation RNA-Seq
System V2. A1, Ladder. B1, Sham 1. C1, Sham 2. D1, Sham 3. E1, Sham 4. F1, Sham 5. G1, Sham 6.
H1, 2 hpi 1. A2, 2 hpi 2. B2, 2 hpi 3. C2, 2 hpi 4. D2, 2 hpi 5. E2, 2 hpi 6. F2, Empty lane.
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Table 7.2: Cell yields, RNA quantity/quality and cDNA quantity. Cell number obtained following FACS of mpeg1 :GFP+ cells. RNA quantity and quality obtained following RNA extraction by analysis
on the LabChip GX24. cDNA quantity obtained by analysis on the NanoDrop One following amplification reaction.
Sample Heads Cells Cells/head RNA quantity (ng/µL) Total RNA extracted (ng) RNA in amplification
reaction (ng)
RIN RNA/cell (pg) cDNA output (ng/µL)
Sham 1 198 35,484 179 1.21 16.94 6.05 10 0.48 26.60
Sham 2 198 29,945 151 0.77 10.84 3.87 10 0.36 20.60
Sham 3 170 24,781 146 0.76 10.57 3.78 10 0.43 16.50
Sham 4 180 26,574 148 0.81 11.35 4,06 10 0.43 26.90
Sham 5 180 28,829 160 1.03 14.39 5.14 10 0.50 26.70
Sham 6 200 28,368 141 0.82 11.49 4.11 10 0.41 26.10
2 hpi 1 198 27,766 140 0.58 8.09 2.89 10 0.29 15.80
2 hpi 2 198 29,796 150 0.54 7.57 2.71 10 0.25 22.00
2 hpi 3 160 25,685 161 0.73 10.23 3.66 10 0.40 15.50
2 hpi 4 150 22,224 148 0.60 8.37 2,99 10 0.38 22.50
2 hpi 5 180 23,885 132 0.58 8.11 2.90 10 0.34 15.30
2 hpi 6 180 20,003 111 0.68 9.49 3.39 10 0.47 12.80
Average 183 26,945 147 0.76 10.62 3.79 10 0.34 20.60
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7.3 RNA sequencing results and exploratory analysis
Illumina Sequencing Library was prepared by Edinburgh Genomics, and sequencing was performed
using the Illumina NovaSeq System. Bioinformatics Analysis was carried out by Dr. Katie
Emelianova at Edinburgh Genomics.
Following PCA analyses, three samples from 2 hpi sorted macrophages were excluded from further
analysis due to high duplicate and low mapping rate, and low clustering with other samples from
their group: 2 hpi 3, 5, and 6. Interestingly, these three samples also had different size distribution
compared to the other samples on the quality control gel following cDNA amplification (Fig. 7.3;
lanes B2, D2, and E2), but were not conspicuous in terms of RNA quality or quantity (Table 7.2).
It is possible that mistakes were made during the amplification reaction, resulting in abnormal size
distribution or a failure of representative cDNA amplification. The NuGEN Ovation R© RNA-Seq V2
System is a highly sensitive amplification kit, and therefore even minor mistakes when carrying out
the protocol could result in considerable changes of the outcome. For clarity of further analysis,
sample 2 hpi 4 was from now on called 2 hpi 3.
For filtering the list differentially expressed genes received from Edinburgh Genomics, I employed
the False Discovery Rate (FDR) rather that p values, as the unadjusted p value would yield a
high number of false positives in my dataset of 32 000 detected genes. By empirical choice, I
set the FDR to ≤ 0.05, accepting a false discovery rate of 5%. With this approach, I obtained
225 significantly downregulated and 567 upregulated genes, which showed that injury elicited a
transcriptional response in microglia/macrophages as early as 2 hpi.
To make sense of this gene list, and focus on the genes with the largest fold change, I further
analysed genes with a logarithmic fold change of at least 1.2 (either up or down); this cut-off was
chosen empirically and only included genes that more than duplicated or halved their expression
in response to injury, although much smaller changes may still carry biological significance. After
applying the fold change cut-off, the list contained 193 upregulated and 65 downregulated genes.
Next, I created heatmaps for a visual representation of changes in transcripts (excerpts of these
Figures shown in Fig. 7.4, Fig. 7.5).
As this list was still difficult to draw conclusions of, and to gain an insight into overall transcriptomic
trends occurring in microglia/macrophages following injury, I decided to perform gene ontology (GO)
enrichment analysis. This could potentially enable me to understand pathways that are enriched in
response to injury. I used an online tool based on the PANTHER Classification system (Mi et al.,
2013) to perform GO enrichment analysis (https://www.panther.db). For this preliminary analysis,
I aimed to go ahead using only upregulated genes. To do so, I uploaded my list of upregulated
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Figure 7.4: Excerpt of significantly upregulated genes and their respective expression in individual
samples. FDR ≤ 0.05, fold change ≥ 1.2.
Figure 7.5: Excerpt of significantly downregulated genes and their respective expression in individual
samples. FDR ≤ 0.05, fold change ≤ 1.2.
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genes (Fold change ≥ 1.2, FDR < 0.05, as previously described), and compared it to a background
gene list of all detected genes in the sequencing. Gene ontology enrichment revealed enrichment
of several GO terms, some of the which were to be expected - such as cell migration and immune
response -, but also some unexpected terms (Fig. 7.6, Table 7.3).
Figure 7.6: Visual representation of enriched GO terms in list of upregulated genes from RNA se-
quencing dataset. Genes were filtered by an FDR ≤ 0.05, and a fold change of ≥ 1.2
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Table 7.3: Gene ontology analysis of upregulated genes in RNA sequencing dataset. Analysis shows
mapped genes in background, and how many of these are represented in the upregulated list. Fold enrichment
is then performed based on expected values in a random dataset.
GO biological process Background Upregulated Expected Fold enrichment FDR
inactivation of MAPK
activity (GO:0000188)




38 5 0.28 17.97 4.16E-02
leukocyte chemotaxis
(GO:0030595)
76 7 0.56 12.58 4.20E-03
response to lipopolysac-
charide (GO:0032496)
58 5 0.42 11.78 3.26E-03
cell chemotaxis
(GO:0060326)








115 7 0.84 8.31 1.48E-02
response to cytokine
(GO:0034097)
141 8 1.03 7.75 1.06E-02
response to lipid
(GO:0033993)




252 9 1.84 4.88 3.54E-02
immune response
(GO:0006955)




654 18 4.97 3.76 6.95E-03
cell migration
(GO:0048870)
468 13 3.43 3.79 2.04E-02
cell motility
(GO:0048870)
490 13 3.59 3.62 2.94E-02
localisation of cell
(GO:0051674)
490 13 3.59 3.62 3.07E-02
immune system process
(GO:0002376)
845 22 6.19 3.56 2.95E-03
response to external
stimulus (GO:0009605)
731 16 5.35 2.99 3.50E-02
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7.4 Comparison of RNA sequencing results to qRT-PCR re-
sults from whole heads
I then assessed whether qRT-PCR results presented in Fig. 6.8 were compabtible with the RNA
sequencing results. Although these samples were obtained from whole heads rather than sorted
cells, the comparison of wild type animals and irf8-/- mutants lacking microglia/macrophages
allowed for preliminary estimation of microglia/macrophage expression changes following injury.
I queried expression of il1b, tnfa, tnfb, il4, il10, tgfb1a, ngfb, and bdnf in my RNA sequencing
dataset. The results are presented in Fig. 7.7 and Table 7.4. il1b, tnfb, and il10 were significantly
upregulated in response to injury (although il10 had a slightly higher FDR than 0.05) (Fig. 7.7,
Table 7.4). This was in line with previous whole head qRT-PCR at 2 hpi, although tnfb upregulation
was not significant at this point in whole heads (Fig. 6.8). il4, tgfb1a, tnfa, ngfb (Table 7.4), and
bdnf expression were not significantly altered 2 hpi, and bdnf transcripts were only detected in a
single sham sample (Fig. 7.7). For tnfa, ngfb, and bdnf, the RNA sequencing results from sorted
microglia/macrophages were therefore different than previous qRT-PCR results from whole heads,
which had revealed a significant upregulation of these genes at 2 hpi (Fig. 6.8).
Table 7.4: Counts per million (CPM) values for genes previously analysed using qRT-PCR from whole
heads in wild type and irf8-/- mutant animals. n.d. = not detected; n.a. = not applicable.
Gene name Mean CPM sham Mean CPM 2 hpi Fold change (linear) FDR
il1b 84.04 360.23 4.29 5.57E-10
tnfb 48.38 72.16 1.49 0.048
il4 5.30 5.64 1.06 0.966
il10 3.93 9.59 2.43 0.088
tgfb1a 13.75 12.89 0.94 0.942
tnfa 1.62 4.83 2.97 0.361
ngfb 0.29 0.05 0.22 0.618
bdnf 0.01 n.d. n.a. n.a.
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Figure 7.7: Expression of genes previously analysed in whole head qRT-PCR in RNA sequencing from
sorted microglia/macrophages.
7.5 Selected findings of interest from RNA sequencing
In this section, I am presenting three groups of genes I found potentially interesting for con-
ferring microglia(/macrophage)-mediated neuroprotection; either indirect, by regulation of mi-
croglia/macrophage polarisation (Chapter 7.5.1, Chapter 7.5.2), or direct, by action on neuronal
survival (Chapter 7.5.2, Chapter 7.5.3). The results in this section were obtained shortly before
compilation of this thesis, therefore any analysis is very preliminary and warrants further validation.
7.5.1 MAP kinase pathway inactivation (dusp gene upregulation)
Inactivation of MAP kinase was the most enriched GO term of significanty upregulated genes with
a more than hundredfold enrichment (Fig. 7.6, Table 7.3), and I decided to analyse this pathway
in more detail. I downloaded the gene list associated with this GO term using the online database
AmiGO (Carbon et al. (2009); http://amigo.geneontology.org/amigo) and created heatmaps vi-
sualising the transcript levels of corresponding genes in my RNA sequencing dataset. Many of
these genes (although not all more than by a fold change of 1.2; Fig. 7.8 A and Table 7.5), were
upregulated in response to injury.
7.5.2 Cytokines and cytokine receptors
I also detected significant increases in the transcript levels of certain cytokines and cytokine receptors
in microglia/macrophages (see Fig. 7.8 C and Table 7.6)
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Table 7.5: Counts per million (CPM) values for dusp genes. Notice the FDR for dusp6 and dusp1 is >
0.05.
Gene name Mean CPM sham Mean CPM 2 hpi Fold change FDR
dusp6 241.91 310.67 1.28 0.090
dusp1 173.32 206.93 1.20 0.350
dusp2 54.90 155.22 2.83 6.39E-07
dusp5 31.08 79.88 2.57 4.21E-05
dusp8a 10.97 28.95 2.64 0.0130
dusp4 3.86 17.60 4.56 0.002
Table 7.6: Counts per million (CPM) values for cytokine and cytokine receptor genes.
Gene name Mean CPM sham Mean CPM 2 hpi Fold change FDR
tnfrsf11a 126.88 190.43 1.51 0.009
il34 64.62 98.03 1.52 0.033
il6st (gp130) 71.84 123.73 1.62 2.51E-05
il1r2 291.97 535.71 1.84 1.75E-05
il13ra1 13.48 25.37 1.88 0.040
il4r.1 43.54 84.00 1.97 0.001
il10 3.93 9.59 2.43 0.088
il1b 84.04 360.23 4.29 5.57E-10
m17 8.12 40.40 4.96 6.63E-06
il6 1.68 9.40 5.58 0.005
il15l 0.40 3.17 7.84 0.133
tnfrsf9b 6.13 51.42 8.40 1.13E-05
tnfrsf18 2.31 23.33 9.99 5.72E-05
lta (tnfb) 0.02 0.90 23.92 0.072
Table 7.7: Counts per million (CPM) values for genes encoding neurotrophic factors.
Gene name Mean CPM sham Mean CPM 2 hpi Fold change FDR
hbegfb 7.89 22.48 2.97 0.003
manf 39.85 66.02 1.66 0.046
inhbaa 20.79 42.29 2.03 0.009
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Figure 7.8: Heatmaps of relative transcript levels of selected genes in RNA sequencing dataset,
normalised per row (assigned z-Score). (A) Relative transcript levels for genes in the GO term MAP
kinase inactivation. (B) Relative transcript levels for cytokine and cytokine receptors that were upregulated
in RNA sequencing dataset. (C) Relative transcript levels for genes implicated in neurotrophic functions.
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7.5.3 Neurotrophic factors
I furthermore found three factors that may have neuroprotective functions upregulated in my RNA
sequencing dataset of microglia/macrophages following injury (Fig. 7.8, Table 7.7), suggesting
that microglia/macrophages are potentially directly conveying neuronal survival via release of these
molecules following brain injury in larval zebrafish.
7.6 Discussion
In this chapter, I have described my most recent results obtained from bulk RNA sequencing of sorted
mpeg1 :GFP+ cells at 2 hour post injury. RNA sequencing confirmed previous results obtained
from whole head qRT-PCR (Fig. 6.8, Fig. 7.7), while offering new insights and a large list of
potentially interesting genes that could modulate neuronal survival directly or indirectly. Although
I have focussed my current preliminary analysis on genes that have previously been implied in
neuroprotection, further experimental studies will potentially allow for discovery of novel injury-
induced genes conferring neuroprotection (see Chapter 7.6.6).
7.6.1 Comparison to whole head qRT-PCR
In my RNA sequencing results, I found il1b upregulation in response to injury, consistent with
previous data comparing whole head RNA in wild type animals and irf8-/- mutants (Fig. 6.8) and
in vivo imaging (Fig. 6.9). Similarly, il10 was upregulated in both experiments (Fig. 6.8, Fig.
7.7). Interestingly, tnfa showed a more heterogeneous picture and was only increased in two out of
three injury samples (Fig. 7.7); this could be explained by the fact that in vivo imaging revealed
only few cells - potentially microglia in the brain, but this has not been confirmed - express tnfa
at 2 hpi (Fig. 6.9), and bulk RNA sequencing may have diluted out the effect, or did not include
said population of tnfa-expressing cells. tnfb was significantly upregulated in the RNA sequencing
dataset but not qRT-PCRs at 2 hpi, suggesting that expression is higher in microglia/macrophages
than in other cells at this time.
Contrary to prior qRT-PCR results comparing wild types and microglia/macrophage-less irf8-/-
mutants (Fig. 6.8), neither ngfb nor bdnf were upregulated in the RNA sequencing dataset
from mpeg1+ cells in response to injury (Fig. 7.7). This suggested that larval zebrafish mi-
croglia/macrophages induce the expression of these two genes in other cells, for example in radial
glia or neurons which have previously been shown to be able to express these factors (Biane et al.,
2014; Fulmer et al., 2014; Cacialli et al., 2018). Neuronal bdnf expression has previously been
demonstrated in the injured adult zebrafish telencephalon, and has been linked to the regenerative
success of the zebrafish brain (Cacialli et al., 2018); microglia could therefore indirectly promote
neuronal survival following injury by enhancing expression of bdnf in these cells (Fig. 6.8). Indeed,
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microglia have recently been shown to have a profound impact on the neuronal transcriptome under
inflammatory conditions (Qiu et al., 2018), rendering this a plausible explanation.
As expected, il4, and tgfb1a were not significantly altered after 2 hpi (Fig. 6.8, Fig. 7.7). This
result confirmed that these genes are not of microglia/macrophage origin following brain injury in
larval zebrafish.
7.6.2 MAP kinase inactivation
I observed a significant enrichment in the upregulation of genes involved in the inactivation of MAP
kinase (Fig. 7.8), in particular dual-specificity phosphatases (DUSPs). DUSPs dephosphorylate,
and thereby inactivate, the p38 MAP kinase. This is of relevance to microglia/macrophage
activation, as p38 MAP kinase is required for the production of several pro-inflammatory cytokines
including TNFα, which has been shown to mediate secondary cell death by several groups, including
my own data (Fig. 6.10; Bachstetter et al. (2011); Bianchi et al. (1996); Cohen et al. (1996);
Kim et al. (2004b)), and is a mediator of microglial inflammation (He et al., 2018). In rodent
experimental models of brain injury, rapid and significant upregulation of p38 MAP kinase pathway
is observed, and is linked to a pro-inflammatory immune response (Bachstetter et al., 2013).
Although I found upregulation of a single MAP kinase in my RNA sequencing data set (mapk6, 1.95
linear fold change, FDR = 3.01E-05), I also detected increased expression of dusp1, dusp2, dusp4,
dusp5, dusp6, and dusp8a. Many of these DUSPs are known to be upregulated upon stimulation
with the anti-inflammatory IL-10 in vitro (Hammer et al., 2005), suggesting their participation in
anti-inflammatory functions.
DUSPs are therefore thought of as proteins capable of putting a brake on excessive inflammation
(Lang et al., 2006), and (alongside pharmacological approaches to inhibition of MAP kinase inac-
tivation) have been implicated in neuroprotection (although not all studies investigated microglial
involvement in this process). For example, the induction of dusp1 or the mammalian protein product
MAP kinase phosphatase 1 (MKP-1) have been shown to mediate the neuroprotective effects of
endocannabinoid anandamide following excitotoxicity in vivo (Eljaschewitsch et al., 2006). Pharma-
cological inhibition of DUSP1 significantly increased the lesion size, and enhanced the inflammatory
and apoptotic response in an experimental stroke model (Liu et al., 2014). Other DUSPs have
also been shown to confer neuroprotection: induction of DUSP2 protected neurons from genotoxic
stress (Morente et al., 2014); DUSP6 prevented glutamate excitotoxicity-induced cell death in hip-
pocampal neurons in vitro (Huang et al., 2017); and DUSP8 mediated the neuroprotective effects
of rosiglitazone following ischaemia in mice (Okami et al., 2013). Although the latter studies look at
neurons directly rather than microglia-mediated neuroprotection, there appears to be a strong role
for inhibition of MAP kinase for neuroprotection following brain injury in several cell types, however
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this does not usually appear to occur at significant levels in rodent models unless modulated by
pharmacological intervention (Bachstetter et al., 2013; Okami et al., 2013).
7.6.3 Cytokine & cytokine receptors
Based on a multitude of prior studies (reviewed by Ziebell and Morganti-Kossmann (2010)),
and prior cytokine level studies in whole heads of larval zebrafish during the course of my own
research (Fig. 6.8, Fig. 7.7, Chapter 7.6.1), it was unsurprising to observe an upregulation of
several cytokines and cytokine receptors in my microglia/macrophage RNA sequencing dataset.
Amongst these were tnfrsf11a (homologue of RANK; 1.51 fold increase), il34 (1.52 fold increase),
il6st (il6 signal transducer, or gp130; 1.62 fold increase), il1r2 (decoy il1 receptor; 1.84 fold
increase), il13ra1 (1.88 fold upregulation), il4r.1 (1.97 fold increase), il1b (4.29 fold increase),
m17 (LIF; 4.96 fold increase), il6 (5.58 fold increase), tnfrsf9b (8.40 fold increase), tnfrsf18
(9.99 fold increase). Also il10, il15l, and lta were significantly upregulated (2.43, 7.84, and
23.92 fold, respectively), although with an FDR > 0.05 (0.088 for il10, 0.133 for il15l, and 0.072
for lta). Increases of tnfa transcript levels were also detected (2.97 fold), although at a FDR of 0.36.
Traumatic brain injury in rodents is predominantly associated with the upregulation of pro-
inflammatory cytokines in microglia/macrophages, which can result in a neuro-inflammatory or
even neurotoxic role of these innate immune cells. However, there is increasing evidence that
there are endogenous neuroprotective pathways activated by cytokines following injury (Morganti-
Kossmann et al., 2018). In line with other transcripts mentioned so far which are thought to
confer neuroprotection, many of the cytokine and cytokine receptor transcripts increased following
zebrafish TBI are thought to be beneficial for neuronal survival.
One of the most prominent anti-inflammatory cytokines is IL-10, and I detected significant
upregulation of il10 transcript levels in response to injury, although the FDR was slightly above 0.05
(0.088). IL-10 has long been known to show pro-recovery properties in response to brain injuries.
As early as 1998, it was discovered that intravenous treatment with IL-10 was able to significantly
improve the neurological outcome of rodents and dampen pro-inflammatory cytokine production
following experimental brain injury (Knoblach and Faden, 1998), and many studies demonstrating
neuroprotective and anti-inflammatory properties followed in a variety of injury models (reviewed
by Garcia et al. (2017)), although no clinical studies have so far tested a beneficial effect of IL-10
administration. This is perhaps due to the fact that IL-10 is used as a prognostic marker for brain
injury, and higher levels are associated with a worse outcome, which may however stem more from
a general immune dysregulation following CNS injury rather than a neurotoxic function of IL-10
(Rodney et al., 2018).
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IL-34, the gene product of il34, is a powerful neuroprotective cytokine, conveying neuroprotection
following a β-amyloid insult both by modulating microglial activation following CSF-1 receptor
stimulation (Mizuno et al., 2011), and by direct action on neurons. There, it has been shown to
promote neuronal survival (also via CSF-1 receptor stimulation) following excitotoxicity in vivo
(Luo et al., 2013).
Another prominent cytokine featured in the RNA sequencing list of upregulated genes was il1b.
My in vivo imaging in the previous chapter (Fig. 6.9), which revealed expression of IL-1β in cells
with microglia/macrophage-like morphology, validated these RNA sequencing results. As discussed
previously, IL-1β has typically been associated with conveying neurotoxic functions following acute
CNS injuries (reviewed by (Murray et al., 2015)), although a recent study showed that IL-1β may
play different roles on endothelial cells, neurons, or glia: while deletion of neuronal or endothelial
IL-1 receptor resulted in a reduced lesion size following ischaemia, global deletion of this receptor
did in fact not cause any change in lesion size, which suggests that action of IL-1β on glia may be
neuroprotective while it may be neurotoxic via action on endothelial cells or neurons. Furthermore,
I detected upregulation il1r2, which is the gene corresponding to a decoy receptor for IL-1β.
While it is structurally similar to IL-1 receptor 1, it lacks the intracellular signalling domain, and
therefore actually dampens IL-1β signalling (Peters et al., 2013). It can also be found intracellularly
in microglia/macrophages, binding to and preventing release of pro-IL-1 (Zheng et al., 2013).
Therefore, increased transcript levels of il1r2 could prevent excessive IL-1β signalling.
IL-4 receptor α (the mammalian homologue gene product of il4r.1, which I found upregulated in my
RNA sequencing dataset) was previously reported to sway microglial activation to a neuroprotective
phenotype. IL-4 itself is thereby usually of neuronal origin, as a stress-released molecule instructing
microglia/macrophages to help: neurons in the penumbra (i.e., neurons who can potentially survive
the insult) but not in the ischemic core expressed IL-4 in a rodent stroke model (Zhao et al., 2015).
Increased neuronal IL-4 in turn leads to upregulation of the IL-4 receptor on microglia/macrophages
(Zhao et al., 2015). Cerebral ischemia in IL-4-/- mice resulted in a larger lesion area, increased
neuronal loss in the acute phase (up to 5 days post injury), and increased sensorimotor and cognitive
deficits compared to wild type animals (Liu et al., 2016); furthermore, microglia showed a more pro-
inflammatory phenotype in these animals. Cerebral infusion of recombinant IL-4 was able to rescue
behavioural deficits and macrophage polarisation in these animals. Similarly, systemic administra-
tion of IL-4 following spinal cord injury promoted cellular survival and behavioural improvements,
as well as a decrease of pro-inflammatory markers as assessed by immunohistochemistry (Lima
et al., 2017). Therefore IL-4 is thought to be a critical player in neuroprotection following CNS injury.
Another potentially neuroprotective receptor I found increased transcript levels of in response to
injury was IL-13 receptor α 1 (il13a1). IL-13, the ligand of IL-13 receptor, is a neuroprotective
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cytokine, although the exact mode of action is not known. It may act synergistically with IL-4
on neurons directly to stimulate survival (Mori et al., 2016), but can also mediate cell death of
activated microglia by induction of cyclooxygenase 2, therefore potentially exerting an indirectly
beneficial effect for neuronal survival following injury by dampening excessive inflammation (Yang
et al., 2002, 2006).
In my RNA sequencing dataset, there was upregulation of several members of the TNF receptor
superfamily (tnfrsf), including tnfrsf11a, tnfrsf9b and tnfrsf18. These can induce both pro-
(tnfrsf9b, tnfrsf18) and anti-inflammatory (tnfrsf11a) activation patterns in microglia, so it would
be interesting to further investigate whether they are co-expressed on the same cells, or distinct
subsets. Tnfrsf9b, or its mammalian homologue protein product CD137-mediated signalling on
microglia, has been shown to cause oligodendrocyte and neuronal apoptosis via downstream
release of reactive oxygen species (Abdullah, 2016; Yeo et al., 2012), potentially contributing to
a pro-inflammatory and pro-apoptotic environment following brain injuries. Similarly, the product
of the mammalian homologue of tnfrsf18, GITR (glucocorticoid-induced TNF receptor), induced
pro-inflammatory and neurotoxic microglial activation (Hwang et al., 2010), and genetic deletion
of GITR or pharmacological inhibition via a GITR-Fc-fusion protein resulted in a significant
reduction of apoptotic cell death following spinal cord injury (Nocentini et al., 2008). In contrast,
tnfrsf11a or the protein of its mammalian homologue receptor activator of NFκB (RANK), have
been associated with an anti-inflammatory role, as inhibition of RANK following experimental
ischemia in rodents resulted in an increased lesion volume (Shimamura et al., 2014), and recently a
partial agonist has been shown to be therapeutically effective in reducing lesion size by dampening
inflammation following ischemia in a pre-clinical study (Kurinami et al., 2016). This effect is in
part associated with a decreased release of pro-inflammatory cytokines upon microglia/macrophage
RANK activation (Maruyama et al., 2006).
I detected significant upregulation of several genes associated with the IL-6 pathway: il6st (gp130),
il6, and m17 (homologue of mammalian LIF). Although IL-6 can have pro- and anti-inflammatory
functions (Scheller et al., 2011), this finding was exciting as in the context of neuronal injuries,
these genes have been implicated in neuroprotection. IL-6-dependent neuroprotection is mediated
by signal transducer (gp130) activation and STAT signalling in ischaemia (Jung et al., 2011;
Loddick et al., 1998), and deficiency of IL-6 has been shown to worsen recovery from brain injury
(Ley et al., 2011), therefore release of IL-6 by microglia/macrophages could improve neuronal
survival following CNS injuries. Similarly, M17 (LIF) promoted neuronal survival following ischaemia
in rats via direct action on neurons by gp130 and downstream STAT signalling (Suzuki et al.,
2005), therefore providing a synergistic pathway to IL-6. LIF-dependent STAT3 activation has been
shown to protect photoreceptors from light damage-induced cell death (Ueki et al., 2008). LIF
also enhanced the expression of neurotrophic factors following CNS injury, and therefore increased
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corticospinal axon growth (Blesch et al., 1999) and locomotor functional recovery following spinal
cord injury (Zang and Cheema, 2003). Finally, LIF has been shown to act on neural progenitors:
in the homeostatic adult mammalian brain, it reduces neurogenesis while it expands the progenitor
pool by promoting neural stem cell renewal (Bauer and Patterson, 2006). Conversely, LIF is a
key mediator of adult neurogenesis following injury in the olfactory bulb (Bauer et al., 2003).
While there is abundant information on the role of IL-6/LIF/gp130 signalling directly in neurons,
less is known about the (autocrine) function, particularly via gp130, on microglia/macrophages,
although it has been suggested that IL-6 can induce the upregulation of SOCS3 and release of IL-
10 upon LPS stimulation while reducing IL-1β and TNFα production in vitro (Minogue et al., 2012).
Taken together, even based on only expression changes in cytokines and cytokine receptors, a
complex picture of injury-induced transcriptomic changes emerges; both pro- and anti-inflammatory
cytokines and cytokine receptors are increasingly transcribed upon injury, and a more thorough
investigation on the effects on the outcome needs to be carried out to dissect the molecular functions
of each (see Chapter 7.6.6).
7.6.4 Neurotrophic factors
In my RNA sequencing dataset, I observed significant upregulation of several genes previously
implicated in neuroprotection.
manf is the gene encoding mesencephalic astrocyte-derived neurotrophic factor, and while the
name suggests this is an astrocyte-specific factor, MANF is in fact highly evolutionarily conserved
and found in both invertebrates and vertebrates (Lindholm and Saarma, 2010). Previous research in
vitro showed that MANF is capable of rescuing neurons (Hellman et al., 2011) and neuroblastoma
cells (SHSY-5Y cells) (Sun et al., 2017a) from apoptosis. In vivo, the role of MANF as a
neuroprotective factor has primarily been studied in models of Parkinson’s disease (Voutilainen
et al., 2009), stroke (Mätlik et al., 2018; Xu et al., 2018b; Yang et al., 2014), spinal cord injury
(Gao et al., 2018), and retinal injury (Neves et al., 2016), where overexpression or administration of
recombinant MANF has been consistently found to improve neuronal survival and, where applicable,
functional recovery (Gao et al., 2018; Mätlik et al., 2018; Xu et al., 2018b). MANF is thought to
rescue from apoptosis by activation of Akt signalling (Gao et al., 2018; Xu et al., 2018b), and may
also have neuroregenerative functions by enhancing neural progenitor differentiation and migration
(Tseng et al., 2018). Interestingly, although many of the effects of MANF may be modulated
via direct action on neurons, MANF has also been shown to be a potent modulator of microglial
function. It was previously shown that MANF is upregulated in microglia following stroke and
predominantly expressed in amoeboid cells (Shen et al., 2012). It increases the phagocytic activity
of microglia (Mätlik et al., 2018), which I have shown can exert a neuroprotective function following
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brain injury (Fig. 6.16, Fig. 6.21), and promotes tissue repair following retinal injury (Neves et al.,
2016).
Heparin-binding epidermal growth factor (HB-EGF, the gene product of hbegfb) has previously been
shown to be released from microglia (Opanashuk et al., 1999) and macrophages (Edwards et al.,
2009) upon IL-4 stimulation. It may act in an autocrine manner to generate a pro-regenerative or
regulatory polarisation of macrophages (and most likely microglia as well) (Wei and Besner, 2015;
Zhao et al., 2016). Aside from its function on immune cells, HB-EGF has been reported to be a
potent neurotrophic factor in the developing CNS (Kornblum et al., 1999), and its induction in
regions of enhanced survival following cerebral ischaemia has led to the hypothesis that it could
be a neuroprotective factor following injury (Kawahara et al., 1999). HB-EGF has subsequently
been shown to directly decrease neuronal cell death following oxygen-glucose-deprivation (a model
of ischaemia) (Zhou and Besner, 2010), and kainate-induced excitotoxicity in vitro (Opanashuk
et al., 1999), potentially via activation of Akt signalling (Farkas and Krieglstein, 2002). This
neuroprotective effect was also demonstrated in vivo, whereby intravitreal injection of recombinant
HB-EGF improved retinal photoreceptor survival following light damage (Inoue et al., 2013),
although the actions in this model were likely to be more complex than a direct action on neurons
as the authors also found decreased levels of ROS compared to controls, pointing to an altered
microglial polarisation following HB-EGF treatment.
Inhibin subunit β a (inhbaa, also called activin β a) is a subunit of the neurotrophic molecule
activin. Similar to MANF and HB-EGF, activin may also exert an autocrine anti-inflammatory
function on microglia (Sugama et al., 2007). Activin exerts a neurotrophic function on hippocampal
neurons in vitro via a calcium-dependent mechanism (Iwahori et al., 1997), and exerts a powerful
neuroprotective effect following a multitude of brain insults in vivo, including models of stroke
(Buchthal et al., 2018; Wu et al., 1999) and Huntington’s disease (Hughes et al., 1999).
7.6.5 Limitations of the current dataset
One of the major limitations concerning this dataset of injury-induced genes is that I was unable
to specifically extract microglial cells using anti-4C4 cell antibody labelling as previously described
by Mazzolini et al. because the cell and subsequent RNA yields were too low to provide me
with sufficient material for bulk RNA sequencing (Fig. 7.1, Table 7.1). As microglia-specific cell
sorting was not feasible under my conditions, I had to extract both microglia and macrophages
using the mpeg1 :GFP transgenic reporter line. Although I cut the heads prior to generation of
the cell suspension to exclude mpeg1 :GFP+ cells from the trunk and rest of the body in my
RNA sequencing dataset, I still included macrophages on the skin, in the eye, and on/in the
heart with this marker (Fig. 7.2), although I sought to exclude cardiac macrophages as much
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as possible by taking care during decapitation. The ’contamination’ of RNA from non-microglial
mpeg1+ cells in the sequencing data could significantly alter the results and their interpretation.
Further experiments based on my RNA sequencing therefore require thorough controls such as
confirming expression of genes of interest in microglia using two-colour in situ hybridisation or
immunohistochemistry using the gene of interest and a microglial transcript or epitope (e.g., p2y12
or 4C4), although the distinction between microglia/macrophages may be achieved by localisation
alone as my previous data has shown (Fig. 6.3).
Following injury, microglia in the brain and macrophages on the skin are likely functionally
and transcriptionally distinct. This is emphasised by the fact that I detected microglia and
macrophages in different locations - in the brain, and on the skin, respectively; while microglia
may predominantly modulate brain repair and secondary cell death following this mechanical
injury assay, macrophages may be involved in skin wound closure and epithelial repair. There-
fore, reiterating the point above, transcripts that are upregulated in response to injury may not
be necessarily brain repair-specific, but may be macrophage-derived and involved in repair of the skin.
Making matters more complex, CNS injury has been shown to result in differential activation of
microglial subsets (Hsieh et al., 2014; Gertig and Hanisch, 2014). Recent advances in single cell
RNA sequencing (scRNA-seq) make it feasible to study such subpopulations (Papalexi and Satija,
2018), and future scRNA-seq could potentially add more depth to injury-induced transcriptional
changes in this larval zebrafish assay, i.e. which transcripts are co-expressed? Is there a subpopula-
tion of microglia that is particularly associated with neuroprotective transcripts?
For the time being, however, the dataset offers a first insight into the transcriptional changes in the
microglia/macrophage population induced by brain injury, and will provide a base for investigating
the role of microglia/macrophages in the future.
7.6.6 Future outlook
The data presented in this chapter was obtained only recently, therefore further validation of the
results is required to confirm transcriptional changes. For this purpose, we will perform qRT-PCR
from sorted mpeg1:GFP+ cells against genes of interest to confirm differential expression. For
the subsequent investigation of genes of interest, we will be able to utilise CRISPR/Cas9 to
generate crispants as described in the previous chapter (Chapter 6.7.2). While these CRISPR/Cas9
mutations will not be cell-specific or temporally controlled at this first stage of investigation, they
have the advantage of allowing us to rapidly investigate alterations in secondary cell death following
gene mutation, for example by use of the H2A:GFP transgenic line. With CRISPR/Cas9, we are
able to design and validate highly active guide RNAs, and following validation of guide efficiency
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in vivo, which takes less than a week, phenotypic data (e.g. cell death at 6 hpi) can be obtained
within one week, effectively allowing us to investigate up to 12 genes of interest within a time
as little as three months. Additionally, some of the genes and pathways presented in this section
also have known pharmacological inhibitors which we can employ in a temporally specific manner.
Therefore, this larval zebrafish model will be a powerful tool to rapidly study genes of interest from
my RNA sequencing results.
Depending on the outcome of initial studies, we can then assess the molecular mechanisms of
how certain genes convey neuroprotection - or neurotoxicity - using other transgenic lines. For
example, as this RNA sequencing experiment was carried out in microglia/macrophages, an obvious
first choice of analysis would be the mpeg1 :GFP transgenic line. Here, we can assess whether
mutation in genes affects recruitment to the injury site or phagocytosis. Furthermore, we can
investigate immune cell composition at the injury site using the mpeg :mCherry;p2y12 :P2Y12-GFP
or mpo:GFP transgenic lines: does knockout of a certain gene allow peripheral macrophages or
neutrophils to enter the brain? Additionally, we will be able to assess whether excitotoxicity will
be altered by quantifying calcium transients in the β-actin:GCaMP6f transgenic line. We are also
interested in oxidative stress, and will quantify the presence of hydrogen peroxide or nitric oxide
using fluorescent probes (Lepiller et al., 2007) or genetically encoded ratiometric (Niethammer
et al., 2009) or fluorescence resonance electron transfer (FRET) sensors (Xu et al., 2018a), and
can assess whether these are altered following genetic mutation of genes of interest.
As a reverse approach, we will be able to study overexpression of genes of interest. This can be
achieved in a cell- and temporally-specific manner by using the previously described tetON system
(Knopf et al., 2010), which allows for tissue-specific conditional gene expression in zebrafish by
crossing cell-type specific tetActivator lines with gene-specific tetResponder lines. A multitude
of tetActivator lines are available within the Edinburgh zebrafish community, and we will be able
to easily generate tetResponder lines using molecular cloning with the Tol2 system (Kwan et al.,
2007) and injection of this construct using Tol2 transposase into one cell stage zebrafish embryos.
Gene expression will then only occur in tissues of interest under control of doxycyclin. Using this
system, we will be able to assess cell-type specific overexpression of genes of interest on cell death
in the context of neuronal injury.
To summarise, the injury model decribed in this thesis in combination with CRISPR/Cas9 will provide





8.1 A simple, new zebrafish assay to investigate secondary cell
death
In this thesis, I have described my work on the establishment and characterisation of a new larval
zebrafish model of mechanical brain injury that allows for real-time in vivo visualisation of cell death
dynamics and repair mechanisms. In comparison to rodent models, where in vivo visualisation of
cell death and microglial injury reactions is much more challenging, the larval zebrafish is ideally
suited for this type of analysis.
Using a simple mechanical injury assay (Fig. 4.1, Fig. 4.2), I was able to elicit immediate cell
death, as labelled by PI staining. Employing PI but also several other markers of cell death, such
as phosphatidyl serine exposure (Fig. 4.6 A), nuclear condensation (Fig. 4.4), and Caspase-3 (Fig.
4.6 C), allowed me to observe the occurrence of cell death dynamics following injury. With the
exception of Caspase-3 activation, which I detected via immunostaining, I could assess all of the
other markers by live imaging as we had transgenic fluorescent reporter lines. For further analyses of
the effects of drugs and other manipulations, I chose to primarily focus on nuclear condensation, as
the background level of positive cells with this markers was very low and therefore provided me with
a high signal to noise ratio. This is explained by the fact that PS exposure and Caspase-3 occur
during early apoptosis (Balasubramanian and Schroit, 2003; Porter and Jänicke, 1999; Segawa
and Nagata, 2015; Wyllie, 1997), while nuclear pyknosis is a late step of apoptosis (Oberhammer
et al., 1994; Toné et al., 2007). The relatively high baseline levels of PS+ and Caspase-3+ cells are
likely the result of developmental apoptosis to control for a surplus of generated neurons (reviewed
by Dekkers et al. (2013) and Nijhawan et al. (2000)). However, these cells are generally rapidly
removed by microglia before they reach later stages of apoptosis, explaining a low baseline of
pyknotic nuclei under normal conditions.
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To my knowledge, this is the first (larval) zebrafish assay assessing neuronal cell death dynamics,
in particular whether cells die through primary or secondary cell death, following CNS injury.
Although some previous studies investigating adult zebrafish CNS trauma, either in brain stab
lesion or spinal cord transection assessed cell death, they predominantly focussed on regenerative
neurogenesis or axon regrowth, respectively (Baumgart et al., 2012; Becker et al., 1997; Kishimoto
et al., 2012; Kroehne et al., 2011; März et al., 2011). In the larval zebrafish, reports have shown
increased numbers of cell death following CNS trauma, but not addressed whether this was primary
or secondary cell death (Ohnmacht et al., 2016). Primary cell death is defined as cell death directly
related to the physical disruption of tissue and cell membranes, while secondary cell death is related
to delayed and indirect neurotoxic biochemical pathways elicited by the injury (Bayly et al., 2006;
Stoica and Faden, 2010). This distinction is important as secondary cell death can potentially be
prevented via pharmacological intervention whereas primary cell death cannot.
Here, I described that mechanical injury of the larval zebrafish induced two waves of cell death
(Fig. 4.2, Fig. 4.4). Immediately upon injury of the brain, I observed accumulation of PI+
cells at and around the injury site (Fig. 4.2). Due to the rapid appearance and large diam-
eter, PI+ were likely to have died from accidental necrosis. Starting from 1 hpi, I observed
progressive accumulation of pyknotic nuclei (Fig. 4.4), which likely corresponds to secondary
cell death. The numbers of Caspase-3+ and phosphatidylserine+ cells also peaked at 6 hpi (Fig.
4.6). In contrast to that, PI+ cells decreased rapidly between zero to one hour post injury (Fig. 4.2).
I was able to significantly decrease the number of pyknotic nuclei at 6 hpi by treatment with
NMDA receptor inhibitors (Fig. 5.10), but not the number of PI+ cells at 0 hpi, suggesting that
the occurrence of pyknotic nuclei was at least in part the result of a progressive dysfunction of the
glutamatergic system, and therefore constituted secondary cell death. An increase of glutamate
significantly increased the appearance of pyknotic nuclei (Fig. 5.11).
I also aimed to investigate the type of cell death. Zebrafish lack the main enzyme regulating
necroptosis (MLKL) (Czabotar and Murphy, 2015), therefore I mainly aimed to distinguish between
necrotic and apoptotic cell death. Caspase-3 is a key enzyme in appoptosis (Wyllie, 1997), whereas
other markers (PI uptake, exposure of phosphatidylserine, and nuclear condensation) can occur
both in necrotic or apoptotic cells (Fink and Cookson, 2005). Given the temporal and spatial
dynamics I detected these markers at, in combination with the fact that I could detect numbers of
Caspase-3+ cells significantly higher than baseline at 6 hpi but not 0 hpi (Fig. 4.6 C-D), suggested
that cells immediately following injury had died through necrosis, and cells at 6 hpi died through
apoptosis. In combination with tracing of individual neurons that were either structurally damaged
directly by mechanical injury or not (Fig. 4.7), this data showed that neurons can die through
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primary necrotic or secondary apoptotic cell death. In mammals, neurons can die both through
necrosis and apoptosis after brain injury (Stoica and Faden, 2010). My experiments show that the
same occurs in larval zebrafish in response to injury (Fig. 4.2, Fig. 4.4). However, in contrast to
mammals, where both necrotic and apoptotic persist for days to weeks following an injury (Clark
et al., 1999; Cortez et al., 1989; Sato et al., 2001; Williams et al., 2001; Zhou et al., 2012), larval
zebrafish are able to remove necrotic cells within two to four hours (Fig. 4.2), and apoptotic cells
within one day (Fig. 4.2). As clearance of debris is a crucial step for successful wound repair in the
CNS (Neumann et al., 2009), this may in part explain the enhanced reparative and regenerative
success of zebrafish following CNS injury.
Maas et al. (2017) reported a lack of success in phase III clinical trials for TBI. While a lot has been
learned about the molecular mechanisms underlying secondary cell death following experimental TBI
in rodents (Maas et al., 2017), the repeated failure of clinical trials raises the possibility that there
are additional mechanisms driving secondary cell death which are still poorly understood. Despite
advances in 2-photon imaging, in vivo timelapse imaging to investigate dynamics of cell death and
the immune system still remains difficult in rodent models. Therefore, I proposed the use of the
larval zebrafish for mechanistic investigations into secondary cell death. The strength of the larval
zebrafish lies in the ease of genetic and pharmacological inhibition in combination with real-time
in vivo imaging tools, allowing for rapid elucidation of molecular mechanisms and visualisation of
dynamic cellular processes following injury. In combination with the large number of animals that
can be processed per experiment, this renders the larval zebrafish a powerful platform to investigate
mechanisms underlying secondary cell death following brain injury in vivo.
8.2 Conserved pathophysiology between rodent TBI and ze-
brafish mechanical brain injury
An important aspect of any disease model is how well it replicates the original pathology. Glutamate
excitotoxicity is one of the main and central pathologies around TBI (Lipton and Rosenberg,
1994; Olney, 1969). Here, I show that this pathophysiological process is conserved in zebrafish.
Following injury, there is a consistent increase of calcium transients in neurons (Fig. 5.8, Fig. 5.2).
Combining in vivo calcium timelapse imaging with quantification of pyknotic nuclei in the same
animals, I found a spatial correlation between regions with high calcium transients and a high
density of pyknotic nuclei (Fig. 5.9).
Inhibition of glutamate signalling via NMDA receptor inhibitors resulted in the significant reduction
of calcium transients down to baseline levels for up to 6 hpi (Fig. 5.10). The same NMDA receptor
treatment also significantly decreased the number of pyknotic nuclei at 6 hpi (Fig. 5.10) but not
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PI+ cells at 0 hpi, therefore specifically targeting secondary cell death. Conversely, application of
L-glutamate as used by McCutcheon et al. (2016) resulted in a significant increase of pyknotic
nuclei in injured animals at 6 hpi (Fig. 5.11), but did not cause cell death in uninjured animals.
This is in contrast to what McCutcheon et al. reported, as treatment with L-glutamate caused
cell death; however, the authors exposed zebrafish larvae to glutamate for 48 h before they saw an
effect in intact animals. The relatively short exposure time to L-glutamate in my experiment (6 h)
is therefore a likely explanation for the lack of a neurotoxic effect.
Similar to secondary cell death following CNS trauma, zebrafish excitotoxicity and cell death have
been adressed in very few zebrafish studies. McCutcheon et al. (2016) developed an excitotoxic
model of brain injury by placing zebrafish larvae in a bath application of L-glutamate for 24 h.
Skaggs et al. (2014) induced an excitotoxic brain injury to mimick Huntington’s disease or stroke by
injection of quinolonic acid in the adult zebrafish brain. Sheets (2017) induced excitotoxic hair cell
loss by exposure to kainate or NMDA. While the above studies show that excitotoxicity is capable of
inducing cell death in the zebrafish, they elicit excitotoxicity by a pharmacological treatment. As far
as I know, the research carried out in my thesis is therefore first to induce and describe excitotoxicity
in zebrafish following mechanical brain injury.
8.3 Early calcium signalling: friend or foe?
In addition to sustained calcium signalling following injury, I also observed immediate calcium
waves and described the underlying signalling pathways. While an early neuronal calcium wave
was elicited by glutamate, potentially released from damaged and dying neurons, a radial glial
wave was elicited specifically by ATP. Previous research in larval zebrafish had shown that calcium
waves in the first few seconds following injury can recruit microglia to a site of brain injury (Sieger
et al., 2012). In other organisms and tissues, calcium waves have been demonstrated to aid
wound repair. Herrgen et al. (2014) show that rapid calcium waves in the Xenopus laevis optic
tectum can induce an actin-dependent expulsion of dead cells following injury to prevent further
cell death. In the larval zebrafish, fin regeneration depends on an immediate epithelial calcium
signalling (Yoo et al., 2012). In Drosophila melanogaster embryos, a rapid calcium wave indirectly
recruits immune cells by activating the NADPH oxidase DUOX and thereby establishing a H2O2
gradient which in turn attracts immune cells (Razzell et al., 2013). I did not address whether H2O2
could play a role in the recruitment of immune cells in my brain injury assay, however Sieger et al.
(2012) demonstrated that H2O2 is not required for microglial recruitment following brain injury
in the 3 dpf larval zebrafish. Therefore, based on my results and previous studies, it seems most
likely that the first microglia are recruited directly by calcium or ATP (Fig. 5.5, Sieger et al. (2012)).
Unfortunately, due to a lack of tools to inhibit calcium signalling with high temporal and spatial
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control and minimal toxic adverse effects, I was unable to further investigate the role of immediate
calcium waves following injury. It would have been particularly interesting to investigate two distinct
questions concerning early calcium signalling:
• What is the effect of early neuronal calcium waves on secondary cell death?
Justet et al. (2016) describe a calcium wave in a bovine epithelial cell culture model of scratch
injury capable of inhibiting excessive apoptosis during epithelial wound healing. These waves
were similar to what I observed following brain injury in vivo (Fig. 5.1), as they developed
within under five seconds of injury, originated from the injury site and subsequently spread
throughout the rest of the tissue in an ATP-dependent manner. In rodent models of brain
injury, neuronal calcium waves following injury are not described so far, which may however be
due to technical constraints hampering in vivo imaging within minutes following brain injury.
It would have been interesting to specifically ablate the early neuronal calcium wave following
injury while not affecting any other mode of signalling, including persistent excitotoxic calcium
activity; however, I was unable to do this as even following ventricular injection instead of bath
application, the effect of NMDA receptor inhibitors MK801+AP5 lasted for at least 60 min
(although n numbers in this experiment were small; Fig. 5.5), which was not temporally
specific enough to only ablate injury-induced neuronal calcium signalling.
• Do radial glial calcium waves affect proliferation behaviour?
Weissman et al. (2004) showed that ATP-dependent calcium waves in neural progenitors can
induce proliferation in vitro. I was therefore interested in whether the early ATP-dependent
radial glial calcium wave could also induce proliferation in progenitors. However, with the tools
at hand I was unable to do this - treatment with ATP inhibitors had an effect on recruitment
of microglia (Fig. 5.5), and these cells have have previously been shown to regulate injury-
induced proliferation in the zebrafish brain (Kyritsis et al., 2012).
8.4 A critical role for microglial phagocytosis of debris in neu-
roprotection
An important finding of my thesis is that rapid microglial phagocytosis of debris following
brain injury exerts a neuroprotective role (Fig. 6.16, Fig. 6.21). Tight coupling of apoptosis
and phagocytosis has previously been shown to be a key function of microglia in health; dis-
ruption of this coupling has been shown to occur in mouse hippocampi following excitotoxic
seizure-like lesions in vitro and in vivo (Abiega et al., 2016). This is in part attributed due to
excessive amounts of ATP, which can destroy danger signal gradients and therefore ’blind’ microglia.
My data show that rapid phagocytosis of debris is crucial for limiting secondary cell death, as the
rate of appearance of pyknotic nuclei was significantly increased by pharmacological and genetic
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inhibition of phagocytosis by targeting PS receptors (Fig. 6.16, Fig. 6.21). This result is in
line with the previous finding that microglial clearance of neuronal debris protected neurons in
microglia-neuronal co-culture (Noda et al., 2011). There is also evidence for a neuroprotective
role of microglial phagocytosis following ischaemia in vivo: Kawabori et al. (2015) show that
deletion of microglial receptor TREM2 results in an attenuation of phagocytic activity and an
exacerbation of lesion volume following ischaemic stroke. In contrast to a neuroprotective role
for microglial phagocytosis, some studies report a detrimental role: Neher et al. (2011) argue
that microglial phagocytosis can be a cause rather than consequence of cell death. Production
of peroxynitrite by activated microglia caused transient exposure of phosphatidyl serine and other
eat-me signals in microglia-neuron co-culture, resulting in phagocytosis of stressed-but-viable
neurons through activated microglia (Neher et al., 2011). Nomura et al. (2017) show that
phagocytosis of live neurons (called phagoptosis) is facilitated by microglial release of adaptor
proteins milk fat globulin-EGF factor 8 protein (MFG-E8) and galectin-3 (Gal-3) (Nomura
et al., 2017). Following microglial activation, for example by lipopolysaccharide (LPS) or
cerebral ischaemia, MFG-E8 and Gal-3 are transiently upregulated in vitro and in vivo (Neher
et al., 2013; Nomura et al., 2017), bind to stressed cells (more so than dead cells), and opsonise
them for microglial Mer tyrosine kinase (MerTK) recogition and phagocytosis (Nomura et al., 2017).
How can the contrasting findings in studies investigating the role of microglial phagocytosis be
explained? The inflammatory environment and polarisation may play a key role. Neher et al.
(2011) and Nomura et al. (2017) observed phagocytosis of live neurons by LPS-stimulated, pro-
inflammatory microglia. Conversely, TREM2 is associated with suppression of inflammation in mi-
croglia. In addition to exacerbating ischaemic tissue damage upon deletion (Kawabori et al., 2015),
TREM2 overexpression has been shown to provide neuroprotection, rescue spatial cognitive defects
in a mouse model of tau pathology, and promote an anti-inflammatory polarisation of microglia
characterised by upregulation of Arg1, IL-10, and IL-4 (Jiang et al., 2016). Interestingly, microglial
LPS stimulation has been shown to result in a downregulation of TREM2 (Owens et al., 2017).
The underlying microglial polarisation may therefore dictate whether phagocytosis is beneficial or
detrimental. In my larval zebrafish model of brain injury, I describe a net beneficial effect of mi-
croglial phagocytosis. Interestingly, in contrast to prior mammalian findings my Neher et al. (2011)
and Nomura et al. (2017), my RNA sequencing dataset reveals that the larval zebrafish does not
upregulate the homologues of alectin-3, MFG-E8 or MerTK in response to injury, suggesting that
these molecules may only play a minor role in the response to injury; conversely, the phagocytosis
receptor BAI1 encoded by the gene adgrb1b was upregulated nearly four-fold (with a FDR of 0.07).
Zebrafish lack a TREM2 homologue, therefore I could not study the contribution of this receptor to
microglial phagocytosis and secondary cell death in larval zebrafish.
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8.5 Conclusion & future outlook
With the work described in this thesis, I proposed the larval zebrafish as a new model or-
ganism to investigate secondary cell death after mechanical brain injury. I aimed to set up a
simple method for the induction mechanical brain injury, and found that I was able to elicit
both primary and secondary neuronal cell death in response to brain injury in larval zebrafish
(Fig. 4.2, Fig. 4.4, Fig. 4.7) as had previously been observed in rodent models and human
patients in response to injury. Due to the larval zebrafish’s amenity for in vivo imaging, this
allowed for imaging-based investigation of the mechanisms underlying secondary neuronal cell death.
Investigating the role of the immune system in response to injury, I have identified a neuroprotective
role for rapid microglial phagocytosis of debris; failure to engulf debris as a result of pharmacological
or genetic interference with phosphatidyl serine receptors resulted in a significantly enhanced rate
of secondary cell death (Fig. 6.16, Fig. 6.21). I have furthermore investigated changes in immune
messengers and neurotrophic factors in response to injury (Fig. 6.8), and most recently performed
an RNA sequencing experiment from sorted microglia/macrophages (Chapter 7). The results
obtained from RNA sequencing of microglia/macrophages will provide a useful starting point for
the identification of neuroprotective transcripts following validation.
With the key advantages of an amenability to in vivo timelapse imaging and readily available
fluorescent reporter lines, as well as the emergence of rapid CRISPR/Cas9-mediated genome editing
(Jao et al., 2013) and high-throughput automated screening technologies for larval zebrafish (Pardo-
Martin et al., 2010), this model will provide a powerful platform for the future investigation of cellular




Abdullah NSB, 2016. Role of CD137-CD137L interaction in microglia-mediated immune response.
Ph.D. thesis, National University of Singapore.
Abiega O, Beccari S, Diaz-Aparicio I, Nadjar A, Layé S, Leyrolle Q, Gómez-Nicola D,
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V, Turski L, and Olney JW, 1999. Blockade of NMDA receptors and apoptotic neurodegener-
ation in the developing brain. Science, 283(5398):70–4.
Ikonomidou C, Stefovska V, and Turski L, 2000. Neuronal death enhanced by N-methyl-D-
aspartate antagonists. Proceedings of the National Academy of Sciences, 97(23):12885–12890.
doi:10.1073/pnas.220412197.
Ikonomidou C and Turski L, 2002. Why did NMDA receptor antagonists fail clinical trials for
stroke and traumatic brain injury? The Lancet Neurology , 1(6):383–386. doi:10.1016/S1474-
4422(02)00164-3.
Ilie G, Boak A, Adlaf EM, Asbridge M, and Cusimano MD, 2013. Prevalence and correlates
of traumatic brain injuries among adolescents. Journal of the American Medical Association,
309(24):2550–2552. doi:10.1001/jama.2013.6750.
Inoue K, Nakajima K, Morimoto T, Kikuchi Y, Koizumi S, Illes P, and Kohsaka S, 1998. ATP
stimulation of Ca(2+)-dependent plasminogen release from cultured microglia. British Journal of
Pharmacology , 40:156–163.
Inoue Y, Tsuruma K, Nakanishi T, Oyagi A, Ohno Y, Otsuka T, Shimazawa M, and Hara
H, 2013. Role of heparin-binding epidermal growth factor-like growth factor in light-induced
photoreceptor degeneration in mouse retina. Investigative Ophthalmology and Visual Science,
54(6):3815–3829. doi:10.1167/iovs.12-11236.
189
Ishii T, Sato K, Kakumoto T, Miura S, Touhara K, Takeuchi S, and Nakata T, 2015.
Light generation of intracellular Ca2+ signals by a genetically encoded protein BACCS. Nature
Communications, 6(May):8021. doi:10.1038/ncomms9021.
Iwahori Y, Saito H, Torii K, and Nishiyama N, 1997. Activin exerts a neurotrophic effect on cul-
tured hippocampal neurons. Brain Research, 760(1-2):52–58. doi:10.1016/S0006-8993(97)00275-
8.
Izumi Y, Clifford DB, and Zorumski CF, 1992. Inhibition of long-term potentiation by NMDA-
mediated nitric oxide release. Science, 257(5074):1273–1277.
Jafari S, Etminan M, Aminzadeh F, and Samii A, 2013. Head injury and risk of Parkinson
disease: A systematic review and meta-analysis. Movement Disorders, 28(9):1222–1229. doi:
10.1002/mds.25458.
Jaffrey SR, Erdjument-Bromage H, Ferris CD, Tempst P, and Snyder SH, 2001. Protein S-
nitrosylation: a physiological signal for neuronal nitric oxide. Nature Cell Biology , 3(2):193–197.
doi:10.1038/35055104.
James G and Butt AM, 2002. P2Y and P2X purinoceptor mediated Ca2+signalling in glial cell
pathology in the central nervous system. European Journal of Pharmacology , 447(2-3):247–260.
doi:10.1016/S0014-2999(02)01756-9.
Jao LE, Wente SR, and Chen W, 2013. Efficient multiplex biallelic zebrafish genome editing using
a CRISPR nuclease system. Proceedings of the National Academy of Sciences, 110(34):13904–
13909. doi:10.1073/pnas.1308335110.
Jara JH, Singh BB, Floden AM, and Combs CK, 2007. Tumor necrosis factor alpha stimulates
NMDA receptor activity in mouse cortical neurons resulting in ERK-dependent death. Journal of
Neurochemistry , 100(5):1407–1420. doi:10.1111/j.1471-4159.2006.04330.x.
Jeong HK, Ji K, Min K, and Joe EH, 2013. Brain Inflammation and Microglia: Facts and
Misconceptions. Experimental Neurobiology , 22(2):59. doi:10.5607/en.2013.22.2.59.
Jeong HK, Ji Km, Kim B, Kim J, Jou I, and Joe Eh, 2010a. Inflammatory Responses Are Not
Sufficient to Cause Delayed Neuronal Death in ATP-Induced Acute Brain Injury. PLoS ONE ,
5(10):e13756. doi:10.1371/journal.pone.0013756.
Jeong HK, Jou I, and Joe Eh, 2010b. Systemic LPS administration induces brain inflammation but
not dopaminergic neuronal death in the substantia nigra. Experimental and Molecular Medicine,
42(12):823. doi:10.3858/emm.2010.42.12.085.
Jiang T, Zhang YD, Chen Q, Gao Q, Zhu XC, Zhou JS, Shi JQ, Lu H, Tan L, and Yu
JT, 2016. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau
transgenic mice. Neuropharmacology , 105:196–206. doi:10.1016/j.neuropharm.2016.01.028.
190
Jiang Y, Wei N, Lu T, Zhu J, Xu G, and Liu X, 2011. Intranasal brain-derived neurotrophic
factor protects brain from ischemic insult via modulating local inflammation in rats. Neuroscience,
172:398–405. doi:10.1016/j.neuroscience.2010.10.054.
Johansen T, Krabbe C, Schmidt SI, Serrano AM, and Meyer M, 2017. Comparative Analysis of
Spontaneous and Stimulus-Evoked Calcium Transients in Proliferating and Differentiating Human
Midbrain-Derived Stem Cells. Stem Cells International , 2017:1–14. doi:10.1155/2017/9605432.
Johnson WD and Griswold DP, 2017. Traumatic brain injury: a global challenge. The Lancet
Neurology , 16(12):949–950. doi:10.1016/S1474-4422(17)30362-9.
Jorge RE, Robinson RG, Moser D, Tateno A, Crespo-Facorro B, and Arndt S, 2004. Major
Depression Following Traumatic Brain Injury. Archives of General Psychiatry , 61:42–50. doi:
10.1001/archpsyc.61.1.42.ABSTRACT.
Jung JE, Kim GS, and Chan PH, 2011. Neuroprotection by interleukin-6 is mediated by signal
transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke. Stroke,
42(12):3574–9. doi:10.1161/STROKEAHA.111.626648.
Justet C, Hernandez JA, Torriglia A, and Chifflet S, 2016. Fast calcium wave inhibits ex-
cessive apoptosis during epithelial wound healing. Cell and Tissue Research, 365:343–356. doi:
10.1007/s00441-016-2388-8.
Kalkonde YV, Jawaid A, Qureshi SU, Shirani P, Wheaton M, Pinto-Patarroyo GP, and
Schulz PE, 2012. Medical and environmental risk factors associated with frontotemporal de-
mentia: A case-control study in a veteran population. Alzheimer’s & Dementia, 8(3):204–210.
doi:10.1016/j.jalz.2011.03.011.
Kamm K, VanderKolk W, Lawrence C, Jonker M, and Davis AT, 2006. The Effect of Traumatic
Brain Injury Upon the Concentration and Expression of Interleukin-1β and Interleukin-10 in the
Rat. Journal of Trauma, 60(1):152–157. doi:10.1097/01.ta.0000196345.81169.a1.
Kanemaru K, Kubota J, Sekiya H, Hirose K, Okubo Y, and Iino M, 2013. Calcium-
dependent N-cadherin up-regulation mediates reactive astrogliosis and neuroprotection after
brain injury. Proceedings of the National Academy of Sciences, 110(28):11612–11617. doi:
10.1073/pnas.1300378110.
Katayama Y, Becker DP, Tamura T, and Hovda DA, 1990. Massive increases in extracellular
potassium and the indiscriminate release of glutamate following concussive brain injury. Journal
of Neurosurgery , 73(6):889–900. doi:10.3171/jns.1990.73.6.0889.
Kawabori M, Kacimi R, Kauppinen T, Calosing C, Kim JY, Hsieh CL, Nakamura MC,
and Yenari MA, 2015. Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Deficiency
191
Attenuates Phagocytic Activities of Microglia and Exacerbates Ischemic Damage in Experimental
Stroke. Journal of Neuroscience, 35(8):3384–3396. doi:10.1523/JNEUROSCI.2620-14.2015.
Kawahara N, Mishima K, Higashiyama S, Taniguchi N, Tamura A, and Kirino T, 1999.
The Gene for Heparin-Binding Epidermal Growth Factor-Like Growth Factor is Stress-Inducible:
Its Role in Cerebral Ischemia. Journal of Cerebral Blood Flow & Metabolism, 19(3):307–320.
doi:10.1097/00004647-199903000-00009.
Kawamata T, Katayama Y, Hovda DA, Yoshino A, and Becker DP, 1992. Administration of
Excitatory Amino Acid Antagonists via Microdialysis Attenuates the Increase in Glucose Utilization
Seen following Concussive Brain Injury. Journal of Cerebral Blood Flow & Metabolism, 12(1):12–
24. doi:10.1038/jcbfm.1992.3.
Keane RW, Kraydieh S, Lotocki G, Alonso OF, Aldana P, and Dietrich WD, 2001. Apoptotic
and Antiapoptotic Mechanisms after Traumatic Brain Injury. Journal of Cerebral Blood Flow &
Metabolism, 21(10):1189–1198. doi:10.1097/00004647-200110000-00007.
Keller JN, Kindy MS, Holtsberg FW, Clair DKS, Yen Hc, Germeyer A, Steiner SM, Bruce-
keller AJ, Hutchins JB, and Mattson MP, 1998. Apoptosis and Reduces Ischemic Brain
Injury: Suppression of Peroxynitrite Production, Lipid Peroxidation, and Mitochondrial Dysfunc-
tion. Journal of Neuroscience, 18(2):687–697. doi:10.1523/JNEUROSCI.18-02-00687.1998.
Kenne E, Erlandsson A, Lindbom L, Hillered L, and Clausen F, 2012. Neutrophil depletion
reduces edema formation and tissue loss following traumatic brain injury in mice. Journal of
Neuroinflammation, 9(1):512. doi:10.1186/1742-2094-9-17.
Kielian T, Mayes P, and Kielian M, 2002. Characterization of microglial responses to Staphy-
lococcus aureus: effects on cytokine, costimulatory molecule, and Toll-like receptor expression.
Journal of Neuroimmunology , 130(1-2):86–99. doi:10.1016/S0165-5728(02)00216-3.
Kim CC, Nakamura MC, and Hsieh CL, 2016. Brain trauma elicits non-canonical macrophage
activation states. Journal of Neuroinflammation, 13(1):117. doi:10.1186/s12974-016-0581-z.
Kim DH, Sun Y, Yun S, Kim B, Hwang CN, Nelson B, and Lee SH, 2004a. Mechanical
property characterization of the zebrafish embryo chorion. In Annual International Conference of
the IEEE Engineering in Medicine and Biological Society , pages 5061–4.
Kim S, Elkon KB, and Ma X, 2004b. Transcriptional Suppression of Interleukin-12 Gene
Expression following Phagocytosis of Apoptotic Cells. Immunity , 21(5):643–653. doi:
10.1016/j.immuni.2004.09.009.
Kinoshita K, Chatzipanteli K, Vitarbo E, Truettner JS, Alonso OF, Dietrich WD, Selman
WR, Lee SM, and Kelly DF, 2002. Interleukin-1β messenger ribonucleic acid and protein levels
192
after fluid-percussion brain injury in rats: Importance of injury severity and brain temperature.
Neurosurgery , 51(1):195–203. doi:10.1097/00006123-200207000-00027.
Kishimoto N, Shimizu K, and Sawamoto K, 2012. Neuronal regeneration in a zebrafish model
of adult brain injury. Disease Models & Mechanisms, 5(2):200–209. doi:10.1242/dmm.007336.
Kizil C, Dudczig S, Kyritsis N, Machate A, Blaesche J, Kroehne V, and Brand M, 2012. The
chemokine receptor cxcr5 regulates the regenerative neurogenesis response in the adult zebrafish
brain. Neural Development, 7(1):27. doi:10.1186/1749-8104-7-27.
Klepeis VE, Cornell-Bell A, and Trinkaus-Randall V, 2001. Growth factors but not gap junctions
play a role in injury-induced Ca2+ waves in epithelial cells. Journal of Cell Science, 114(23):4185–
4195.
Knoblach SM and Faden AI, 1998. Interleukin-10 Improves Outcome and Alters Proinflamma-
tory Cytokine Expression after Experimental Traumatic Brain Injury. Experimental Neurology ,
153(1):143–151. doi:10.1006/EXNR.1998.6877.
Knoblach SM, Fan L, and Faden AI, 1999. Early neuronal expression of tumor necrosis factor-α
after experimental brain injury contributes to neurological impairment. Journal of Neuroimmunol-
ogy , 95(1-2):115–125. doi:10.1016/S0165-5728(98)00273-2.
Knoblach SM, Nikolaeva M, Huang X, Fan L, Krajewski S, Reed JC, and Faden AI, 2002.
Multiple Caspases Are Activated after Traumatic Brain Injury: Evidence for Involvement in Func-
tional Outcome. Journal of Neurotrauma, 19(10):1155–1170. doi:10.1089/08977150260337967.
Knopf F, Schnabel K, Haase C, Pfeifer K, Anastassiadis K, and Weidinger G, 2010. Dually
inducible TetON systems for tissue-specific conditional gene expression in zebrafish. Proceedings
of the National Academy of Sciences of the United States of America, 107(46):19933–8. doi:
10.1073/pnas.1007799107.
Kocher T, 1901. Hirnerschütterung, Hirndruck und chirurgische Eingriffe bei Hirnkrankheiten.
Technical report, Alfred Holder, Wien, AT.
Kohman RA and Rhodes JS, 2013. Neurogenesis, inflammation and behavior. Brain, Behavior,
and Immunity , 27(1):22–32. doi:10.1016/j.bbi.2012.09.003.
Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, Shinozaki Y, Ohsawa K, Tsuda M, Joshi
BV, Jacobson KA, Kohsaka S, and Inoue K, 2007. UDP acting at P2Y6 receptors is a
mediator of microglial phagocytosis. Nature, 446(7139):1091–1095. doi:10.1038/nature05704.
Kontos HA and Wei EP, 1986. Superoxide production in experimental brain injury. Journal of
Neurosurgery , 64(5):803–807. doi:10.3171/jns.1986.64.5.0803.
193
Kornblum HI, Zurcher SD, Werb Z, Derynck R, and Seroogy KB, 1999. Multiple trophic
actions of heparin-binding epidermal growth factor (HB-EGF) in the central nervous system.
European Journal of Neuroscience, 11(9):3236–3246. doi:10.1046/j.1460-9568.1999.00744.x.
Kotwal GJ, Sarojini H, and Chien S, 2015. Pivotal role of ATP in macrophages fast track-
ing wound repair and regeneration. Wound Repair and Regeneration, 23(5):724–727. doi:
10.1111/wrr.12323.
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mar S, Lipton SA, Malorni W, Nuñez G, Peter ME, Tschopp J, Yuan J, Piacentini M,
Zhivotovsky B, and Melino G, 2009. Classification of cell death: recommendations of the
Nomenclature Committee on Cell Death 2009. Cell Death & Differentiation, 16(1):3–11. doi:
10.1038/cdd.2008.150.
Kroner A, Greenhalgh A, Zarruk J, PassosdosSantos R, Gaestel M, and David S, 2014. TNF
and Increased Intracellular Iron Alter Macrophage Polarization to a Detrimental M1 Phenotype
in the Injured Spinal Cord. Neuron, 83(5):1098–1116. doi:10.1016/J.NEURON.2014.07.027.
Krysko O, de Ridder L, and Cornelissen M, 2004. Phosphatidylserine exposure during early
primary necrosis (oncosis) in JB6 cells as evidenced by immunogold labeling technique. Apoptosis,
9(4):495–500. doi:10.1023/B:APPT.0000031452.75162.75.
194
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Nguyen-Chi M, Laplace-Builhé B, Travnickova J, Luz-Crawford P, Tejedor G, Lutfalla G, Kissa
K, Jorgensen C, and Djouad F, 2017. TNF signaling and macrophages govern fin regeneration
in zebrafish larvae. Cell Death and Disease, 8(8):e2979. doi:10.1038/cddis.2017.374.
Nguyen-Chi M, Laplace-Builhe B, Travnickova J, Luz-Crawford P, Tejedor G, Phan QT,
Duroux-Richard I, Levraud JP, Kissa K, Lutfalla G, Jorgensen C, and Djouad F, 2015. Iden-
tification of polarized macrophage subsets in zebrafish. eLife, 4:e07288. doi:10.7554/eLife.07288.
Nicholls J and Saunders N, 1996. Regeneration of immature mammalian spinal cord after injury.
Trends in Neurosciences, 19(6):229–234.
Niethammer P, Grabher C, Look AT, and Mitchison TJ, 2009. A tissue-scale gradient of
hydrogen peroxide mediates rapid wound detection in zebrafish. Nature, 459(7249):996–9. doi:
10.1038/nature08119.
Nijhawan D, Honarpour N, and Wang X, 2000. Apoptosis in Neural Development and Disease.
Annual Review of Neuroscience, 23(1):73–87. doi:10.1146/annurev.neuro.23.1.73.
Nimmerjahn A, Kirchhoff F, and Helmchen F, 2005. Resting microglial cells are highly dynamic
surveillants of brain parenchyma in vivo. Science, 308(5726):1314–8. doi:10.1126/science.1110647.
Nocentini G, Cuzzocrea S, Genovese T, Bianchini R, Mazzon E, Ronchetti S, Esposito E,
Rosanna DP, Bramanti P, and Riccardi C, 2008. Glucocorticoid-Induced Tumor Necrosis Fac-
tor Receptor-Related (GITR)-Fc Fusion Protein Inhibits GITR Triggering and Protects from the
Inflammatory Response after Spinal Cord Injury. Molecular Pharmacology , 73(6):1610–1621. doi:
10.1124/mol.107.044354.
Noctor SC, Flint AC, Weissman TA, Dammerman RS, and Kriegstein AR, 2001. Neurons
derived from radial glial cells establish radial units in neocortex. Nature, 409(6821):714–720.
Noda M, Doi Y, Liang J, Kawanokuchi J, Sonobe Y, Takeuchi H, Mizuno T, and Suzumura A,
2011. Fractalkine Attenuates Excito-neurotoxicity via Microglial Clearance of Damaged Neurons and
Antioxidant Enzyme Heme Oxygenase-1 Expression. Journal of Biological Chemistry , 286(3):2308–
2319. doi:10.1074/jbc.M110.169839.
Nomura K, Vilalta A, Allendorf DH, Hornik TC, and Brown GC, 2017. Activated Microglia
Desialylate and Phagocytose Cells via Neuraminidase, Galectin-3, and Mer Tyrosine Kinase. Journal
of Immunology , 198(12):4792–4801. doi:10.4049/jimmunol.1502532.
206
Nonaka M, Chen XH, Pierce JE, Leoni MJ, McIntosh TK, Wolf JA, and Smith DH, 1999.
Prolonged Activation of NF-κB Following Traumatic Brain Injury in Rats. Journal of Neurotrauma,
16(11):1023–1034. doi:10.1089/neu.1999.16.1023.
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